Defining the Aetiology and Antimicrobial Susceptibility Patterns of the Predominant Bacteria Associated with Bloodstream Infections at the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam by Nguyen, Phu Huong Lan
Open Research Online
The Open University’s repository of research publications
and other research outputs
Defining the Aetiology and Antimicrobial Susceptibility
Patterns of the Predominant Bacteria Associated with
Bloodstream Infections at the Hospital for Tropical
Diseases in Ho Chi Minh City, Vietnam
Thesis
How to cite:
Nguyen, Phu Huong Lan (2018). Defining the Aetiology and Antimicrobial Susceptibility Patterns of the Predominant
Bacteria Associated with Bloodstream Infections at the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam.
PhD thesis The Open University.
For guidance on citations see FAQs.
c© 2017 The Author
Version: Version of Record
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
0 
 
DEFINING THE AETIOLOGY AND ANTIMICROBIAL 
SUSCEPTIBILITY PATTERNS OF THE PREDOMINANT 
BACTERIA ASSOCIATED WITH BLOODSTREAM 
INFECTIONS AT THE HOSPITAL FOR TROPICAL 
DISEASES IN HO CHI MINH CITY, VIETNAM   
 
 
 
by 
 
NGUYEN PHU HUONG LAN 
 
 
 
 
 
 
A thesis submitted to the Open University U.K 
For the degree of Doctor of Philosophy in the field of Life Sciences 
 
 
 
 
Oxford University Clinical Research Unit 
Hospital for Tropical Diseases 
Ho Chi Minh City, Viet Nam 
Dec, 2017 
1 
 
 
i 
 
Abstract 
Bloodstream infections (BSI) are among the most common critical diseases that require 
intensive care and continuous surveillance. According to many multinational 
antimicrobial resistance surveillance schemes, Asia represents a substantial reservoir of 
clinically relevant antimicrobial resistant genes. These genes include extended spectrum 
Beta lactamases (ESBLs) and AmpC lactamases in the Enterobacteriaceae, methicillin-
resistance genes in Staphylococcus aureus, carbapenemase-resistance genes in Gram-
negative bacilli and vancomycin-resistance genes in enterococcus. Asian countries are 
also burdened with high prevalence of HIV, in which BSI can be a major health 
problem in these immunocompromised people. Currently, there are no national data 
regarding the pathogens associated with BSI in Vietnam. Additionally, there are limited 
BSI data in specific populations, such as those infected with HIV, and there is limited 
information regarding the distribution and epidemiology of hospital-acquired and 
community-acquired infections. Data contributing to our understanding of common 
antimicrobial resistance mechanisms or profiles, including ESBLs, AmpC, KPC, and 
MRSA in BSI pathogens in Vietnam are also scarce.  
 
The aims of this study were to describe the characteristics of BSI in the Hospital for 
Tropical Diseases (HTD), a tertiary healthcare facility for infectious diseases in the 
south of Vietnam. I aimed to identify the most common BSI pathogens and their 
antimicrobial resistance profile in the context of the aetiological agent and disease 
outcome. Further, I aimed to define the specific types of ESBLs and AmpC genes 
circulating in Gram-negative bacilli isolated from BSI patients. I further describe the 
clinical and laboratory characteristics of BSI infections caused by the non-typhoidal 
Salmonella (iNTS) a particular group of BSI pathogens that are prevalent in 
immunocompromised patients. Lastly, I aimed to validate an automatic antimicrobial 
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susceptibility testing system for Salmonella isolates in comparison to manual testing 
methods. I found that BSI in HTD was characterised by a low annual blood culture 
positivity rate (7%) and a declining annual trend of mortality. A high proportion of BSI 
was from patients in the intensive care unit (33%) and the HIV ward (22%). I report an 
increased trend of multidrug-resistant Gram-negative and Gram-positive pathogens in 
both hospital-acquired and community-acquired BSI infections.  
 
I additionally report a case study for BSI due to Vibrio cholerae non-O1, non-O139 and 
the first-ever outbreak report of Brucella melitensis in Vietnam. I performed molecular 
characterisation for all Gram-negative organisms isolated over a four-year period that 
exhibited reduced susceptibility against 3rd cephalosporin. Phenotypic screening found 
304/1,017 (30%) organisms that were resistance to third generation cephalosporins; 
172/1017 (16.9%) of isolates exhibited ESBL activity, 6.2% (63/1017) had AmpC 
activity, and 0.5% (5/1017) had both ESBL and AmpC activity. E. coli and Aeromonas 
spp. were the most common organisms associated with ESBL and AmpC phenotypes, 
respectively. There was no significant difference (p>0.05) between antimicrobial 
resistance phenotypes of organisms associated with community and hospital-acquired 
infections. I retrospectively identified 102 cases of iNTS infections in HTD between 
2008 and 2013. Of 102 iNTS patients, 71% were HIV-infected, >90% were adults, 71% 
were male, and 33% reported intravenous drug use. Twenty-six/92 (28%) patients with 
a known outcome died; HIV infection was significantly associated with death 
(p=0.039). S. Enteritidis (Sequence Type (ST)11) (48%, 43/89) and S. Typhimurium 
(ST19, 34 and 1544) (26%, 23/89) were the most commonly identified serovars; S. 
Typhimurium was significantly more common in HIV-infected individuals (p=0.003). 
Through comparison of different antimicrobial testing methods for Salmonella, I 
identified a problematic agreement or errors were with quinolone antimicrobials. I 
found that the VITEK automatic antimicrobial susceptibility testing system did not 
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produce satisfactory results for the Salmonella. However, the disk-diffusion method was 
a more reliable method for testing beta-lactams, azithromycin, and trimethoprim-
sulfamethoxazole. In conclusion, BSI in HTD are characterised with an increasing trend 
of multi-drug resistant organisms that will challenge clinical and laboratory diagnostic 
as and future treatment options. 
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Chapter 1 
Literature Review 
 Bloodstream infections (BSI) 
Typically, blood is a sterile body environment, which is free from microorganisms. A 
Bloodstream infection (BSI) is defined by the presence of microorganism (bacteria or 
fungi) circulating in the blood. BSI can be classified by duration of bacteria presenting 
in the blood as transient bacteraemia (few minutes or hours), intermittent bacteraemia 
(intermittent isolation of the same bacteria from one patient) and persistent bacteraemia. 
The diagnosis of BSI is usually established by a positive blood culture taken from 
infection-suspected patients when contamination has been ruled out (Laupland et al., 
2013; Viscoli, 2016).  
 
 Laboratory-confirmed BSI (LCBI) 
For the purposes of surveillances CDC/NHSN developed criteria to identify laboratory-
confirmed BSI (LCBI) for all types of patients(NHSN, 2018). LCBI must meet at least 
one of the three criteria: a) a recognized pathogen cultured from blood which is not 
related to an infection at another site, b) the presence of one or more of the following 
signs or symptoms: fever ( >380C), chill or hypotension with a positive laboratory 
results and not related to an infection at another site, c) common commensal bacteria 
cultured from two or more blood cultures drawn on separate occasions. It is noted that 
various elements must occur within one day while considering the LCBI diagnosis. 
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 Classification of BSI 
For the purposes of clinical management and antimicrobial treatment, BSI are 
classified based on place of acquisition (Australian Infection Control Association, 
2003; Laupland and Church, 2014) and on the characteristics of the host (Laupland 
and Church, 2014; Viscoli, 2016). 
 
 Classification by place of acquisition 
If classification is made on the place of acquisition, BSI can categorized into groups as 
community-acquired BSI, Hospital-acquired BSI, or maternally-acquired BSI 
(Anderson et al., 2014; Hugonnet et al., 2004). Community-acquired BSI is defined as 
BSI occurring in an outpatient or first identified (culture drawn) <48 hours following 
admission to hospital. Hospital-acquired BSI is the BSI that is first identified (culture 
drawn) ≥48h after hospital admission and within 48 hours following hospital discharge. 
Lastly, maternally-acquired BSI is BSI that appears <48 hours after birth in an 
infant.(Australian Infection Control Association, 2003) 
 Classification by characteristics of the host 
If classification is made on the characteristics of the host, BSI is classified as in 
immunocompetent patients with intact defences, in new-borns, or elderly patients 
with impairing defences, and in immunocompromised patients with deficient 
defences (HIV-infected patients, patients on immunosuppression, cytotoxic therapy 
etc.)(Viscoli, 2016) To establish a BSI case, recent definitions combine microbiology 
results (mostly blood culture) together with the clinical signs of infection. However, it 
is not always easy to exclude contamination and the clinical signs of infection are not 
specific.  
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 The manifestations of BSI 
BSI has a variety of clinical manifestations, which can be presented in a single symptom 
like fever or a systematic severe disease like septic shock. Although some asymptomatic 
BSI cases have been documented, most BSI cases have specific signs and symptoms. In 
this case, BSI is called sepsis. 
 
  Sepsis 
 According to the Third International Consensus Definitions for Sepsis and Septic 
Shock (Sepsis-3), sepsis is defined as “life-threatening organ dysfunction caused by a 
dysregulated host response to infection” (Singer et al., 2016). In general hospital, sepsis 
can be quickly approached via a new bedside clinical quick score (qSOFA): respiratory 
rate more than 21 times per minute, altered mentation or systolic blood pressure less 
than or equals to 100 mmHg. Notably, qSOFA is a tool to assess sepsis, not septic shock 
in Sepsis-3. 
In Sepsis-3, the systemic inflammatory response syndrome (SIRS) was no longer used 
to diagnosed sepsis because its criteria were unspecified for sepsis and can result from 
other many conditions such as trauma, ischemia…However, SIRS was advised to use 
for general diagnosis of infection. Clinical SIRS is established if two or more criteria 
are met:  body temperature >38°C (100.4°F) or <36°C (96.8°F); heart rate >90 beats per 
minute; hyperventilation (respiratory rate >20 breaths per minute or arterial carbon 
dioxide tension (PaCO2) of <32 mm Hg); white blood cell count (>12,000/µL, or < 
4,000/µL, or >10% immature band forms)(Singer et al., 2016). 
 
 Septic shock 
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Septic shock is a severe and late stage of sepsis. The most recent definition was also 
established in The Sepsis-3 consensus as “Septic shock is a subset of sepsis in which 
underlying circulatory and cellular/metabolic abnormalities are profound enough to 
substantially increase mortality”(Singer et al., 2016). Patients with septic shock can be 
identified with a clinical construct of sepsis with persisting hypotension requiring 
vasopressors to maintain a mean arterial pressure ≥65 mmHg and having a serum lactate 
level >2 mmol/L (18mg/dL) despite adequate volume resuscitation.  
 
 The epidemiology of BSI 
BSI is well-known severe disease with high morbidity and mortality worldwide. It 
remained the 11th leading causes of death in 2013 - 2014 in the US (Kochanek et al., 
2016; Xu et al., 2016) and in the top seven causes of death in the US and Europe 
combined (Goto and Al-Hasan, 2013).  Identifying the importance of bloodstream 
infection, population-based studies or longitudinal respective surveillances have been 
made in many countries, but these originate mostly in Europe and North America. 
Although there are differences in methods, populations and time, data in these various 
studies showed that BSI was a heavy burden with high incidence, mortality, and fatality. 
The annual incidence of BSI ranged from 40 to 257/100,000 persons-year in population-
based studies in which incidence in most was >150/100,000 persons-year (Goto and Al-
Hasan, 2013; Laupland et al., 2013; Mehl et al., 2017; Uslan, 2007; Wisplinghoff et al., 
2004).   
 
 Geographical distribution 
1.5.1.1 America 
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In the US, despite the mortality data for notifiable diseases being reported annually, the 
most recent population-based study was conveyed in Olmsted County, Minnesota since 
2003 (Uslan, 2007). The annual incidence was 189/100,000 persons-year with mortality 
rate of 13.5%. Comparatively, in Canada, Laupland et al. conducted a population-based 
study for bloodstream infections for five years (2000-2005) in the Calgary Health 
Region; this study included community-onset BSI only. The overall annual incidence 
was 81.6/100,000 persons-year, which was lower than in the US. However, the fatality 
rate was the same as in the US at 13% (Gregson and Church, 2007). Further analysis on 
severe BSI cases was conducted in the same population in 2010-2012. The annual 
incidence of severe BSI was 15.7/100,000 people while the case-fatality was report to 
be 6.5/100,000 populations (Laupland et al., 2004). 
1.5.1.2 Europe 
Several countries in Europe have conducted population-based BSI studies; most were 
conducted before 2010. In Denmark, BSI was the seventh most common cause of death 
(Goto and Al-Hasan, 2013). A study conducted over 15-years (1992-2006) in North 
Denmark showed a remarkable increase in BSI incidence from 120 to 201/100,000 
person-year over this period. This increasing trend was observed in both community and 
hospital acquired BSI groups. In contrast, the mortality rate reduced with time, 
beginning at 22.7% during 1992-1996 to 20.6% during 2002-2006, this was mostly 
attributed to the reduction of mortality rate in community-origin BSI(Søgaard et al., 
2011). A further population based study from Funen, Denmark in 2000-2008 found a 
higher incidence rate of 215.7/100,000 persons-year, but the trend declined by 3.7% 
annually (Nielsen et al., 2014). 
 
Finland conducted a BSI study at a country level during 2004-2007 that investigated 
>30,000 BSI episodes. The annual BSI incidence was 159/100,000 person-year with a 
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significant average increase of 4.4%/year. The mortality rate was approximately 
21/100,000 persons-year which increased 4% every year (Skogberg et al., 2012). 
Comparable to Denmark, BSI was the seventh leading causes of death in Finland (Goto 
and Al-Hasan, 2013).  
 
A further population-based conducted over 12 years (2002-2013) in Mid-Norway 
investigated 1,995 episodes of BSI in adult patients. The incidence rate was as high as 
215/100,000 person-years, which was higher in male and elderly group (Mehl et al., 
2017). The overall mortality rate 32/100,000 person-years, decreasing up to 29/100,000 
person-years in the last period of the study (2008-2013). 
 
The most recent multi-centre population-based study in Europe took place in 
Switzerland from 2008 to 2014 as part of the National Surveillance for BSI. Although 
there was no information about the annual incidence, the number of BSI episodes 
increased from 5,754 to 6,694 in 2008 and 2014, respectively. The mortality rate was 
not documented in this study (Buetti et al., 2016). In order to have a broader view of 
BSI in Europe, a recent point-prevalence survey in 29 European countries showed that 
BSI was the most common healthcare-associated infection (45%) in 2011-2012 (Zingg 
et al., 2017). 
1.5.1.3 Australia 
There are no population incidence for BSI in Australia (Bloodstream et al., 2012; 
Laupland et al., 2013), there are few studies about the rate and characteristics of BSI. In 
a 350 bed-tertiary hospital in Melbourne, the number of patients with microbiologically-
confirmed BSI was >2,000 over a 9 years period (Akova, 2017). A similar study in 
Townsville hospital over a 10 year had a bacteraemia rate of 10.12 per 1,000 
admissions(Porter et al., 2013).  
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1.5.1.4 Sub-Saharan Africa 
Like Australia, there are limited data the incidence of BSI in Africa. However, many 
African countries have conducted retrospective studies about BSI which highlighted the 
importance of BSI across the continent (Moyo et al., 2010; Obeng-Nkrumah et al., 
2016; Reddy et al., 2010; Tariq, 2014). According to a systematic review of >20 studies 
about BSI during 1984-2006 in Africa, there were >58,000 patients receiving a blood 
culture request for BSI diagnosis. Among them, laboratory-confirmed BSI cases were as 
many as 5,578 cases (9.6%). A specific characteristic of BSI in Africa was that many 
patients were co-infected with malaria, HIV, or M. tuberculosis. In 16 studies with 
fatality rate data, the overall death rate was 18.1 % due to BSI, which is considerably 
higher than in patients without BSI (Reddy et al., 2010). Hospital based research from 
some African hospitals demonstrated a high prevalence of positive blood cultures. In a 
referral hospital in Ghana, the overall positive blood culture rate was 9.3% with a higher 
prevalence in the elderly (13.3%) and infants (20.9%)(Obeng-Nkrumah et al., 2016).  
 
1.5.1.5 Asia 
Unlike Europe and North America, there are little data about BSI at a population level. 
However, many countries have published data regarding notifiable issues related to BSI. 
 
Thailand 
Thailand is one of the few countries in Asia that has population-based data for BSI 
bloodstream infection. According to multicentre surveillance in northeast Thailand over 
seven years, the overall incidence rate for all types of BSI was 31/100,000 person-years, 
which increased over time. CA-BSI were as many as 73% of total cases while HA-BSI 
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were only 16%. In the CA-BSI group, highest incidence was found in infants and the 
elderly (83 and 221/100,000 person-years, respectively). Males were more likely to 
have CA-BSI than females (34 vs. 28/100,000 person-years, p<0.001)(Kanoksil et al., 
2013). The prevalence of nosocomial BSI in Thailand was approximately 6.5% in 2006. 
A report from a hospital in the country measured the prevalence of hospital bacteraemia 
as 11.6/1000 admissions in 2012. 22.5% cases developed septic shock, while the 
mortality rate was 28.3% (Chusri et al., 2012).  
 
Cambodia 
In Cambodia, BSI surveillance has been conducted for children and as adults. In the 
pediatric study, the incidence rate rose from 14/1,000 to 50/1,000 admission during 
2007-2011. Community acquired BSI was predominant (89%). The mortality rate was 
as high as 19%, particularly in neonates (Stoesser et al., 2013). Surveillance in adults 
over the same period (2007-2010) was focused on 463 laboratory-confirmed BSI cases. 
The rate of CA-BSI in adult was comparable to children (89% and 86%, respectively). 
Common underlying diseases in adults were Human Immunodeficiency Virus infection 
(HIV) and diabetes. One notable piece of data from this study was antimicrobial 
consumption prior hospitalization, which was reported in 22% cases (Vlieghe et al., 
2013). 
 
 Sex 
In most BSI studies, males have a higher incidence of BSI than female (Uslan, 2007). In 
a population based study from Olmsted County, Minnesota, USA reported that the BSI 
incidence in elderly patients was twice as high in males than women (Uslan, 2007).  
 
 Length of ICU stay and hospitalization for BSI 
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One of the major impacts of bacteraemia is the extra length of stay in the healthcare 
facility. In 1990s, Crowe and his researchers compared the length of Intensive care unit 
(ICU) stay from different illnesses. BSI patients had four-times longer stay in the ICU 
than the other illnesses (12 days vs. 3 days) (Crowe et al., 1998). In a case-control study 
from Scotland, BSI patients had higher ICU stay than a control group (17 days vs. 7.8 
days, p=0.001). Data in this study originated from an adult hospital during 2011-2013 
(Brooks et al., 2016) Another study in nine public hospitals in Queensland, Australia in 
2013 also showed a significantly longer ICU stays in patients with bacteraemia than 
those without (15.5 days vs. 4 days, p<0.001)(Barnett et al., 2013). An additional length 
of hospital stay was also found in BSI patients who were discharged alive. 
 
 Seasonal variation in BSI 
Seasons tend to affect the epidemiology of BSI. In Africa, a shift of the predominant 
pathogens associated with BSI has been observed in the sunny and rainy season. Many 
African countries such as Malawi, Egypt, Gambia have non-typhoidal Salmonella as a 
main cause of BSI in the wet season, while S. pneumoniae is the commonest cause of 
BSI in the dry season(Bell et al., 2001; Reddy et al., 2010). 
 
The incidence of E. coli BSI also exhibits seasonal variation.  In a population-based 
study from the US, the incidence rate of in BSI increased by up to 35% in the warm 
months (June -September). This study concluded that for every 5oC increased in 
temperature, incidence rate of BSI increased by 7%(Al-Hasan et al., 2009). In Israel, an 
eight-year study investigated 983 BSI cases caused by between 2001 and 2008; the rate 
of in BSI was significantly higher in summer than in the other seasons (31+/-6 days vs. 
28+/-6, 27+/-4,p<0.001, respectively)(Chazan et al., 2010).  In tropical regions, the 
prevalence of some infectious diseases increases in rainy season. One supportive 
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example is typhoid fever, a well-known bacteraemia caused by Salmonella Typhi. 
Typhoid fever is more common during periods of rainfall. A 4-year study conducted in 
Kathmandu, Nepal showed that the typhoid cases correlated with rainfall. July was the 
peak of S. Typhi as well as the peak of the wet season (Karkey et al., 2010). In Europe 
and US, there were found to be more severe sepsis cases (35% higher in the Europe and 
17% higher in the US) in cold months (fall and winter season) of the year (Mayr et al., 
2014). This may be due to increasing respiratory infection incidence in cold weather, 
which can lead to sepsis in some risk group patients. However, the season had no 
impact on the nosocomial infections. In a nationwide surveillance of nosocomial 
infection in the US, there were no changes of causative agent in BSI infection due to 
seasonal variation (Wisplinghoff et al., 2004). 
 Source of infection 
Pneumoniae is the most common source of BSI globally, both in community-acquired 
and hospital -acquired infection. In a CA-BSI study, pneumoniae was found in 15% of 
all cases which was characterized by common respiratory pathogens (Streptococcus 
pneumoniae, Staphylococcus aureus)(Timsit et al., 2014). Urinary tract infections are 
another common source of BSI. In a population-based study from Norway, the rate of 
BSI from the urinary source was 81/100,000 person-years, which was higher than from 
the respiratory tract and biliary tract (Mehl et al., 2017). In Australia, urinary infection 
was the most common primary site of BSI with the percentage of 33% in all cases over 
ten years(Lim et al., 2014). However, there were a considerable proportion of primary 
BSI cases with an unidentified source of infection. Primary BSI was as many as 53% of 
all nosocomial cases reported in a nationwide US surveillance study and 29% of all 
community -acquired BSI cases in a study from Australia ( Wisplinghoff et al., 2004; 
Lim et al., 2014;). Infection via catheter is also a common infection site for nosocomial 
BSI(Tan et al., 2007; Timsit et al., 2012). Other primary sources of BSI infection have 
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been reported as being from an abdominal origin, wound and soft tissue abscesses (Lim 
et al., 2014; Son et al., 2010). 
 
 Community- acquired infections and hospital-acquired infection 
Based on the place of acquisition, BSI can be divided into two main categories: 
community-acquired infection(CAI) and hospital-acquired infection (HAI). These 
definitions are widely used for the clinical management of BSI. There are certain groups 
of patients who are at risk of CAI or HAI and there are various bacteria causing CAI or 
HAI. Hence, clinical care and antimicrobial regime for each group are also different. 
 
The time-point 48 hours after hospitalization is used to distinguish between community 
and nosocomial infection. Community-acquired infection, or community-associated 
infection can be defined as infection origins in the community or happens in the hospital 
within 48 hours after admission. According to this definition, community-acquired BSI 
is diagnosed if at least one positive blood culture is collected during 48 hours after 
admission and excluding the contaminants. Hospital-acquired BSI (HA-BSI) can be 
determined if at least one blood culture grew with pathogenic microorganism after 48 
hours of admission(Goto and Al-Hasan, 2013; Gregson and Church, 2007; Hugonnet et 
al., 2004; Kang et al., 2012; Nagao, 2013). 
1.5.6.1 Community-acquired BSI:  
Epidemiology 
A large proportion of BSI originates from the community. The National BSI 
Surveillance programme in Switzerland from 2008-2014 found that 70% of BSI were 
CA-BSI (Buetti et al., 2016). The prevalence of CA-HAI increased from 39% to 45% 
over 7 years. In a Norway population- based study, CA-HAI incidence was much higher 
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than HA-BSI (102 vs. 30/100,000 persons-year)(Mehl et al., 2017). The rate of CA-HAI 
also increased from 36 to 40/100,000 bed-days in 12 years. Mortality rate in CA-BSI 
group was 10%, which was higher than in HA-BSI group (6%). In Denmark, 47% of all 
BSI were CA-BSI according to a population based cohort study(Søgaard et al., 2011). 
Mortality rate in CA-BSI decreased from 19% to 15.4% from 1992 to 2006. A 
multicentre study in Thailand regarding CA-BSI was conducted in 2004-2010. CA-BSI 
accounted for 73% of all BSI cases in the study time. The incidence rate for CA-BSI 
increased significantly year by year with an average of 31/100,000 persons-year. The 
mean mortality rate was 37%, which decreased over time (Kanoksil et al., 2013). 
 
Risk factors for CA-BSI  
There were certain groups of people who are at greater epidemiological risk of 
community-acquired bloodstream infection. 
 
Diabetes mellitus increases the risk of CA-BSI in severe ICU patients. An observational 
cohort study concluded that diabetes was a predictor of CA-BSI. CA-BSI and sepsis 
were found significantly higher in patients with diabetes (OR 1.42, p=0.02; OR1.26, 
p=0.02, respectively) than patients without. High HbA1C level (>6.5%) was also 
increased the risk of BSI (McKane et al., 2014). A further group of patients who were at 
risk CA BSI is those infected with HIV. In an epidemic area of HIV, community-
acquired BSI was found more frequently in HIV-infected patients than those without 
HIV. In Africa, a systematic review showed a high prevalence of community acquired 
BSI due to non-typhoidal Salmonella or fungi in HIV-infected people(Reddy et al., 
2010). In Southeast Asia, the prevalence of CA-BSI was as high as 1 in 35 HIV-patients 
enrolled in public healthcare services in Cambodia, Thailand and Vietnam. Notably, this 
study found that immunosuppression was closely linked to CA-BSI. HIV-infected 
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patients with CD4 counts <100 had high prevalence of CA-BSI while there was no CA-
BSI case in those on ART treatment(Jay K Varma et al., 2010). 
1.5.6.2 Hospital-acquired BSI 
Epidemiology 
Hospital -acquired infection, or nosocomial infection is defined as infection arising 48 
hours after admission. Therefore, hospital-acquired BSI is diagnosed if there is at least 
one blood culture taken after two days from admission grow pathogenic organism.  
Although the proportion of nosocomial BSI is often smaller than community acquired 
BSI, nosocomial BSI is healthcare burden due to its high cost, fatality and 
mortality(Kaye et al., 2014; Laupland et al., 2002; Pittet et al., 1994) . Many countries 
have large surveillances to obtain epidemiology, clinical and microbiology data about 
nosocomial BSI in a purpose to set up proper management for this disease. Nosocomial 
BSI usually is usually associated with 7%-39% of all BSI (Goto and Al-Hasan, 2013; 
Johannes and Marlborough, 2008; Uslan, 2007); therefore the rate of nosocomial BSI is 
typically lower than the rate of community-origin BSI(Buetti et al., 2016; Goto and Al-
Hasan, 2013; Kiertiburanakul et al., 2012; Mehl et al., 2017; Uslan, 2007). 
 
There is a rising trend of HA-BSI with time in many countries. In Europe, both 
population based-studies in Norway and Denmark showed an increase in HA-BSI rate 
with time. The annual incidence rate of HA-BSI increased from 36 to 40 
episodes/100,000 bed-days(Mehl et al., 2017) during 2002-2013 while the incidence 
was from 45 to 65/100,000 bed-days in Denmark during 1992-2005(Søgaard et al., 
2011). In the US, the Surveillance and Control of Pathogens of Epidemiological 
Importance (SCOPE) study reported >24,000 hospital-acquired BSI during 1995-2002 
in 42 hospitals across the country. The annual incidence of hospital-acquired BSI was 
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60/100,000 hospital admissions while the crude mortality rate was 27%(Wisplinghoff et 
al., 2004). 
 
There are some patients who are at higher risk of hospital-acquired BSI than the others. 
Some underlying diseases make the host vulnerable to HA-BSI. Common underlying 
diseases includes malignancies, neurologic disorders, cardiovascular diseases, 
gastrointestinal respiratory and renal diseases (Al-Otaibi et al., 2016; Marra et al., 2011; 
Wisplinghoff et al., 2004). According to a multicentre surveillance for nosocomial 
infection in the US, patients with malignancies accounted for 10.3% of all nosocomial 
BSI. Among them, those with neutropenia (mostly due to primary neoplastic disease) 
had a higher crude mortality rate than the others (36% vs. 31%, p=0.053)(Wisplinghoff 
et al., 2003).  
 
Potential risk factors for HA-BSI 
There are various potential risk factors for HA-BSI, which includes plastic catheters, 
ICU admission, and underlying diseases. Plastic device, such as intravenous catheters, 
are a well-known predisposing factor for HA-BSI. Although plastic devices play an 
important role in intensive care, they also act as an entry for bacteria to the blood 
circulation.  Therefore, patients who have plastic devices during hospitalization have 
high risk of nosocomial infection, including HA-BSI.  In Brazil, 70% of nosocomial 
BSI patients had a central venous catheter and 41% of them also had a urinary catheter 
(Marra et al., 2011).  In a longitudinal study in Spain, the incidence of HA-BSI due to 
central venous catheter increased from 10/100,000 to 31/100,000 patient-days during 
1992-2008 (Marcos et al., 2011). 
 
In the US, intravenous catheters have been considered as a great predisposed factor for 
HA-BSI, therefore any case with central line-related BSI should be reported(Reddy et 
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al., 2017). In 2004, the SCOPE study listed intravascular catheters (including central, 
peripheral and arterial catheters) are the most frequent predisposed factors for HA-BSI 
(Wisplinghoff et al., 2004). A multicentre study showed that nearly 80% of HA-BSI in 
elderly patients were catheter-related(Kaye et al., 2014). Another study found that 
catheter-related BSI occurred in >250,000 patients per year and the average mortality 
attributed to central-venous catheters was 20% (Guggenbichler et al., 2011). However, 
the Center for Disease Control and Department (CDC) reported that there was a recent 
decrease in central line-associated BSI to 46% in the US (Reddy et al., 2017). 
 
In France and Japan, intravascular catheters were the top cause of HA-BSI (29% and 
43%, respectively) as described in their national multicentre surveillance (Nagao, 2013; 
Timsit et al., 2012). 
In Southeast Asia, central line associate-BSI is an important cause of HA-BSI. Review 
data from 6 studies in Malaysia, Thailand and Philippines showed the pooled incidence 
density was 4.7/1000 catheter-days(Ling et al., 2015). 
 
Besides intravenous catheters, other studies showed that surgery or invasive 
interventions (hemodialysis, mechanic ventilator support) predispose patients to HA-
BSI(Arnoni et al., 2007; Gauna et al., 2013; Guggenbichler et al., 2011; Pfeiffer et al., 
2006; Prowle et al., 2011; Rello et al., 1994). Moreover, patients who are admitted to 
the intensive care unit (ICU) have a higher risk of HA-BSI. More than half of HA-BSI 
occurs in the ICUs (Marra et al., 2011; Wisplinghoff et al., 2004) with an incidence of 
5-19 /1,000 patient days(Laupland and Church, 2014; Pittet et al., 1994; Rello et al., 
1994). The crude mortality in HA-BSI patients varied from 21% to 66%(Hoenigl et al., 
2014; Prowle et al., 2011; Rello et al., 1994; Søgaard et al., 2011). Underlying diseases 
or chronic diseases can be frequently found in ICU patients who developed CA-HAI 
later(Wisplinghoff et al., 2004). Risk factors for ICU-acquired BSI were identified as 
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raised APACHE III score, renal replacement therapy, liver disease, and surgery (Prowle 
et al., 2011). Other hospital wards that have a high rate of HA-CAI are: surgical units, 
pediatric units, organ-transplant department, internal medicine, and oncology 
unit(Marra et al., 2011; Nagao, 2013; Wisplinghoff et al., 2004) 
 
 Patient groups and outcome of BSI 
1.5.7.1 Critically-ill patients 
Critically ill patients and BSI have a close relation. There is a high rate of BSI in 
patients with critical conditions such as traumatic injuries, renal failure, chronic 
pulmonary diseases, last stage of AIDS, hepatitis, organ-transplantation, and 
malignancies(Kiertiburanakul et al., 2012; Mayr et al., 2014; Wisplinghoff et al., 2003). 
These patients need intensive support such as intubation, intravenous catheter, and 
parental nutrition, which predispose them to a high risk of nosocomial infection. 
Treatment regimens require broad-spectrum antimicrobial or combination therapy 
because nosocomial pathogens are generally highly resistant to common antimicrobials.  
Moreover, bacteraemia in critical ill patients can progress to severe stages such as 
severe sepsis and septic shock. In these critical stages, the fatality rate can be 
>50%(Martin, 2012). 
1.5.7.2 HIV infected patients 
BSI is a major health problem in HIV-infected people. In areas Africa where HIV is 
epidemic, BSI is commonly associated with HIV infection. According to a systematic 
review of BSI in Africa, data generated from 17 studies showed that more patients with 
BSI in HIV groups than in non-HIV infected groups (34.5% vs. 15.2%, p<0.001)(Reddy 
et al., 2010). This review also reported the prevalence of HIV-infection was 18.5% in 
pediatric patients and 53.5% in adults who was presented with BSI on admission.  
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Most BSI in HIV infected patients is community-associated. The mortality rate in HIV 
infected patients ranges from 7%-46%, which is higher in developing countries(Huson 
et al., 2014). A common risk factor for BSI were associated with HIV infection is a CD4 
count <200 cells/mm3, antiretroviral therapy is protective (Kiertiburanakul et al., 2012; 
Moyo et al., 2010; Reddy et al., 2010; Jay K. Varma et al., 2010). 
 
Several African countries have conducted studies regarding BSI in relation to HIV 
status. All of them report a high morbidity and mortality rate due to BSI in HIV infected 
participants. A survey from Nigeria, where the HIV rate is approximately 6%, showed 
that BSI rate was 18.5% in all HIV-seropositive patients(Kolo et al., 2015). In Moshi, 
northern Tanzania, HIV-seropositive was identified in 39% of all adult patients with 
BSI. The death rate in those infected with HIV was significantly higher than in those 
without HIV infection (19.8% vs. 4.8%, p<0.001)(John A. Crump et al., 2011). In 
Nairobi, Kenya during 1988-1997, 38% of HIV infected admissions to a national 
hospital had bloodstream infection. The mortality rate of BSI in HIV infected patients in 
this hospital reduced significantly from 58% to 18.5% after a new treatment regime for 
tuberculosis infections was introduced(Arthur et al., 2001). The most recent sentinel 
surveillance of bacteraemia was done in Malawi during 1998-2016. This study marked 
the decreased incidence of bloodstream infection (327/100,000 in 1998 to 120/100,000 
in 2016; p<0.0001) in concordance with the increased enrolment on the ART program 
(2.3% in 2004 to 67% in 2014)  in this country during the investigation time (Musicha 
et al., 2017).  
 
Besides Africa, Southeast Asia is also an epidemic area for HIV-infection. Reports 
about BSI in HIV infected individuals are available from Thailand, Cambodia, and 
Vietnam. According to an international study in Southeast Asia, bacteraemia was found 
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in 1/35 out patients who were seropositive for HIV. In this patient group, the median 
CD4 count was significantly lower in HIV patients with BSI than in those without (15 
vs. 261 cells/mm3, p<0.001) (Jay K. Varma et al., 2010).  In Thailand, a retrospective 
cohort study regarding BSI in HIV patients over 5 years showed that nearly 90% of the 
BSI cases were community acquired. The predominant sex was male and the crude 
mortality was 21%(Kiertiburanakul et al., 2012).  In the US, although the prevalence of 
HIV-infected cases is lower than in Africa and Asia, the rate of severe sepsis in HIV 
people has increased overtime. Notably, most BSI cases in HIV patients in the US are 
nosocomial or healthcare associated, whereas in Asia and Africa these infections arise 
in the community(Kiertiburanakul et al., 2012; Mayr et al., 2014). 
 
CD4 counts have an inverse relationship with the prevalence of BSI in HIV patients. 
Patients with CD4 <200 cells/µl had a higher rate of BSI than those with CD4 >200 
cells/µl (Adeyemi et al., 2010; Kolo et al., 2015; Jay K. Varma et al., 2010). CD4 count 
<100 cells/µl act as a predicting factor for tuberculosis and fungal 
infection(Kiertiburanakul et al., 2012). Even on antiretroviral therapy (ART), HIV-
seropositive patients can develop BSI if CD4 is <100 cells/µl (Meynard et al., 
2003).ART is a protective factor for HIV-infected person for BSI. After the era of 
highly active antiretroviral therapy (HAART), the prevalence of BSI in HIV-infected 
patients reduced significantly globally.  A prospective case-control study showed that 
incidence of bacteraemia reduced from 11 to 8/1,000 person-years during this period 
(p<0.001)(Tumbarello et al., 2000). In another case-control study from France, rate of 
BSI fell from 10.5 to 5.5/1,000 hospitalizations before and after HAART era(Meynard 
et al., 2003). In Southeast Asia, a study about BSI in HIV-infected outpatients showed 
that no patient on ART developed BSI over the period of investigation (Jay K. Varma et 
al., 2010). 
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 Pathogens associated with BSI 
The epidemiology of pathogens causing BSI has changed with time. The main changes 
are a shift towards Gram-negative organisms and the revolution of multi-drug resistant 
organism from both a community and a hospital origin. The causative agents of BSI 
include a wide variety of bacteria and fungi, of which bacteria predominate. Of the 
bacteria, the Gram-negative bacilli are usually the main pathogens for BSI. Common 
Gram-negative bacilli that cause BSI include, Klebsiella, Salmonella, Pseudomonas, 
and Acinetobacter. Gram-positive bacteria are also important BSI pathogens. 
Streptococcus pneumoniae and Staphylococcus aureus are the two most notable 
pathogens associated with BSI in this group.  
 
If the primary infection site is from the urinary tract or intra-abdominal source, then 
Gram-negative bacilli, especially members of the Enterobacteriaceae are the main 
pathogens(Mehl et al., 2017; Timsit et al., 2014). Gram-positive organisms, such as 
Streptococcus pneumoniae are more prevalent if the source of BSI is from community-
acquired pneumoniae(Timsit et al., 2014). Some studies have shown that BSI due to 
Gram-negative bacilli is more common in females whereas Gram-positive cocci are 
more common in males(Mehl et al., 2017).  According to nosocomial BSI surveillance 
in the USA, Gram-positive organisms accounted for a largest proportion (65%), 
followed by Gram-negative organisms (25%), and then fungi (10%)(Wisplinghoff et al., 
2004) . In developed countries, the most common BSI bacteria are, Streptococcus 
pneumoniae, and Staphylococcus aureus(Buetti et al., 2016; Gregson and Church, 2007; 
Lim et al., 2014; Mehl et al., 2017). However, a few surveillance studies in pediatric or 
critically-ill patients identified Klebsiella spp. as the leading Gram-negative pathogen 
(Folgori et al., 2014; Orsini et al., 2012). 
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In hospital-acquired BSI, pathogenic agents are commonly multidrug-resistant (MDR; 
resistant to three of more groups of antimicrobials). Analyses from the EUROBAC 
study found that pathogens from HA-BSI respiratory infection were more likely to be 
MDR than organisms than other HA-BSI sources (76.3% vs. 56.7%, p<0.001). Gram-
negative organisms, mainly Acinetobacter and Klebsiella were more frequently isolated 
than the Gram-positive organism. The important Gram positive pathogen caused HA-
BSI pneumonia was methicillin-resistant Staphylococcus aureus(Timsit et al., 2014).  
 
 Gram-positive BSI pathogens 
1.6.1.1 Staphylococcus aureus 
Staphylococcus aureus is a Gram-positive cocci and is distributed widely in the 
environment. In humans, this bacterium is a common colonizer of body surfaces. S. 
aureus can cause several infections, including invasive BSI. It is typically the most 
common BSI Gram-positive pathogen (Deen et al., 2012; Myat et al., 2014; Nagao, 
2013; Reddy et al., 2010; Son et al., 2010). Moreover, S. aureus is a common Gram-
positive pathogen in HA-BSI. In Europe, annual incidence of BSI S. aureus was 
estimated to be 26/100,000 population/year with a 34% increase during 2002-
2009(Paulsen et al., 2015). Common primary infections sources include soft tissue 
infection, respiratory, arthritis, and urinary tract infections(Paulsen et al., 2015). The 
important resistant phenotype of S.aureus, methicillin resistance, has been reported 
around the globe(Kang and Song, 2013; Kim et al., 2014; Tariq, 2014). In a 
retrospective cohort study regarding nosocomial BSI in the US, S. aureus was number 
one ranked pathogen (33%) with a large proportion of methicillin-resistant S.aureus 
(MRSA)(Chen and Huang, 2014). The important source of HA-BSI due to was via 
intravenous catheter(Marcos et al., 2011; Tan et al., 2007; Timsit et al., 2012), and 
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infection with this organism was more prevalent in males than females(Buetti et al., 
2016). 
 
1.6.1.2 Streptococci 
Streptococci are a common genus of bacteria associated with BSI. Common 
Streptococcus species causing BSI are S. pneumoniae, S. pyogenes, and S. viridans 
group(Laupland et al., 2004; Mehl et al., 2017). S. pneumoniae is the most well 
described member of the Streptococcus genus and the most common BSI associated 
with pneumoniae originating in the community. Population based studies in Europe and 
north America typically report S. pneumoniae in the list of common pathogens. The 
annual incidence of BSI was reported as 12-14/100,000 population in various 
regions(Goto and Al-Hasan, 2013; Laupland et al., 2013; Mehl et al., 2017; Skogberg et 
al., 2012). The rate of BSI due to S.pneumoniae in adult patients is between 11 and 
24%(John A. Crump et al., 2011; Orsini et al., 2012; Reddy et al., 2010), which is 
generally lower than the rate of bacteraemia. 
An important pathogenic Streptococcus member associated with meningitis and 
bloodstream infection (co-infection) in East Asia is Streptococcus suis. S.suis, a 
colonizer in pigs has caused large outbreaks in human in China, Hongkong, Thailand. 
Sepsis is the second most common clinical manifestation of S.suis infection after 
meningitis according to a systematic review in 2014(Huong et al., 2014). The 
proportion of S.suis BSI was approximately 7.6% in a tertiary hospital of Vietnam(Dat 
et al., 2017). 
 
1.6.1.3 Enterococci 
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Enterococci are Gram-positive cocci, which previously belonged to Streptococcus 
group D. The incidence of BSI enterococcus was usually at 48/100,000 in the US 
(Wisplinghoff et al., 2004).  The most common clinically relevant Enterococcus species 
are Enterococcus faecalis and Enterococcus faecium(Billington et al., 2014; Zheng et 
al., 2017). BSI associated Enterococcus are usually hospital-acquired. In recent years, 
trend of nosocomial bacteraemia Enterococcus has risen in many countries, infection 
with this organism is associated with mortality a rate of 16%-29.5%(Billington et al., 
2014; Gudiol et al., 2013; Hoenigl et al., 2014; Nagao, 2013; Suppli et al., 2011). Risk 
factors associated with BSI Enterococcus include ICU admission, urinary tract 
infections, abdominal infections and malignancies(Henning et al., 1996; Kara et al., 
2015; Nagao, 2013; Wisplinghoff et al., 2003). A big concern in Enterococcus is the 
ability of the organism to develop vancomycin resistance. Since the first description of 
vancomycin-resistant Enterococcus (VRE) in 1991, VRE has been reported as 
colonising organism and a pathogen internationally(Billington et al., 2014; Henning et 
al., 1996; Kara et al., 2015; Wisplinghoff et al., 2004). VRE is associated with treatment 
failure, hence leading to more death cases(Gudiol et al., 2013; Henning et al., 1996); the 
Enterococci species most commonly associated with vancomycin resistance is 
Enterococcus faecium(Gudiol et al., 2013; Wisplinghoff et al., 2004). 
 
 Gram-negative BSI pathogens 
1.6.2.1 Salmonella 
Salmonella are gram- negative bacilli that belong to the family Enterobacteriaceae.  
Salmonella are facultative anaerobes, motile by flagella, and non-spore forming. 
Salmonella are ubiquitous, and can be commonly found in soil, water and vegetation. 
Salmonella can also form part the normal gut microbiota in humans and animals 
(Giannella, 1996). 
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According to the CDC, Salmonella is divided into two main species: Salmonella 
bongori and Salmonella enterica. The later is composed of six subgroups (subspecies): 
enterica (I), salamae (II), arizonae (IIIa), diarizonae (IIIb), houtenae (IV), and indica 
(VI). Salmonella bongori itself is considered as subspecies (V)(Center for Disease 
Control, 2011) . 
 
These subspecies are classified according to serology by Kauffman-White classification 
(JCICSP 2005)(Center for Disease Control, 2011). In this classification, each serotype 
is considered a unique species that results in 2,463 serotypes (or subspecies). The order 
of division is first by the somatic O antigen, then by flagella H antigens. In this CDC 
system, 59% of the described 2,463 Salmonella serotypes belong to S. enterica subsp. I, 
all human Salmonella pathogens are all in these groups.  Non-typhoidal Salmonella 
(NTS) belong to the species Salmonella enterica and are referred to as ‘non-typhoidal’ 
to distinguish them from Salmonella Typhi and Salmonella Paratyphi (A, B and C), 
which cause enteric fever. Among these, Salmonella enteritidis serogroup D and 
Salmonella Typhimurium serogroup B are the two most common serotypes causing 
NTS infections worldwide(Centers for Disease Control and Prevention, 2014; Fields, 
2006). People get infected with Salmonella via faecal-oral transmission. The modes of 
transmission are consumption of food of animal origin (eggs, poultry, undercooked 
meat and dairy products), fresh products that have been contaminated with animal 
waste, consumption of contaminated water, or direct contact with infective humans or 
animals(McDermott et al., 2011).  
 
Infection with Salmonella has many clinical manifestations. However, there are five 
main types: typhoid fever (enteric fever), gastroenteritis, bacteraemia, suppurative 
infection and asymptomatic carrier state. Briefly, during typhoid fever, when S. Typhi 
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or S. Paratyphi are consumed and enters the digestive system of the host, the bacteria 
are engulfed by the phagocytic cells(Velge et al., 2012). These cells then deliver and 
present the bacteria to the macrophages in the distal ileum. The bacteria travel within 
the macrophages to series of lymph nodes and the reticuloendothelial tissues of the 
liver, spleen, and bone marrow. After reaching these sites, the bacteria multiply and 
pass into the bloodstream. Untreated cases can suffer from the disease for month and are 
at risk of severe complication such as intestinal haemorrhage or perforation (Biggs et 
al., 2014; Crump et al., 2015, 2004). 
 
Typhoid is a common disease; there are an estimated 22 million cases of typhoid fever 
annually globally with 200,000 deaths(McDermott et al., 2011).  According to a global 
analysis in 2008, the highest incidence of typhoid (>100 cases per 100,000 population 
annually) is in South Central Asia, Southeast Asia, and Southern Africa (Kothari et al., 
2008). Vietnam has a medium incidence of typhoid fever and was estimated to be 
23.2/100,000 per year from 1991 to 2011. Data from Ho Chi Minh City (HCMC) found 
that S. Typhi was the dominant pathogen in bloodstream infection until 2002. Since 
then, the number of infection has been declined steadily at a rate of approximately 30% 
per year(Nga et al., 2012). 
 
Infection with NTS has four main presentations, a self-limiting gastroenteritis disease, 
septicaemia (the most frequent type of invasive NTS infection), suppurative infection 
and asymptomatic carriage(de Jong et al., 2012; Morpeth et al., 2009). The World 
Health Organization (WHO) reported that 93.8 million cases of enteric infection every 
year in the world with 155,000 fatalities annually (Ao et al., 2015). It is estimated that 
2.1 to 6.5 million cases of invasive NTS (iNTS) annually, with the large proportion of 
cases is in Africa. Bloodstream infection, a common iNTS is often found in certain 
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high-risk groups such as immuno-compromised individuals, HIV patients, malaria 
association and malnutrition.  
 
Enteric infections caused by NTS have similar clinical manifestations to those induced 
by other enteric bacteria, and can rarely be distinguished by clinical presentation. NTS-
associated gastroenteritis is characterised by abdominal pain, fever, watery diarrhoea, 
and occasionally mucoid or bloody diarrhoea. Vomiting and/or nausea occur frequently 
but are not severe or protracted. The disease is usually self-limiting but can be more 
severe in the very young and elderly or immunocompromised, with a typical duration of 
illness of 4 to7 days(Gordon, 2011).  In severe illnesses, antimicrobials should be 
prescribed. There is no effective vaccine against NTS; hence, disease prevention and 
control programs mostly rely on improving personal hygiene and sanitation with 
particular attention paid to food safety. 
 
There are very few studies regarding invasive NTS infection in Asia, therefore data 
describing the clinical symptoms of this disease mostly originates from Africa. The 
common presentation is general bacteraemia, with high fever and splenomegaly. 
Meningitis is not as common as sepsis but NTS had been reported as a second most 
cause in bacterial meningitis in Malawi. The fatality rate in NTS meningitis is very high 
in both children and adults(Crump et al., 2015; Feasey et al., 2012).  
 
The epidemiology of invasive NTS is highly geographical and common in parts of sub-
Saharan Africa. A systematic literature review in 2015 estimated that approximately 3.4 
million cases of iNTS with more than 600,000 deaths annually in the world, with the 
highest incidence in African countries (227/100,000 population). (Ao et al., 2015; 
Crump and Heyderman, 2015).  Over the past 10-15 years invasive NTS has come to 
forefront of Salmonella research, lead mainly by groups in Kenya, Malawi, and 
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Tanzania (Arthur et al., 2001; John A. Crump et al., 2011; Melita A. Gordon et al., 
2002). It appears that invasive NTS disease is associated with a regional epidemic in 
sub-Saharan Africa and is associated y with HIV and Malaria. The disease appears to 
affect malnourished or malaria associated children, and can have a mortality rate as high 
as 40% in some locations(Gordon, 2011).  Additionally, a systematic review on blood 
culture positive patients in Africa showed that NTS accounted for 17% of 5,578 positive 
blood samples and was associated with HIV infection; S. Typhi were isolated at a lower 
rate (9.9%) and mostly in non-HIV infected individuals.  S. Typhimurium and S. 
Enteritidis are the two most common serovars associated with invasive NTS disease 
(Gordon, 2011).  Recently, a multidrug-resistant strain, S.Typhimurium ST313, has 
been identified as the predominant strain of iNTS in Africa which contributed on the 
burden of disease in this region(Crump and Heyderman, 2015).  
 
The limited data available on invasive NTS diseases in Asia originates from a multi-
centre study conducted in people aged 2-15 years, which found that NTS accounted for 
<1% (only 6 cases/ 20,537 total blood samples) of all the pathogens associated with 
febrile disease (Khan et al., 2010). This study did not collect data on HIV or malaria co-
infection but the incidence of the two diseases is not as high as in parts of sub-Saharan 
Africa.  
 
1.6.2.2 E. coli 
In most population-based studies, E. coli has been found to be the predominant 
pathogen in BSI(Buetti et al., 2016; Lim et al., 2014; Son et al., 2010).  E. coli is a 
common pathogen for both CA-BSI and HA-BSI, especially in elderly patients(Yahav 
et al., 2016). The proportion of BSI due to E. coli varies from 28% -59.4% in all agents 
of BSI(Buetti et al., 2016; Lim et al., 2014; Son et al., 2010). Longitudinal studies have 
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generally shown that the trend of E. coli BSI increases overtime with more and more 
MDR organisms isolated (Datta et al., 2012; Lim et al., 2014). European longitudinal 
studies demonstrated that BSI caused by E. coli were found more commonly in females 
than males (Norway: 93 vs. 56/100,000 person-years, Switzerland 36% vs. 23%; 
p<0.001) (Buetti et al., 2016; Mehl et al., 2017).  E. coli was also more prevalent in 
people over 65 years old(Buetti et al., 2016). Season also appears to have some 
influence on the incidence of E. coli BSI. A ten-year study of seasonal variation in the 
US concluded that the incidence of E. coli BSI increased in the warmer seasons. With 
every 5.5oC increased, the bloodstream incidence of E. coli increased >7% 
(p=0.004)(Al-Hasan et al., 2009). 
 
1.6.2.3 Klebsiella 
In many BSI studies, Klebsiella pneumoniae is the second most commonly isolated 
pathogen after E. coli(Kang et al., 2005; Koupetori et al., 2014; Son et al., 2010; 
Vlieghe et al., 2013) . K. pneumoniae is often characterized by the ability of broad-
spectrum resistance to antimicrobials, producing not only extended-spectrum beta 
lactamases (ESBL) but also carbapenemases(Orsini et al., 2012; Tan et al., 2007). 
Highly-resistant K.pneumoniae are most commonly isolated from the hospital, 
especially ICU settings(Arnoni et al., 2007; Marra et al., 2011; Orsini et al., 2012; Tan 
et al., 2007). In a recent study, ESBL-producing K. pneumoniae was also associated 
with community-acquired infection.(Lee et al., 2011) 
 
1.6.2.4 Other significant Gram-negative pathogens 
Acinetobacter baumannii and Pseudomonas aeruginosa are both important Gram-
negative nosocomial pathogens. While and Klebsiella spp. are associated with both 
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community and hospital-acquired infections, A. baumannii and P. aeruginosa are more 
commonly associated with hospital-acquired infection(Wisplinghoff et al., 2004). They 
are characterized with causing severe nosocomial infections and are commonly have an 
MDR phenotype (Al-Mously, 2013; Mudau et al., 2013; Wisplinghoff et al., 2000; 
Zavascki et al., 2010). Acinetobacter species are Gram-negative coccobacilli, which are 
widely distributed in soil, water, and able to colonise in hospital environment or plastic. 
In human, they are able to colonize the external and internal surfaces of healthy people 
and patients(Thom et al., 2010). This pathogen also has the ability to acquire 
antimicrobial resistant genes making it resistant to many broad-spectrum 
antimicrobials(Zavascki et al., 2010). Pseudomonas aeruginosa is an aerobic Gram-
negative bacillus, which is well known for causing infection in burn, ventilator-
associated pneumoniae, urinary tract infection, skin and soft tissue infection and 
neutropenic sepsis(Micek et al., 2005; Mudau et al., 2013; Wisplinghoff et al., 2004). Its 
specific characteristics are an ability to cause a severe systemic infection and a 
propensity to develop MDR (Arnoni et al., 2007; Zavascki et al., 2010). 
 
 Contamination 
During the process of blood culturing, environment bacteria can access the blood 
sample and yield positive result after incubation. This contamination can lead to 
unnecessary antimicrobial treatment or further laboratory analysis for repeat testing. 
The general rate of blood culture contamination is expected to be <3% (Bentley et al., 
2016; Clinical and Laboratory Standards Institute, 2007), recent studies have reported 
contamination rates within the range of 4%-14%(Bentley et al., 2016; Obeng-Nkrumah 
et al., 2016; Self et al., 2013; Vlieghe et al., 2013). Factors associated with 
contamination include critical illness, heavy workload in a healthcare setting, blood 
collection via intravenous catheter (Chang et al., 2015; Lloyd Towns et al., 2010). 
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Blood culture contamination is defined if one blood culture bottle yielding a possible 
contaminating bacteria, which includes coagulase negative Staphylococcus, 
Corynebacterium spp., Bacillus spp., Diphtheroid spp., Micrococcus spp., 
Propionibacterium spp., and Streptococcus viridans group(Gregson and Church, 2007; 
Kanoksil et al., 2013; Kiertiburanakul et al., 2012). However, a large investigation of 
blood culture contamination found that some bacteraemia associated pathogens such as 
and Staphylococcus aureus can be contaminants(Chang et al., 2015). If a set of two 
bottles are collected simultaneously, it is possible to rule out the contamination based on 
Clinical Laboratory Standard Institute (CLSI) blood culture guidelines(Clinical and 
Laboratory Standards Institute, 2007). However, in case only one blood culture is taken, 
discussion between microbiology laboratory and clinicians is required to assess a 
plausible association.  
 
 Laboratory diagnosis of BSI 
 Blood culture 
According to the CLSI, a blood culture is a laboratory test to detect the presence or 
bacteria or fungi in the blood by using a nutrient media(Clinical and Laboratory 
Standards Institute, 2007). Therefore, a blood culture is an obligate laboratory test to 
diagnose a BSI. The aim of the test is to grow and identify bacteria present in the 
patient’s blood. Moreover, the isolated bacteria can be tested for using antibiotic 
susceptibility, which helps select an appropriate antimicrobial regime for treatment.  
 
To remove the colonizing skin bacteria and prevent commensal organism from 
contaminating the blood culture skin antisepsis is performed before a blood sample is 
taken. It is an essential first step for the blood culture technique. Common skin 
antiseptic substances include alcohol, povidone-iodine, and chlorhexidine. Alcohol or 
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alcohol in combination with other antisepsis has been found to be most effective 
disinfectants with the lowest contamination rate(Caldeira et al., 2011; Calfee and Farr, 
2002; Kiyoyama et al., 2009).  
 
According to CLSI guidelines for the management of severe sepsis and septic shock, at 
least a set of one aerobic culture and one anaerobic culture should be taken for culturing 
(Clinical and Laboratory Standards Institute, 2007; P. Dellinger et al., 2013; Towns et 
al., 2010). However, some studies showed that the positivity rate was approximately 80-
93% of BSI cases if a set was used. There have been suggestion to take more (up to 
four) consequence sets of blood cultures for optimal pathogen discovery (Cockerill et 
al., 2004; Kirn and Weinstein, 2013; Lee et al., 2007). Instruction for infective 
endocarditis should include three sets of blood culture within one hour(Clinical and 
Laboratory Standards Institute, 2007; Cockerill et al., 2004). In case only one blood vial 
is taken, aerobic culture is advised. The number of blood samples does directly affect 
the recovery rate of pathogen. Many studies showed that the more samples collected, 
the higher chance to isolate the causative pathogen (Kirn and Weinstein, 2013; Lee et 
al., 2007; Weinstein et al., 1994). 
 
In adults, the number of organisms circulating in the blood is typically <1 CFU/ml. 
Therefore, the possibility of yielding blood culture is strongly associated with the 
amount of blood volume inoculated into a culture bottle (Weinstein, 1996). A standard 
amount of blood is 10ml inoculated into a culture bottle(P. Dellinger et al., 2013). An 
adequate blood volume collection plus 2 sets of cultures improved the pathogen 
discovery rate to up to 90-95% of bacteremias(Towns et al., 2010).  In paediatrics, there 
is higher concentration of pathogen organisms in the children’s blood than in adults, 
therefore an adequate volume is 1-5ml of blood depending on body weight and age(Kirn 
and Weinstein, 2013; Weinstein, 1996).  
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There are two common types of blood culture systems: a traditional manual system and 
a modern automatic system. The traditional manual blood culture system uses a broth-
based approach (agar broth biphasic blood culture) in which blood is infused with the 
broth bottle before incubation. Daily macroscopic examination is required to observe 
the signs of organism growth such as turbidity, colony, and haemolysis. The organisms 
are then subcultured onto agar plates for further testing. All broth bottles without 
obvious signs of bacterial growth sign are required to be subcultured after 7-10 days 
incubation(Doern, 1994; William Dreyer, 2012). The conventional blood culture 
technique has some disadvantages including, false positives and false negatives, limited 
ability to grow anaerobes and fastidious bacteria, and more labour (William Dreyer, 
2012). Manual culture is however low cost and suitable and easy to run and justify in 
smaller laboratories. 
 
Overcoming many of the weaknesses of conventional blood culture system, automated 
blood culture systems have been developed and rapidly applied in clinical laboratories 
from the 1970s. The automated blood culture system is considered to have had a major 
impact in the field of clinical microbiology. The principle of an automated blood culture 
system is the indirect detection of organism’s presence based on the concentration of 
CO2 level. In general, if an organism is replicating in the culture media it will utilize the 
available carbon source and release CO2. Recent commercial automated blood culture 
such as BACTEC, BacAlert, or VersaTrek have used this principle to develop their own 
bacterial detection systems(Clinical and Laboratory Standards Institute, 2007; Cockerill 
et al., 2004; Dilnessa et al., 2016; Gebert et al., 2008). If the concentration of CO2 
reaches the detection limit, the machine alerts the operator and the bottle requires 
subculture, further identification, and antimicrobial susceptibility testing. All the bottles 
require incubation for a minimum duration of 5 days, and then discharge as negative 
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results. In some circumstances, blood culture can be incubated for a longer periods to 
identify slow-growing organisms such as HACEK group, Brucella, or fungi(Kirn and 
Weinstein, 2013; Weinstein, 1996).  However, there are some undeniable issues about 
automatic systems such as cost, power requirement, and maintenance.(Gebert et al., 
2008; Lloyd Towns et al., 2010; William Dreyer, 2012) 
 
Several variables can impact on the ability to isolate organisms from a blood culture. 
Prior antimicrobial consumption is a major inhibitor of the growth of bacteria in blood 
culture. Therefore, the addition of substances that neutralise antimicrobials is essential 
for enhancing bacterial growth. The most popular antimicrobial removal agent is resin, 
which was firstly introduced into the BACTEC system blood culture bottle (Becton 
Dickinson). Resin-containing media have been proven to eliminate most common 
antimicrobials such as: cephalosporins, carbapenems, fluoroquinolones, 
aminoglycosides, and vancomycin.(Crepin et al., 1993; Rohner et al., 1997) A 
comparison between resin-containing media and non-resin-containing media showed 
that higher recovery rate was found in resin-containing media.(Cockerill et al., 1997) 
Guidelines recommend the use of resin-containing bottles in sepsis management(Towns 
et al., 2010). 
 
Whenever an incubated blood culture has positive signal, it needs to be removed from 
the incubator for further testing. A certain amount from the blood culture is withdrawn 
for direct Gram staining. The primary morphology of bacteria on Gram stain is an 
important indicator that helps guide antimicrobial treatment. The type of media for 
isolation will be selected depending on the characteristics of the organism on staining. 
Typically, blood agar, chocolate, agar and MacConkey agar are suitable for most 
bacteria; Sabouraud agar is used for fungal growth. Routinely, subculture media will be 
incubated at 37oC for up to 5 days with everyday examination. 
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 Identification of BSI bacteria 
1.8.2.1 Biochemical tests 
Bacteria have different metabolic profile, which can be used to differentiate organisms 
from the other bacteria. Therefore, a series of biochemical test have been used to 
identify specific metabolic products. Table 1 shows common biochemical tests in 
clinical microbiology laboratories(Giannella, 1996; Koneman Elmer, 1992; Macffaddin 
F. Jean, 1976; Patricia Clarke and S.T. Cowan, 1952): 
 
However, bacteria in a same species (e.g. Enterobacter, Pseudomonas, Streptococcus) 
may share many similar biochemical reactions. Hence, the more biochemical reactions 
performed, the more precise the identification. Before the availability of API strip 
testing, clinical laboratories used a limited number of manual biochemical tests for 
bacterial identification, hence limited the accuracy of identification. Currently, modern 
identification systems (API, VITEK system, and MALDI- TOF) are available and have 
made a great impact on clinical microbiology.
 34 
Table 1. 1 Common biochemical tests for bacteria identification 
Name of test Purpose Common application 
Catalase Detect the ability to catalyse the release 
of oxygen from H2O2 
Differentiate between Staphylococci (catalase 
positive) and Streptococci (catalase negative) 
Coagulase Detect the coagulase enzyme that 
converts fibrinogen (soluble) in plasma to 
fibrin (insoluble). 
Differentiate between (coagulase positive) 
and other Staphylococci (coagulase negative) 
Bile solubility Lyses bacteria cells in the presence of bile Differentiate between (possible soluble) and 
other Streptococci (non-soluble). 
Oxidase Detect the ability to produce cytochrome 
oxidase 
 
Supportive identification of Pseudomonads, 
Neisseria, Moraxella, Pasteurella sp.  
Carbohydrate 
fermentation 
Detect acid products from the fermenting 
specific carbohydrate (glucose, lactose, 
sucrose…). Changing colour of pH 
indicator indicates the acid production. 
Differentiate among bacterial groups (Exp: 
Most Enterobacteriaceae members are 
glucose fermenter). 
Urease Detect urease enzyme that hydrolyses 
urea to ammonia and carbon dioxide  
Supportive identification of Proteus species, 
Morganella species, Providencia species 
Citrate Detect the ability to use citrate as a source 
of nitrogen, which breaks down citrate to 
oxaloacetate and acetate. 
Differentiate between Enterobacteriaceae 
members (Exp: Salmonella has citrate test 
positive, has citrate test negative) 
Indole Detect the ability to produce indole by 
deamination of tryptophan 
Differentiate between Enterobacteriaceae 
members (Exp: E.coli has indole test positive, 
Klebsiella pneumoniae has indole test 
negative) 
Methyl red Detect the ability to use glucose and 
convert it to stable acids (acid lactic..) 
Differentiate between Enterobacteriaceae 
members (Exp: E.coli has methyl red test 
positive, Klebsiella pneumoniae has methyl 
red test negative) 
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1.8.2.2 Matrix assisted laser absorption ionization-time of flight mass spectrometry 
(MALDI-TOF MS) 
MALDI-TOF MS is a major advance for clinical microbiology for fast and accurate 
organism identification. The principle of MALDI-TOF MS is that bacterial cells are 
fragmented and the components are accelerated in in an electric field, then quantified 
according to their mass-to-charge value and analysed by a mass spectrometer. Every 
bacterial genus/species has a distinctive spectra which can be compared with a database 
software so that the organism with the nearest spectra can be identified(Murray, 2012; 
N. Singhal et al., 2015). An important application of MALDI-TOF is the possibility to 
identify bacteria directly from the alerted blood culture samples. Therefore, a confirmed 
identification is generated within an hour instead of waiting 18-24 hours for the growth 
of colonies. However, the identification process directly on blood cultures requires more 
steps and reagents than on the colonies(Murray, 2012). Advantages of MALDI 
techniques are simplicity, rapid, high accuracy, and low sample volume requirement, 
also cheap to run, which overcomes all the disadvantages of biochemical identification 
tests(Pavlovic et al., 2013). However, MALDI-TOF MS is unable to give identification 
if the bacterial spectrum is not yet in the database and cannot identify between very 
closely related organisms such as E. coli and Shigella. 
 
1.8.2.3 Molecular identification 
Besides MALDI-TOF, molecular- based assays are a promising tool to diagnose rapidly 
and precisely the cause of BSI. In recent years, many studies have emphasized the 
usefulness of PCR in for identifying pathogens associated with BSI. Molecular 
identification from culture has proven its value for detecting most pathogens, even rare 
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organism. The most common target gene is the 16S rRNA gene, which is present in all 
bacteria, and possesses a conserved specific genetic section.  This target gene is 
sequenced and compared with the gene reference database libraries (MicroSeq, 
Genbank, Ribosomal Database Project). Acceptable identity score is equal or more than 
97% for the bacterial genus and 99% for the species. However, if the group of bacteria 
share >99% identical 16S rRNA sequence, they are unable to be differentiated by this 
method.   
 
Another application of 16S rRNA sequencing on direct blood is for rapid detection of 
pathogen within hours. Based on this technique, commercial test kits have been 
developed. SeptiFast (Roche) is multiplex PCR targeting the ribosomal gene, and has 
the ability detect 20 common pathogens causing BSI. The performance of the SeptiFast 
test has been evaluated with high sensitivity and specificity with a turnaround time of 4-
6 hours (Dark et al., 2011; Rutanga and Nyirahabimana, 2016). Another commercial 
test kit, IRIDICA (Abbot), which can detect bacteria, fungi, and some antimicrobial 
resistant genes, had an overall agreement of up to 70% with blood culture. The 
IRIDICA test discovered more bacteria and fungi than blood culture. Moreover, the 
blood volume required for PCR is six times smaller than that for the blood culture 
techniques (5 ml vs. 30 ml) and the time to result was also shorter (Jordana-Lluch et al., 
2015). A systematic review about the clinical impact of PCR for BSI showed that all 
PCR assays delivered rapid result less than 6 hours which is very crucial for sepsis 
management.  
 
1.8.2.4 Genotypic bacterial typing methods  
Genotypic typing (genotyping) is a process to determine the genetic variant (specific 
alleles or single nucleotide polymorphisms) of an individual bacterium by polymerase 
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chain reaction (PCR) amplification and sequencing. The main purpose of genotyping is 
epidemiological surveillance(Tümmler, 2014). 
 
There are several methods for bacterial genotyping, but pulsed-field gel electrophoresis 
(PFGE) and Multilocus Sequence Typing (MLST) are the most commonly 
used(Tümmler, 2014). PFGE is a laboratory technique that allows different sizes of 
DNA fragments from 10kb to 10Mb to be separated by using electrophoresis. Although 
PFGE is expensive and laborious, it is still the gold standard typing method for 
investigation of bacterial pathogen and outbreaks in many public health laboratories 
(Herschleb et al., 2007; Peacock et al., 2002). 
 
MLST is a technique that sequences fragments of housekeeping genes (typically 7) to 
identify genetic variation with an individual isolate from a known bacterial species. The 
purpose to identify distinct allelic profiles (sequence type (ST)) in the housekeeping 
genes(Ibarz Pavón et al., 2009; Tümmler, 2014). The sequence data library for MLST 
(MLST databases: http://www.mlst.net/databases/) are available online for comparison 
and surveillance. The MLST technique is highly reproducible between laboratories, can 
be performed on living or dead cells, or even of clinical specimen (e.g. blood, 
cerebrospinal fluid)(Ibarz Pavón et al., 2009). Due to its high value in epidemiology 
surveillance, MLST has been applied to study several bacterial epidemics such as 
meningococcal disease, outbreaks of typhoid, MRSA, and MDR Pseudomonas 
aeruginosa.(Baker et al., 2011; Brehony et al., 2007; Faria et al., 2008; Mudau et al., 
2013) 
 
1.8.2.5 Whole genome sequencing 
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Whilst ribosomal PCR, PFGE, and MLST are targeted towards specific DNA, whole 
genome sequence explores the entire whole DNA content of an individual bacterium. 
Therefore, whole genome sequencing provides more information about the genetic 
composition of the organism than other genotyping methods. However, whole genome 
sequencing can be complicated by several processes (technical ability, cost, 
bioinformatics analysis data interpretation) As a result, whole genome sequencing is 
currently more suitable for research purposes than routine clinical use(Khromykh and 
Solomon, 2015; Salipante et al., 2015).  
 
Overall, molecular-based techniques have many advantages in a diagnostic 
microbiology laboratory for BSI. Nevertheless, these methods are not performed 
routinely, particular in low income countries, due to high cost and extensive skill 
required to perform these techniques(Angeletti et al., 2015). Therefore, blood culture 
remains the gold standard for laboratory diagnosis of BSI in clinical settings globally. 
 
 Antimicrobial susceptibility testing 
Antimicrobial susceptibility testing (AST) is a laboratory method to obtain the 
susceptibility of an isolated organism to one or many antimicrobials. The result of the 
AST provides vital information about antimicrobial choice and treatment regime for an 
individual infection. As BSI is a critical disease, some types of AST are able identify 
some specific resistant mechanisms (e.g. ESBL, KPC) or phenotype (MRSA) so that 
appropriate antimicrobials can be administered in an appropriate clinical time frame. 
 
Although there are many technical methods for AST, the results should be reported in a 
standardised fashion, the tested pathogen is reported as susceptible/intermediate/ or 
resistant (Susceptible, the antimicrobial agent is able to treat the infection caused by the 
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isolated organism; Intermediate, the antimicrobial agent is able to treat the infection if a 
higher dose is used or higher concentration in infected sites is archived; and Resistant; 
the antimicrobial agent is unable to treat the infection caused by the isolated organism.  
 
The functionality of antimicrobials is further assessed against an organism by its 
Minimum inhibition concentration (MIC) (µg/ml). The MIC is defined as the lowest 
concentration of antimicrobial that inhibits visual growth of bacteria in a defined period 
of time. An MIC is obtained under in-vitro testing conditions. The broth dilution test is 
considered to be the gold standard method for antimicrobial susceptibility testing. This 
technique requires test tubes containing a defined concentration of bacteria (1-5x105 
CFU) in liquid growth medium. A series of two-fold dilution of the screened 
antimicrobial (e.g. 1, 2, 4, 8, and 16 µg/ml) are dispensed in the test tubes and incubated 
for 18-24 hours at 35oC. After incubation, the tubes are examined for the turbidity, 
which indicates growth of bacteria. The lowest concentration of antimicrobial that has 
no evidence of bacterial growth is the MIC of the antimicrobial. The MIC is compared 
with the interpretation range in published guidelines such as those validated by CLSI 
and EUCAST (European Committee on Antimicrobial Susceptibility Testing). The 
main advantage of broth dilution is to give a quantitative result (MIC value), which is 
more precise than the qualitative result generated by other less quantitative methods. 
However, the broth dilution method is laborious and utilises differing reagents(Amsler 
et al., 2010; Jorgensen et al., 2009; Mounyr Balouiri n and Moulay Sadiki, 2015). 
Therefore, this method is generally used more for research than for clinical purpose. 
 
1.8.3.1 Antimicrobial gradient method 
The antimicrobial gradient method uses an antimicrobial gradient plastic strip to test on 
an agar plate. The plastic strip contains an increasing gradient antimicrobial 
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concentration, which is impregnated into the strip and called an E-test. After incubation 
the MIC result can be read at the point of intersection between the bacterial growth and 
the value printed on the E-test strip.  The gradient method gives quantitative result 
similar to the agar dilution method but is easier to perform. Many comparative studies 
have shown that the E-test method produces a good correlation with the broth dilution 
method(Amsler et al., 2010; Heijden et al., 2007; Mounyr Balouiri n and Moulay 
Sadiki, 2015) . E-tests are suitable for obtaining the MIC of one or few antimicrobials 
because the price for each test strip is costly. 
  
1.8.3.2 Disk diffusion test 
Disk diffusion test is a manual antimicrobial susceptibility test, which was standardized 
by Kirby and Bauer in 1960s. The disk diffusion method is continuously updated by the 
CLSI annually for new resistance mechanisms and interpreted for newer 
antimicrobials(Clinical and Laboratory Standards Institute, 2015; Hudzicki, 2009). Disk 
diffusion is an alternative method to the broth dilution technique. In the Kirby-Bauer 
method, a specific bacterial suspension (~0.5 McFarland) is applied on a 90 mm-
diameter Muller-Hinton agar plate. The paper disk, which is impregnated with a known 
concentration of an antimicrobial, is placed on the prepared Muller-Hinton agar. The 
plate is incubated in 37oC for 16-24 hours in aerobic environment or in 5% CO2 
depending on the bacteria species. After a sufficient incubation time, the plate can be 
examined for the inhibition zones around the antimicrobial disks. The diameter of 
inhibition zone is measured in millimetres and compared with the criteria of the CLSI or 
other guidelines. The result of each antimicrobial will be described as susceptible, 
intermediate, or resistant to the tested bacteria. The Kirby-Bauer method is very popular 
in clinical microbiology laboratory due to its simplicity and standardisation(Hudzicki, 
2009; Jorgensen et al., 2009). However, the antibiogram generated by disk diffusion 
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method is not precise for slow-growing or rare organism, which have not yet been 
standardized by guidelines(Gaudreau et al., 2008; Hudzicki, 2009).  
1.8.3.3 Automatic systems for antimicrobial susceptibility testing 
The limitation of manual antimicrobial susceptibility testing are that they are laborious 
and have a long turn-a-around time. Automatic blood culture systems have been 
developed to overcome these limits. Common automatic susceptibility testing systems 
are VITEK (BioMerieux), Phoenix (Becton Dickinson), and Microscan Walkaway 
(Siemens). Each system has a private card (VITEK)/panel (Phoenix)/tray (Walkaway) 
that contains multiple antimicrobials in different dilutions. All automated systems 
generate MICs for several antimicrobials simultaneously. These systems use 
colorimetric or turbidometric detection for the growth of bacteria in antimicrobial 
dilution wells within 6-14 hours. Moreover, these systems have software, which can 
detect specific resistance activity (ESBL, AmpC, MRSA, VRE, and KPC). 
 
A comparison between various automated blood culture systems and manual testing 
methods generally show high agreement. A study in India compared the antimicrobial 
susceptibility results of common pathogens by the Phoenix (Becton Dickinson) and disk 
diffusion method. Categorical agreement in this study was as high as 98% and 95.7% 
for Gram-negative and Gram-positive bacteria, respectively(Duggal et al., 2012). 
Automated systems also generated good results for specific antimicrobials such as 
vancomycin and colistin. A comparative study of many antimicrobial testing methods 
for Acinetobacter baumannii revealed that the VITEK and E-test method had good 
interpretable agreement for colistin susceptibility with broth dilution, but not disk 
diffusion(Lo-Ten-Foe et al., 2007).  
 
 Common resistant mechanism 
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1.8.4.1 Extended-spectrum-β lactamases (ESBLs) 
The Extended-spectrum-β lactamases (ESBLs) are a group of enzymes that hydrolyse 
third and fourth generation cephalosporins and monobactam but have no activity against 
cephamycin (cefoxitin) and carbapenems. The ESBLs are enzymes encoded by various 
plasmid encoded resistance genes (TEM, SHV or CTX-M), which may be able to 
transfer across different Gram-negative bacterial species. 
 
The combination disc method is a confirmatory method for ESBL activity and is 
recommended by the CLSI, CDC, and BSAC (British Society for Antimicrobial 
Chemotherapy) guidelines(British Society for Antimicrobial Chemotherapy, 2012; 
Clinical and Laboratory Standards Institute, 2015; “Laboratory Detection of Extended-
Spectrum β-Lactamases (ESBLs) | HAI | CDC,” 2010). This method should be used 
routinely for all clinical, Klebsiella and Proteus due to the high proportion of ESBLs 
positive organisms within these species. This methods incorporates a 3rd generation 
cephalosporin (mostly cefotaxime or ceftazidime) alone and in combination with 
clavulanic acid under disc diffusion test conditions. After incubation at 35oC overnight, 
ESBL activity is confirmed if the diameter of 3rd cephalosporin-clavulanic acid 
inhibition zone >5mm larger than that of the 3rd cephalosporin alone. 
 
The Double- disc method is an alternative screening method for ESBLs detection and is 
performed under disc diffusion conditions. A ceftazidime/cefotaxime disc and an 
amoxicillin-acid clavulanic disc are placed 25-30 mm apart, centre-to-centre. After 
incubation at 35oC overnight, ESBL activity is considered if there is a sign of an 
increasing zone of inhibition from amoxicillin-acid clavulanic toward the 3rd 
cephalosporin disc. The distinctive image of this method is called as “champagne-cork”, 
or the “key-hole”. (British Society for Antimicrobial Chemotherapy, 2012; Overdevest 
et al., 2011).  
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The E-test designated specifically for ESBL detection contains gradients of cefotaxime 
or ceftazidime at one end and combination of cefotaxime or ceftazidime and clavulanic 
acid at the other. ESBL activity is confirmed if the MIC of combination is 3 times lower 
than the MIC of single antimicrobial(British Society for Antimicrobial Chemotherapy, 
2012; “Laboratory Detection of Extended-Spectrum β-Lactamases (ESBLs) | HAI | 
CDC,” 2010). 
 
1.8.4.2 AmpC lactamases 
AmpC lactamases are an alternative β-lactamase enzyme that can be encoded by either 
chromosomal or plasmid associated genes. Chromosomal AmpC lactamases are present 
in some members of Enterobacteriaceae such as Enterobacter spp., Citrobacter spp., 
Serratia spp., Aeromonas spp., and Morganella spp. Plasmid mediated AmpC 
lactamases are commonly found in and Klebsiella species. Organisms that had have 
AmpC lactamase activity are resistant against penicillins, 3rd cephalosporins 
(ceftazidime, ceftriaxone, cephamycin) and monobactams but susceptible to 4th 
cephalosporins (cefepime) and carbapenems(G. A. Jacoby, 2009; Mohd Khari et al., 
2016). Unlike ESBLs, there is currently no standard manual testing method for AmpC 
lactamase detection. However, there are some recommended detection methods such as 
the cefoxitin disk screening test, the cefoxitin-cloxacillin double disk synergy test, the 
AmpC induction test, and the D69C AmpC detection set.(Mohd Khari et al., 2016; 
Polsfuss et al., 2011; Tan et al., 2009) 
  
 
Cefoxitin disk screening test 
 44 
In the disk diffusion test, AmpC lactamase production is suspected if the bacteria 
resistant to cefoxitin and 3rd cephalosporins and susceptible to 4th cephalosporins. The 
sensitivity of using cefoxitin as a screening agent was 97% while the specificity was 
78.7%(Polsfuss et al., 2011). 
 
Cefoxitin-cloxacillin double disk synergy test 
In the disk diffusion test, a cefoxitin disk (30µg) and a combination disk of cefoxitin-
cloxacillin (30µg-200µg) are placed together. After overnight incubation, if an 
inhibition zone of the combination disc is equal or >4 mm greater than that of the 
cefoxitin disc, AmpC lactamase production is confirmed. The sensitivity and specificity 
of this method is around 95%(Tan et al., 2009). 
 
AmpC induction test  
This method is used to detect induced AmpC lactamase activity. In some bacteria, the 
activity of AmpC lactamase will be expressed in the presence of strong antimicrobial 
inducer, such as cefoxitin or imipenem. During the disk diffusion test, a 3rd 
cephalosporin is placed near cefoxitin/imipenem. A flattening zone of 3rd cephalosporin 
toward the inducer indicates the inducible AmpC lactamase. This method had low 
sensitivity (25%) and high specificity (99%)(Tan et al., 2009). 
 
1.8.4.3 Carbapenem-resistant Enterobacteriaceae (CRE) 
During the routine antimicrobial susceptibility testing, organisms that are non-
susceptible to any carbapenems (ertapenem, imipenem, meropenem) are indicative of 
carbapenemase production. CRE is confirmed later by a carbapenemase test. However, 
there are many types of cabapenemase enzymes, such as Klebsiella pneumoniae 
carbapenemase (KPC), OXA enzymes, the Metallo-β-lactamase (MBLs) group 
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(comprised of IMP, VIM and NDM enzymes), but there is no perfect test to detect all 
enzyme types. Carbapenemase tests include, the broth micro dilution MBL screen, 
gradient MIC strip, Modified Hodge test, Carba NP test, the Carbapenemase 
inactivation method, MALDI-TOF MS, PCR, and whole genome sequencing(Kempf et 
al., 2012; Kost et al., 2017; Lutgring and Limbago, 2016; Miller and Humphries, 2016; 
Tamma et al., 2016). The Modified Hodge’s test, the Carba NP test, and PCR are 
recommended by the CLSI guidelines (Clinical and Laboratory Standards Institute, 
2015; Lutgring and Limbago, 2016). 
 
1.8.4.4 Methicillin-resistant Staphylococcus aureus (MRSA) 
With the high percentage of infections associated with MRSA the CLSI proposed the 
routine testing of MRSA from all Staphylococcus aureus isolates (Clinical and 
Laboratory Standards Institute, 2013). The detection methods for MRSA include, the 
cefoxitin disk-screening test, oxacillin disk screening test, latex agglutination test for 
PBP2a, and PCR for the mecA gene. The oxacillin disk screening test has 80% 
sensitivity and 100% specificity, the other tests have 100% sensitivity and specificity 
(Marlowe and Bankowski, 2011; Pourmand et al., 2014). 
 
1.8.4.5 Vancomycin resistant enterococcus (VRE) 
Screening method for VRE utilises a bile esculin agar plate containing vancomycin or a 
vancomycin E-test(Clinical and Laboratory Standards Institute, 2015). A confirmatory 
PCR test detects the vanA, vanB, or vanC gene from enterococcus isolates or directly 
from clinical samples(Mak et al., 2009; Özsoy and İlki, 2017; Young Seo et al., 2011). 
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 Treatment of BSI 
The more severe the sepsis becomes, the higher greater the risk of death; fatality can 
exceed 50% from severe sepsis and 80% from septic shock(Martin, 2012). Therefore, it 
is crucial to start treatment as soon as possible and antimicrobial are one of the key 
elements for managing BSI. According to the Guidelines for sepsis management, 
antimicrobials should be administered within one hour after a diagnosis of sepsis has 
been made(R. Dellinger et al., 2013). Any delay on antimicrobial prescription or 
inappropriate initial antimicrobial treatment for BSI have been shown to be associated 
with prolonged hospitalization, high treatment costs, and high mortality. A study 
regarding Pseudomonas aeruginosa associated BSI in the US concluded that delaying 
appropriate antimicrobial therapy significantly increased the mortality by an odd ration 
of 4.1, (p=0.03). It has also been reported that MDR P. aeruginosa represents an 
independent risk factor for late appropriate antimicrobial therapy (OR 4.6, 
p<0.001)(Lodise et al., 2007). A further study of BSI with Gram-negative bacilli in 
Korea showed that inappropriate antimicrobial treatment was found in 52.8% patients 
which lead to a 38% increase in mortality rate(Kang et al., 2005). 
 
The duration of antimicrobial usage in BSI remains under debate. The treatment of BSI 
can include a short course (5-7 days) or long course (10-14 days). However, according 
to a meta-analysis review, short course antimicrobial treatment is as effective as long 
course for BSI(Havey et al., 2011). These data support the reducing the use of 
antimicrobials, which decreases cost, adverse event, and the generation of resistant 
organisms. 
 
Appropriate antimicrobial therapy in BSI is defined as the antimicrobial in clinical use 
has in vitro activity against BSI pathogen and the route of administration provides 
enough bioavailability for treatment. It is generally recommended that empirical 
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antimicrobial treatment should use the intravenous broad-spectrum antimicrobials. The 
choice of antimicrobial should depend on infection site (e.g. pneumoniae, and abscess) 
and source (e.g. hospital, community origin), and using local knowledge of 
susceptibility patterns of common BSI pathogens. After the antibiogram is reported, 
escalation to a narrow antimicrobial should be considered for every BSI case to reduce 
the risk of resistance development (R. Dellinger et al., 2013; Timsit et al., 2014).  
 
 Antimicrobial resistance: an increasing global health problem 
Antimicrobial resistance has been identified as a major threat in global health. Broad-
spectrum antimicrobial resistance such as ESBL and MRSA are now common in 
community and hospital-acquired BSI (Kang et al., 2012; Kim et al., 2014; Paulsen et 
al., 2015; Serefhanoglu et al., 2009; Tariq, 2014). In many ICUs, MDR organisms, such 
as Pseudomonas aeruginosa and Acinetobacter baumannii are the most common 
pathogens for hospital-acquired BSI(Micek et al., 2005; Mudau et al., 2013; Tjoa et al., 
2013; Wisplinghoff et al., 2000; Zavascki et al., 2010). Realizing the importance of 
antimicrobial resistance, The European Centre for Disease Prevention and Control 
(ECDC) and the Centres for Disease Control and Prevention (CDC) have established 
definitions for several levels of antimicrobial resistance based on the antimicrobial 
testing lists from CLSI and EUCAST guidelines (Magiorakos et al., 2012). There are 
currently three level of antimicrobial resistance, Multidrug-resistant (MDR; non-
susceptibility to at least one agent in ≥ 3 antimicrobial categories), Extensively-drug-
resistant (XDR; non-susceptibility to at least one agent in all but still remains 
susceptible to one or two antimicrobial categories), and Pan-drug resistant (PDR; non-
susceptible to any antimicrobial in all antimicrobial categories). 
 
 Current status of antimicrobial resistance (AMR) in Asia  
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Antimicrobial resistance has been identified as a major threat recently, especially in the 
Asia. All the most infamous antimicrobial resistant organisms, including MRSA, VRE, 
and CRE are found circulating in many Asian countries (Ahn et al., 2001; Kang and 
Song, 2013; Kim et al., 2014; Manchanda et al., 2010; Phetsouvanh et al., 2006). 
According to Asian Network for Surveillance of Resistant Pathogen (ANSORP), MRSA 
accounted for 25% and 67% of all community and hospital- acquired infections caused 
by S.aureus, respectively (Kang and Song, 2013). The Study for Monitoring 
Antimicrobial Resistance Trends (SMART) found that prevalence of ESBL organisms 
in Asia remained particularly high in comparison with other parts of the world, 
increasing from 18% to 40% of defined organisms within 10 years(Morrissey et al., 
2013). The predominant type of ESBL type in Asia is CTX-M15. Moreover, AmpC 
lactamases were found to coexist with ESBL genes, and AmpC lactamase genes were 
found in >60% of ESBL expressing isolates(Sheng et al., 2013). 
 
 Vietnam  
Vietnam, is located Southeast Asia, and has a high reported rate of antimicrobial 
resistant organisms. According to ANSORP, the rate of MRSA in Vietnam is >74% of 
all the hospital-acquired infections with S.aureus; the MRSA rate for community-
acquired S.aureus infection is approximately 30% of cases(Kang and Song, 2013). The 
rates of ESBL-producing E.coli and Klebsiella pneumoniae were >50% of all urinary 
tract infections, which is higher than the 8 participating countries in Asia. Lastly, the 
rate of carbapenem-resistant Enterobacteriaceae in Vietnam was around 3%, which was 
only lower than in Indonesia (5.8%)(Xu et al., 2015). 
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 Previous studies of BSI in Vietnam  
There are no routinely available national data regarding BSI in Vietnam. However, 
some hospitals in Vietnam have BSI researches in their own institution. A tertiary 
paediatric hospital had laboratory-confirmed BSI rate of 6.7% (385/5,763 cases) in 
neonates within one year. Gram-negative bacilli were the predominant BSI pathogen 
and associated with high mortality, in comparison with Gram positive pathogens 
(p<0.01)(Kruse et al., 2013). In another tertiary hospital for adults, nosocomial BSI 
were investigated in a prospective cohort study in 2013-2015. This study found that 
underlying diseases, such as diabetes, chronic kidney disease, and chronic heart diseases 
were associated with 30-day mortality. Central lines were identified as the most 
important source of nosocomial BSI in this hospital; Candida was the most common 
pathogen, followed by bacteria such as Enterococcus, and Acinetobacter(Dat et al., 
2017). 
 
There has been only one longitudinal retrospective study of BSI in Hospital for Tropical 
Diseases (HTD), a tertiary hospital for infectious diseases in HCMC in the south of 
Vietnam. The median positive rate of blood culture was 11.6% during the study period. 
S. Typhi was the predominant pathogen of BSI in the first 8 years of the study; E.coli 
and Klebsiella accounted for a very small portion of infections. After 2002, the rate of 
S. Typhi declined 30% annually (p<0.01) while there were a noticeable increased in 
NTS, Cryptococcus neoformans, and T. marneffei due an increasing prevalence of HIV 
infected patients. S. Typhi had a high MDR rate (92%) at the beginning of the study 
(1995), but then decreased gradually 18% every year, and remained at 17.6% at the end 
of the study (2008). In contrast, E.coli became increasing resistant to common 
antimicrobials such as aminoglycosides, fluoroquinolones, and 3rd cephalosporins(Nga 
et al., 2012). 
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 What do we know and do not know about BSI in Vietnam? 
Although routine surveillance data for the antimicrobial resistance in Vietnam is 
limited, available data outlines a picture of high rate of MDR pathogens. However, there 
are no current longitudinal data regarding the pathogen causing BSI, especially in some 
particular populations such as those infected with HIV, and those with hospital-acquired 
or community -acquired infections. Data contributing to understanding common 
antimicrobial resistance mechanisms or phenotype, including ESBLs, AmpC, KPC, and 
MRSA in BSI pathogens in Vietnam are also scarce. As a clinical microbiologist I think 
these data are valuable for management of BSI in my hospital and in Vietnam. 
 
In previous data regarding BSI from 1994-2008 in Vietnam showed there was a shift in 
epidemiology from S. Typhi to other bacteria, including NTS and fungi, when HIV-
infected patients became more commonly admitted to the hospital(Nga et al., 2012). We 
observed a smaller but comparative change to the HIV epidemic observed in parts of 
Africa. Details of invasive NTS disease in sub-Saharan Africa have been well 
investigated. The main epidemic invasive NTS is Salmonella Typhimurium ST313, 
which is characterized by an MDR phenotype (Feasey et al., 2015, 2012). The situation 
for BSI and invasive NTS disease in Vietnam is different from Africa. Malaria became 
uncommon in Vietnam, (Thanh et al., 2015) and anti-retroviral therapy is readily 
available(Kato et al., 2014). NTS BSI is present in Vietnam but information about the 
disease, such as clinical presentation, pathogen characteristic, and disease outcome has 
not been described. 
 
In recent years, automated antimicrobial susceptibility testing using machines has 
become commonly adopted in Vietnamese microbiology laboratories. Comparison of 
automatic susceptibility testing and other manual methods have showed an acceptable 
performance of the automatic method for common pathogenic bacteria such as E.coli 
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and Staphylococcus aureus(Lee et al., 2013; Stone et al., 2007) .The CLSI has recently 
changed the breakpoints for some antimicrobials for Salmonella, this reclassification 
has resulted in more organisms being reported as resistant to fluoroquinolone (Clinical 
and Laboratory Standards Institute, 2015, 2013). However, we do not know whether 
automatic susceptibility testing is appropriate for the interpretation of antimicrobial 
susceptibility data for NTS using the CLSI guidelines.  
 
 Focus, aims, and the structure of my thesis research 
For a better understanding of BSI in Vietnam in an era when antimicrobial resistance is 
a global threat, there is an epidemic of HIV in Southeast Asia, and automated 
microbiological techniques are becoming more widely used, I proposed the following 
research questions: 
  
Question 1. 
What are the characteristics of main pathogens causing BSI and what is the trend of 
antimicrobial susceptibility at HTD (the tertiary site for infectious diseases in the south 
of Vietnam) in recent years? 
 
In HTD, the primary antimicrobial regime for BSI is ceftriaxone as monotherapy or 
ceftriaxone in combination with an aminoglycoside or a fluoroquinolone. However, this 
antimicrobial regime is less effective if the pathogen is resistant to 3rd generation 
cephalosporins. We know that Vietnam is a key location for antimicrobial resistant 
bacteria in Asia. Therefore, it is essential to understand the common pathogens causing 
BSI and their antimicrobial resistance pattern in Vietnam. I aimed to retrospectively 
investigate all pathogens data from BSI and their corresponding clinical information 
over a 5 years period at HTD. I aimed to investigate the major causes of bacteraemia in 
this healthcare facility, their distribution by ward, their association with HIV, their 
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antimicrobial susceptibility patterns, and their antimicrobial resistance gene content. I 
also aimed to generate data regarding common resistant mechanisms such as ESBLs, 
AmpC lactamase, KPC, and MRSA. Based on the admission time and the blood culture 
collection time, data will be stratified into hospital-acquired and community acquired 
infections. These data will contribute to more appropriate antimicrobial regimes for BSI 
as well as a future antimicrobial stewardship program in this setting.  
 
Question 2. 
What are the characteristics of ESBL and AmpC lactamases, the two main types of β-
lactamase in Enterobacteriaceae associated with BSIs at HTD?  
 
β-lactamase producing Enterobacteriaceae have become increasingly common in human 
infections, especially in BSI. The commonest group of β-lactamases is the ESBL, which 
are generally plasmid-mediated. Recently, another group of β-lactamase, AmpC, has 
also been reported in the Enterobacteriaceae. These β-lactamases are able to hydrolyse 
the 3rd generation cephalosporins, which leads to failure of ceftriaxone and other 3rd 
generation cephalosporin antimicrobials. In HTD, ceftriaxone is the primary treatment 
for BSI. However, ceftriaxone is ineffective for ESBL and/or AmpC expressing 
bacteria. Therefore, it is essential that ESBL or AmpC activity and genes can be 
identified in a clinical microbiology laboratory. At HTD, manual detection method for 
ESBL activity has been performed since 1994; AmpC activity since 2011. However, the 
sensitivity and specificity of these manual methods remains unclear. I aimed to evaluate 
conventional methods to detect ESBL and AmpC activity in this setting in comparison 
with molecular methods. Multiplex PCR for common ESBL and AmpC genes will be 
performed for each organism with evidence of ESBL and AmpC activity. Based on the 
molecular screening results, the common ESBL and AmpC genes associated with BSI 
in this setting will be identified. 
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Question 3. 
What are clinical and laboratory characteristics of NTS BSI in Vietnam?  
 
It is apparent that there is a changing epidemiology of Salmonella infections in Vietnam 
and in other parts of Southeast Asia. However, the nature, the scale, and the 
implications of this changing epidemiology are, as yet, unknown. I think, from limited 
available data, that the number of invasive NTS infections in Vietnam is small in 
comparison to those observed in sub-Saharan Africa. I am unsure of the clinical 
manifestations, the potential success of the treatment regimes, and the affected patient 
population. I hypothesise that the epidemiology of invasive NTS infections is 
ecologically different to that of sub-Saharan Africa, and I predict that as hospital care, 
antiretroviral drugs, and nutrition is good in Vietnam that mortality is low and limited to 
few specific risk factors. To address this hypothesis I aimed to perform a retrospective 
analysis on all patients hospitalised at HTD in HCMC over a four-year period. Data will 
be collected from hospital records, entered into a custom designed database, stratified 
by HIV status, age, sex, nutrition, treatment, hospital stay, complications, 
gastrointestinal complaints, and outcome. Data will be described and then analysed to 
assess risk factors or outcome, prolonged hospital stay, complications, co-morbidities, 
and death. This will be the first study of its type originating from outside sub-Saharan 
Africa. 
 
Question 4. 
Does automatic antimicrobial susceptibility testing using the VITEK system produce 
antimicrobial results as reliable as conventional methods for Salmonella? 
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Since automatic antimicrobial susceptibility testing systems have become available they 
have been widely adopted by clinical microbiology laboratories. With advantages such 
as rapidity and reproducibility, the VITEK system, which is one of the most common 
automated system, has been evaluated with good performance for many common 
pathogens such as E.coli, Klebsiella, Pseudomonas, and Staphylococcus aureus (Lee et 
al., 2013; Stone et al., 2007; Tan and Ng, 2007). The clinical microbiology laboratory at 
the HTD installed a VITEK 2 compact system in 2012. This machine was routinely 
used for testing the antimicrobial susceptibility profiles of resistant bacteria isolated 
from patients within the hospital. To date, there have been no studies using the VITEK 
system for testing Salmonella antimicrobial susceptibility, with most studies using disk-
diffusion or E-tests (Chiou et al., 2014; Lee et al., 2009; Lunguya et al., 2013). 
Therefore, I think it is necessary to understand the accuracy of VITEK susceptibility 
testing method for Salmonella by comparing VITEK method with E-tests, and the disk 
diffusion method. This information will be valuable for clinical microbiology 
laboratories in selecting appropriate antimicrobial susceptibility methods for Salmonella 
in an era of automation. 
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Chapter 2 
Material and methods 
 
 Setting 
 Vietnam 
Vietnam is a country in located in Southeast Asia; it has a landmass of 332 thousand 
km2 and a population approaching 90 million people. According to the Ministry of 
Health, the infrastructure for healthcare services in Vietnam is below the national 
requirement. There are 23.5 hospital beds/10,000 people, which are not evenly 
distributed between regions and provinces. Since 1998, the Centre for Disease Control 
had supported Vietnam for strengthening healthcare facilities, which has included the 
management of HIV and other infectious diseases(Global Health, 2016). In recent years, 
specific infectious diseases and antimicrobial resistance have become a large burden in 
Vietnam. The country is now trying to tackle the spread of high level of antimicrobial 
resistance; this requires more attention from the healthcare systems and the government. 
 
  Hospital for Tropical Diseases (HTD) 
HTD in HCMC is a major referral hospital for infectious diseases in the south of 
Vietnam. The hospital has 550 beds and receives more than 2,500 outpatients daily. 
More than 70% patients are citizens of HCMC; the remaining patients are from the 
nearby provinces. The hospital receives both adults and children and also provides 
healthcare service for HIV- infected patients. The HTD has 14 clinical wards including 
three ICUs (adult ICU, pediatric ICU, and an ICU for central nervous system 
infections), six adult non-ICU wards, four non-ICU pediatric wards and one HIV ward.  
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 The Oxford Clinical Research Unit in Vietnam (OUCRU-VN) 
Being part of the Wellcome Trust Major Overseases Programme, OUCRU-VN is a 
large institution for research and training in Vietnam. The headquarters of OUCRU-VN 
has been located within the grounds of the HTD hospital, HCMC since 1991. This 
alliance forms an advantage for collaboration with this tertiary referral hospital for 
infectious diseases and other large hospitals in HCMC. OUCRU-VN had achieved 
broad success in many important research areas including on central-nervous system 
infections, opportunistic diseases in HIV infections, enteric infections, and 
antimicrobial resistance. 
 Methods 
 Methods for chapter 3: A retrospective study of bloodstream infection in 
HTD from 2010-2014:  
 
2.2.1.1 Study design and setting 
This was a retrospective, descriptive study conducted on data and organisms collected 
over a five-year period from patients with bacteraemia at HTD, and performed in 
collaboration with OUCRU-VN. This study was a part of a larger study coded 15EN 
(HTD research code CS/ND/14/20) which was been approved by the Ethical Review 
Board of HTD. 
 
2.2.1.2 Inclusion and exclusion criteria 
The inclusion criteria for this analysis were every patient at HTD with a positive culture 
from a blood sample taken between the 1st January 2010 and 31st December 2014. There 
were no exclusion criteria.  
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2.2.1.3 Data collection 
The data for this analysis was all available routine microbiology laboratory data 
regarding bacteraemia at HTD from 2010-2014 inclusive that was stored on the hospital 
computerised database. These data included; all cause bacteraemia from 2010-2014, 
aetiology, date of isolation, ward, sex, HIV status, antimicrobial susceptibility patterns 
from all bacterial isolates. Clinical data from BSI patients were not collected routinely, 
except for the outcome, which was derived from the data network of the hospital. 
 
2.2.1.4 Blood culture and organism identification  
Blood cultures at HTD are performed for patients in whom an infection was suspected 
on the basis of a fever (>38oC) or who has evidence of sepsis on the basis of the 
presence of two or more of the following features: fever (>38oC) or low temperature 
(<36oC); tachycardia (exact level according to age); tachypnea (exact level according to 
age); an elevated white cell count (>12,000 cells/mm3) or depressed white cell count (< 
4,000 cells/mm3). There was no systematic change in the application of these criteria 
during the time course of the study. All data originating from consecutive patients 
admitted to the hospital who had a blood culture performed for suspected bloodstream 
infection between 1st January 2010 and 31st December 2014 were included in this 
retrospective study. Routinely, a member of the hospital staff recorded the date of blood 
draw, the patient’s age, sex, and suspected diagnosis, the number of blood culture 
bottles inoculated, the result of the culture (whether positive or negative) and the 
susceptibility of the isolate to commonly used antimicrobial agents. These are the 
source data for this study.  
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Single venous blood culture of 8-15 mL from adults and 2-5 mL of venous blood from 
infants and children were routinely obtained and inoculated into BACTECplus aerobic 
bottles (Becton Dickenson, USA). Inoculated BACTEC bottles were incubated at 37C 
in a BACTEC 9240 automated analyser for up to five days and sub-cultured when the 
machine indicated a positive signal. All sub-cultures were plated onto fresh sheep blood 
agar, MacConkey agar, and chocolate agar for bacterial isolation. Sabouraud agar plate 
was used only when yeast or fungi was seen on the direct smear. Plates were incubated 
at 37C in air for five days and organisms were subsequently identified by standard 
methods including API20E and API20NE identification kits (Bio-Mérieux, France). 
Staphylococcus aureus ATCC 29213 and Pseudomonas aeruginosa ATCC 27853 were 
used as controls. 
 
2.2.1.5 Antimicrobial susceptibility testing and interpretation 
The susceptibility to relevant antimicrobial agents was determined by the modified 
Bauer-Kirby disc diffusion method. The antimicrobial susceptibility profiles of Gram-
negative pathogens were generated using a 3rd generation cephalosporin, a 
fluoroquinolone, and a carbapenem. Data is presented in the number or the proportion 
of non-susceptible (intermediate and resistant) bacteria to a specific antimicrobial 
group. Non-susceptible to 3rd cephalosporins were determined using ceftriaxone for the 
Enterobacteriaceae (E.coli, Klebsiella spp., S. Typhi, and NTS), and ceftazidime for 
Acinetobacter spp. and Pseudomonas spp. Non-susceptible against carbapenems was 
determined using ertapenem and/or imipenem and/or meropenem for E.coli, Klebsiella 
spp., S. Typhi, NTS, imipenem and/or meropenem against Acinetobacter spp. and 
Pseudomonas spp.. If an isolate was non-susceptible to one carbapenem but susceptible 
to another it was considered as “non-susceptible”. Lastly, ofloxacin, ciprofloxacin or 
levofloxacin was used to determine the non-susceptibility against fluoroquinolones. 
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Detection for MRSA was performed routinely for all Staphylococcus aureus using 
cefoxitin disk screening test (MRSA was concluded if the cefoxitin zone of inhibition 
was <21 mm). The breakpoint zone sizes were interpreted according to CLSI 
guidelines. 
 
The double disk diffusion method was used to identify ESBL activity. This method was 
performed using a combination of cefepime (30 g), ceftazidime (30 g), ceftriaxone 
(30 g), Amoxicillin (20 g)/clavulanate (10 g). ESBL producers were identified by 
reduced zone sizes to third-generation cephalosporins (ceftazidime and ceftriaxone), and 
expansion of these zones in the presence of an inhibitor (clavulanate). Confirmatory 
tests for ESBL producers were performed using oxyamino-cephalosporins/-lactam 
inhibitor combinations, namely cefotaxime (30 g)/clavulanate (10 g) and ceftazidime 
(30 g)/clavulanate (10 g). Zone sizes were measured and interpreted according to the 
CLSI guidelines. 
 
2.2.1.6 Definitions 
For the purposes of these analyses postive blood samples taken for culture >48 hours 
after admission to HTD were classified as a Hospital Acquired Infections (HAI) and 
samples taken within 48 hours of admission to HTD were classed as a Community 
Acquired Infections (CAI). 
 
Contamination was determined in the microbiology laboratory if the organisms grown 
in blood culture were Corynebacterium spp., Bacillus spp., Diphtheroid spp., 
Micrococcus spp., and Propionibacterium spp. Coagulase negative Staphylococcus and 
Burkholderia cepacia were considered as contaminants on a case by case basis, after the 
agreement of the microbiology laboratory and attending clinician. 
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2.2.1.7 Sample size 
As this was retrospective descriptive study, the sample size was dependent on the 
number of patients with available data according to the inclusion criteria during from 
2010-2014. 
 
2.2.1.8 Statistic method 
The resulting data is presented in the form of tables and bar charts for descriptive 
variables i.e. the number of specific organisms per year and number of resistant 
organisms per year. Time trends (over the 5-year period), including the proportion of 
cultured isolates by year, the antimicrobial susceptibility patterns were determined by 
logistic regression, and odds ratios will be presented in units of time (per year). All 
statistical analysis were performed using R (version 3.2.3); p values of ≤0.05 will be 
considered significant.  
 
 Methods for chapter 4: The phenotypic and genotypic characteristics of 
ESBL and AmpC producing organisms associated with bacteraemia from 2011-
2013:  
2.2.2.1 Study design and setting 
This was a retrospective study on the ESBL and AmpC producing Gram negative bacilli 
isolated from positive blood cultures in HTD from 2011 to 2013. 
2.2.2.2 Ethics statement 
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Ethical approval for this study was provided by the ethical review board of HTD in 
HCMC. 
2.2.2.3 Sample collection 
HTD microbiology laboratory stored the organisms and their data for this study under a 
routine storage procedure. All the organisms isolated from blood cultures were fully 
identified and antimicrobial susceptibility tested. Identification, the antibiogram and the 
patients’ data were saved in Labconn, computer software and manual logbooks in 
Microbiology laboratory. Pure organisms were stored in Brain-heart infusion glycerol 
and stored at -40oC. Based on the stored microbiology data, information regarding 
ESBL or AmpC lactamase producing Gram-negative bacilli was extracted from the 
Labconn. The desired stored strains were selected from the freezer and cultured on 
nutrient agar plate. Weak growing strains were subcultured again on nutrient agar or 
MacConkey agar for the optimal growth. After recovery all the strains were identified 
again by using the set of conventional biochemical tests (including oxidase, glucose, 
lactose, indole, citrate, urea, methyl red, motility test). If identification was unable to be 
determined by biochemical testing an API test strips (20NE and 20E) was performed. 
Acinetobacter spp., Pseudomonas spp. and other non-Enterobacteriaceae were excluded 
from this study. 
 
2.2.2.4 Sample size 
All Gram-negative bacilli bacteria that were subcultured from the frozen stock. 
 
2.2.2.5 Antimicrobial susceptibility testing 
The susceptibility to relevant antimicrobial agents was determined by the modified 
Bauer-Kirby disc diffusion method. Enterobacteriaceae were tested with discs 
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containing amikacin(10 g) , ceftazidime (30 g), ceftriaxone (30 g), cefepime (30 
g), imipenem (10 g), ertarpenem (10 g), meropenem (10 g), ofloxacin (5 g), 
ciproloxacin (5 g), amoxicillin/ acid clavulanic ( amoxicillin 20 g / acid acid 
clavulanic 10 g), trimethoprim/ sulfamethoxazole (trimethoprim 1.25 g / 
sulfamethoxazole 23.75 g), ticarcillin/ acid clavulanic (ticarcillin 75 g/ acid 
clavulanic 10 g) , piperacilline/ tazobactam (piperacillin 100 g / tazobactam 10 g) 
and cefoxitin (10 g). The breakpoint zone sizes were interpreted according to CLSI 
guidelines. As before the double disk diffusion method was used to identify ESBL 
activity.  
 
Phenotypic AmpC activity was detected using two different tests. First, I measured zone 
sizes using a combination of cefoxitin and an alternative third- and fourth-generation 
cephalosporin, where an AmpC positive organism would be resistant to cefoxitin and 
exhibit reduced susceptibility to the alternative third generation cephalosporin 
(ceftriaxone 30 g) and complete susceptibility to the fourth generation cephalosporin 
(cefepime). Secondly, I determined inducible AmpC phenotypes by assessing reduced 
zone sizes against a third generation cephalosporin (ceftriaxone 30 g or ceftazidime 30 
g) in the presence of imipenem (30 g) as an inducing substrate (Figure 2.1). AmpC 
producing organism was phenotypically determined by cefoxitin disk screening test and 
AmpC induction test (Table 2.1). 
Phenotypic screening for ESBL was performed by both double disc method and 
combination disc method. Interpretation was described in Table 2.1 and illustrated on 
Figure 2.1.  
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Figure 2. 1 Representative results of the double disk diffusion test 
(A) for ESBL production and the AmpC disk test (B). Abbreviations. AMC: amoxicillin, CTX: 
cefotaxime, CAZ: ceftazidime, CRO: ceftriaxone, CLA: clavulanate, FEP: cefepime, FOX: 
cefoxitin, IPM: imipenem 
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Table 2. 1 Interpretation of ESBL and AmpC lactamase from detection methods 
Mechanism Method Positive result 
ESBL Combination disc test Special “champagne-cork” or “key-hole” images between 
amoxicillin/clavulanate and ceftazidime/ceftriaxone. 
Double-disc test Inhibition zone diameter of either 
(cefotaxime-clavulanate) – cefotaxime ≥ 5mm 
(ceftazidime-clavulanate) – ceftazidim ≥ 5mm 
 
AmpC 
lactamase 
Cefoxitin disk screening 
test 
Inhibition zone diameter of : 
Ceftriaxone <23 mm and/or ceftazidime < 21mm plus 
Cefepime ≥ 24 mm plus  
Cefoxitin < 17mm 
 
AmpC induction test A flattening zone of ceftazidime/ceftriaxone toward imipenem 
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2.2.2.6 Genotypic screening of ESBL and AmpC genes 
Blood isolates collected from the same patient at two different time-points with the 
same phenotypic AMR profile were denoted as duplicates and only one was 
subsequently selected for further PCR analysis. If the AMR profile of the two isolates 
selected differed, both were selected for PCR analysis. Multiplex PCR reactions were 
used to detect ESBL (blaCTX-M subtypes) and AmpC genes. Other -lactamase genes, 
blaTEM, blaOXA, and blaSHV were also detected by multiplex PCR using the following 
cycling conditions, initial denaturation step at 95°C for 15 minutes, followed by 25 
cycles of DNA denaturation at 94°C for 30 seconds, primer annealing at 57°C for 40 
seconds, and primer extension at 72°C for 30 seconds. After the last cycle, a final 
extension step at 72°C for 10 minutes was added. PCR amplicons were examined by 
agarose gel (BioRad) electrophoresis made up to a concentration of 1.5% (w/v). The 
primers used in this study are shown in Table 2.2. 
 
All positive ESBL (blaCTX-M) and AmpC (blaCIT) PCR amplicons were sequenced to 
further subtype these genes. DNA was extracted using the Agencourt AMPure XP PCR 
purification system (Beckman Coulter) and sequenced using the BigDye Terminator 
v3.1 cycle sequencing kit (Applied biosystems) on the 3130 genetic analyser (Applied 
biosystems). DNA sequences were compared against the National Centre of 
Biotechnology Information (NCBI) GenBank sequence database using the BLAST 
algorithm and gene variants were subsequently deduced based on sequence similarity. 
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Table 2. 2 Primers for the multiplex PCR assays to detect ESBL and AmpC targeted genes  
Multiplex Resista
nt 
mecha
nism 
Target gene Name Sequence (5’-3’) Expect
ed 
amplic
on size 
(bp) 
Reference 
I AmpC MOX-1, MOX-
2, CMY-1, 
CMY-8 to 
CMY-11 
MOXFa GCTGCCAAGGAGCACAGGAT  520 Pérez-Pérez 
J. et 
al(Pérez-
Pérez and 
Hanson, 
2002) 
  MOXRa CACATTGACATAGGTGTGGTGC    
I AmpC LAT-1 to LAT-
4, CMY-2 to 
CMY-7, BIL-1 
CITF TGGCCAGAACTGACAGGCAAA 462 Pérez-Pérez 
J. et 
al(Pérez-
Pérez and 
Hanson, 
2002) 
  CITR  TTTCTCCTGAACGTGGCTGGC    
I AmpC DHA-1, DHA-
2  
DHAF  AACTTTCACAGGTGTGCTGGGT  405 Pérez-Pérez 
J. et 
al(Pérez-
Pérez and 
Hanson, 
2002) 
  DHAR  CCGTACGCATACTGGCTTTGC    
I AmpC ACC  ACCF AACAGCCTCAGCAGCCGGTTA  346 Pérez-Pérez 
J. et 
al(Pérez-
Pérez and 
Hanson, 
2002) 
  ACCR  TTCGCCGCAATCATCCCTAGC    
I AmpC MIR-1T ACT-
1  
EBCF  TCGGTAAAGCCGATGTTGCGG  302 Pérez-Pérez 
J. et 
al(Pérez-
Pérez and 
Hanson, 
2002) 
  EBCR  CTTCCACTGCGGCTGCCAGTT    
I AmpC FOX-1 to FOX-
5b  
FOXF AACATGGGGTATCAGGGAGATG  190 Pérez-Pérez 
J. et 
al(Pérez-
Pérez and 
Hanson, 
2002) 
  FOXR CAAAGCGCGTAACCGGATTGG    
II ESBL CTX-M1 M1F AAAAATCACTGCGCCAGTTC 415 Woodford 
N. et 
al(Woodfor
d et al., 
2004) 
  M1R AGCTTATTCATCGCCACGTT    
II ESBL CTX-M2 M2F CGACGCTACCCCTGCTATT  552 Woodford 
N. et 
al(Woodfor
d et al., 
2004) 
  M2R CCAGCGTCAGATTTTTCAGG   
II ESBL CTX-M9 M9F CAAAGAGAGTGCAACGGATG  205 Woodford 
N. et 
al(Woodfor
d et al., 
2004) 
  M9R ATTGGAAAGCGTTCATCACC    
II ESBL CTX-M8/25 M8F CGCGTTAAGCGGATGATGC  666 Woodford 
N. et 
al(Woodfor
d et al., 
2004) 
  M25F GCACGATGACATTCGGG  327  
  M8/25R AACCCACGATGTGGGTAGC   
III ESBL TSO-T-F TGCGGTATTATCCCGTGTTG 296 Nguyen et 
al (Thi 
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TEM variants 
including TEM-
1 &TEM-2 
Khanh Nhu 
et al., 2010) 
  TSO-T-R TCGTCGTTTGGTATGGCTTC   
III ESBL SHV variants 
including SHV-
1 
TSO-S-F AGCCGCTTGAGCAAATTAAAC 713 Nguyen et 
al (Thi 
Khanh Nhu 
et al., 2010) 
  TSO-S-R ATCCCGCAGATAAATCACCAC   
III ESBL OXA-1, OXA-4 
& OXA-30 
TSO-O-F GGCACCAGATTCAACTTTCAAG 564 Nguyen et 
al (Thi 
Khanh Nhu 
et al., 2010) 
  TSO-O-R GACCCCAAGTTTCCTGTAAGTG   
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2.2.2.7 Statistical analysis  
Statistical analysis was performed in R. Comparisons between HAI and CAI 
antimicrobial resistance instance rates was assessed using the Fisher’s exact test (two-
tailed). A p-value <0.05 was considered statistically significant. 
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 Methods for chapter 5: A retrospective study of BSI caused by nontyphoidal 
Salmonella in HTD from 2008-2013:  
 
2.2.3.1 Study design 
The study population consisted of all individuals from which an NTS organism was 
isolated alone or in combination with an additional pathogen in blood culture from 
January 2008 through June 2013. This source data was collected from routine 
microbiology laboratory logbooks in which data from positive and negative blood 
culture are recorded. Patients with multiple positive blood cultures for the same NTS 
serogroup and antimicrobial susceptibility profile were considered to be a single case. 
 
2.2.3.2 Ethical approval 
The protocol for this study was submitted to the Ethical and Scientific Committee of 
HTD in 2012 and got approval at the same year (HTD study code: CS/ND/12/26). The 
OUCRU application code was 07EN. 
 
2.2.3.3 Data collection and definition of disease outcome 
A patient record form was used to collect clinical and laboratory data from the hospital 
chart for every patient. Clinical data recorded on admission included sex, HIV status 
(HIV diagnosed according to the WHO guidelines), axillary temperature, presence of 
co-infection and hospital outcome. Outcome was classified based on clinician notes as 
follows: (1) recovery or improvement, (2) worsening status on discharge (often 
deteriorating patients taken from hospital by their relatives to die at home – a common 
custom in Vietnam), (3) death or (4) transfer to a different hospital (patient’s condition 
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was unchanged but transferred to other hospital for specific treatment or surgery 
intervention, or patient left against medical advice). Outcome 2 and outcome 3 were 
considered to be fatal. Laboratory data was comprised of standard hematology and 
biochemical testing from hospital records on the day of admission.  
 
2.2.3.4 Statistical analysis of clinical and laboratory data  
Clinical and laboratory data were compared between groups using Fisher's exact or 
Kruskal-Wallis tests for categorical and continuous data, respectively. We performed 
univariable and multivariable logistic regression to evaluate covariates that were 
independently associated with fatal outcome.  Covariates selected for multivariable 
analysis a-priori included age, sex and immunosuppression (HIV status, chronic 
hepatitis), in addition to other fixed demographic or clinical covariates that were 
significantly associated (p<0.05) with outcome from the univariate analysis. All 
statistical analyses were performed using Stata version 11 (StataCorp, College Station, 
TX, USA). Plots were made in R (v3.1.1; R Foundation for Statistical Computing). 
 
2.2.3.5 Microbiological procedures 
Organisms were identified by standard methods including API20E identification kits 
(Bio-Mérieux, Craponne, France). Specific grouping antisera were used to identify the 
serogroup of the isolated Salmonella on original culture. Vi antisera (along with 0:9) 
was used to identify S. Typhi; these were excluded from all analyses. All NTS isolated 
from blood cultures were stored in Brain Heart Infusion (BHI) glycerol at -70oC. For the 
purposes of this study all NTS isolated were recovered on MacConkey agar and 
subjected to re-identification and antimicrobial susceptibility testing. Re-identification 
of Salmonella serogroups was performed using specific grouping antisera as before. 
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Antimicrobial susceptibility testing was performed on Muller-Hinton agar against 
ampicillin, amoxicillin/clavulanate, azithromycin, ceftazidime, ceftriaxone, 
chloramphenicol, ciprofloxacin, gentamicin, nalidixic acid, ofloxacin and trimethoprim-
sulfamethoxazole, using the disk diffusion method as recommended by CLSI 
guidelines.  
 
To further characterize the iNTS isolates, all organisms were genotyped (and molecular 
serotyped) using multi-locus sequence typing (MLST) following previously described 
methods. Briefly, a set of seven housekeeping genes (aroC, dnaN, hemD, hisD, purE, 
sucA and thrA – primer sequences accessed at 
http://mlst.warwick.ac.uk/mlst/dbs/Senterica) (Table 2.3) were PCR amplified using 
template DNA extracted from each isolate after boiling bacterial colonies in phosphate 
buffered saline. PCR amplicons were cleaned using Agentcourt Ampure XP (Beckman 
Coulter) and were sequenced in both directions using BigDye Terminator v3 (Applied 
Biosystems, USA) followed by capillary sequencing on a 3130XL Genetic Analyzer 
(Applied Biosystems, USA). All sequences were manually trimmed to align to a 
reference sequence and were submitted to the previously mentioned MLST database for 
allelic profile and molecular serotyping (i.e. inferring serovar from MLST profile). A 
minimum spanning tree was created using the allelic profiles (variation in number of 
alleles between isolates of the seven housekeeping genes) using Bionumerics software 
(Applied Mathematics). 
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Table 2. 3 Primers for primary PCR to detect 7 house-keeping genes of nontyphoidal 
Salmonella(Noda et al., 2011) 
House-keeping gene Sequence (5’-3’) 
thrA GTC ACG GTG ATC GAT CCG GT 
purR ATG TCT TCC CGC AAT AAT CC 
sucA AGC ACC GAA GAG AAA CGC TG 
hisD GAA ACG TTC CAT TCC GCG CAG AC 
aroC CCA CAC ACG GAT CGT GGC G 
hemD CCA CAC ACG GAT CGT GGC G 
dnaN ATG AAA TTT ACC GTT GAA CGT GA 
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 Method for chapter 6: A descriptive study about the progress of 
antimicrobial resistance of Salmonella species and comparison between several 
susceptibility testing methods for Salmonella species 2008-2015:  
2.2.4.1 Study design and setting 
This was a descriptive study testing the antimicrobial susceptibility profiles of 
Salmonella spp. isolated from blood cultures at the HTD over 8 years (2008-2015) 
period. All organisms were tested by 3 methods: E-test, disk diffusion, and automatic 
VITEK 2 system. 
 
2.2.4.2 Ethical approval 
This study was a part of the large study 15EN (HTD research code CS/ND/14/20), 
which was approved by the Ethical Review Board of HTD. 
 
2.2.4.3 Sample collection 
All Salmonella organism isolated from blood cultures were routinely stored in 
Microbiology laboratory of HTD. The strains were stored at -40oC in glycerol brain-
heart-infusion cryotubes. 
When recovered, all Salmonella organisms were extracted from the stock and 
subcultured for two generations on MacConkey agar. Young and pure colonies were 
picked up for re-identification and antimicrobial susceptibility testing. All Salmonella 
were re-identified by routine biochemical tests and antisera. Isolates were identified as 
S. Typhi, S. Paratyphi A, B, C or Salmonella spp. using conventional biochemical 
testing and Salmonella polyvalent antisera (polyvalent O, O2, O4, O9 and Hd). 
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2.2.4.4 Antimicrobial susceptibility testing 
All Salmonella were tested by disc-diffusion, E-test and by automatic susceptibility test 
by VITEK system at together. The antimicrobials tested by disc-diffusion (Kirby-
Bauer), and E-test were nalidixic acid, ofloxacin, ciprofloxacin, azithromycin, 
trimethoprim-sulfamethoxazole, ampicillin and ceftriaxone. These antimicrobials are 
common used for Salmonellosis treatment at HTD. Chloramphenicol was performed by 
disk-diffusion to determine MDR resistant Salmonella (resistant to chloramphenicol, 
ampicillin, and trimethoprim-sulfamethoxazole). 
 
For the VITEK system, there are no available antimicrobial susceptibility cards 
containing all the antimicrobial listed above. Nalidixic acid and azithromycin were not 
been produced in any commercial cards VITEK cards available in Vietnam at the time 
of this work. Ofloxacin and ciprofloxacin are also not combined on any card, so that I 
selected a VITEK card containing only one. Finally, I used the most appropriated 
VITEK AST card (AST GN67) which contained ampicillin, ceftriaxone, ciprofloxacin, 
trimethoprim-sulfamethoxazole, and variety of less clinically relevant antimicrobials. 
 
2.2.4.5 Interpretation of antimicrobial testing result 
Interpretation of all testing antibiotics is described in Table 2.4. 
Susceptibility interpretation for all antimicrobials (except ofloxacin) was determined 
using the CLSI guidelines M100-S25 (2015)(Clinical and Laboratory Standards 
Institute, 2015).  Susceptibility results are presented as Susceptible (S), Intermediate (I) 
and Resistant (R). There were no diameter breakpoints for ofloxacin in latest CLSI 
guidelines (CLSI deleted the paper breakpoint for this antimicrobial from 2013). 
However, some research groups have evaluated the breakpoints for ofloxacin using the 
presence of resistant genes and MIC. According to Parry et al (2010), an interpretation 
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of Salmonella which is to susceptible against ofloxacin by disk inhibition zone diameter 
≤ 28 mm (or MIC ≤0.25 µg/ml) has a sensitivity and specificity of  >94%(Parry et al., 
2010). However, the author did not suggest breakpoints for intermediate and resistance 
mutations were screened in the gyrA gene only. In 2014, a group in the US set a zone 
diameter breakpoint for ofloxacin: ≥25 mm (Susceptible), 16 to 24 mm (Intermediate), 
and ≤15 mm (Resistant) using the MIC breakpoints in CLSI M100-S23(Sjölund-
Karlsson et al., 2014). This diameter breakpoint was established from testing 100 
Salmonella whose with resistance mechanisms identified by PCR and sequence in the 
both gyrA and parC genes.  
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Table 2. 4 Susceptibility interpretation of Salmonella species by Clinical Laboratory 
Standard Institute M100-S25 (2015) and other researches 
Antimicrobial 
agent 
 
Zone diameter interpretive criteria 
(mm) 
MIC interpretive criteria (µg/ml) 
 Susceptible Intermediate Resistant Susceptible Intermediate Resistant 
Ampicillin ≥ 17 14–16 ≤ 13 ≤ 8 16 ≥ 32 
Ceftriaxone ≥ 23 20–22 ≤ 19 ≤ 1 2 ≥ 4 
Azithromycin ≥ 13 - ≤ 12 ≤16 - ≥ 32 
Ofloxacin ≥ 
25(Sjölund-
Karlsson et 
al., 2014) 
 
16-
24(Sjölund-
Karlsson et 
al., 2014) 
 
≤ 152v58 
 
≤0.12 
 
0.25-1 ≥2 
 
Ciprofloxacin 
 
≥ 31 
 
21-30 
 
≤20 
 
≤0.06 
 
0.12-0.5 
 
≥1 
Nalidixic acid ≥ 19 14-18 ≤ 13 ≤ 16 - ≥ 32 
Trimethoprime- 
sulfamethoxazol 
≥ 16 11-15 ≤ 10 ≤ 2/38 - ≥ 4/76 
Chloramphenicol ≥ 18 13-17 ≤ 12 ≤ 8 16 ≥ 32 
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2.2.4.6 E -test method as a reference 
Although agar dilution is considered as the best reference method for antimicrobial 
susceptibility testing, it is not a common method for antimicrobial testing in clinical 
laboratory due to procedure. The E-test method has been reported to produce an 
acceptable antimicrobial result as comparison for the agar dilution method(Amsler et 
al., 2010; Heijden et al., 2007; Tan and Ng, 2007). Therefore, this study utilised the E-
test method as a reference to evaluate the Kirby-Bauer method and the VITEK system.  
 
2.2.4.7 Definition of categorical agreement and errors 
Categorical agreement between methods was defined as the percentage of isolates 
tests results that exhibit the same susceptibility rank with the reference method (E-test 
method). A Minor error was defined as susceptible or resistant with the comparison 
method (Kirby-Bauer or VITEK) and intermediate by using the reference method (E-
test) and vice versa. A Major error was defined as the resistant with the Kirby-Bauer 
or VITEK methods and susceptible by E-test method. A very major error was defined 
as susceptible with the compared method (Kirby-Bauer or VITEK) and resistant by the 
E-test (Ling et al., 2001).  
 
2.2.4.8 Antimicrobial resistant data 
Data are presented in the form of tables and bar charts for the descriptive variables i.e. 
number of specific Salmonella species (S. Typhi, S. Paratyphi, and NTS) per year and 
number of resistant organisms per year. The resistance profiles of specific Salmonella 
spp. against each antimicrobial are presented by the MIC90 and the MIC50. 
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2.2.4.9 Comparison between antimicrobial testing methods 
ISO 20775:2007 standard: The comparison of antimicrobial testing methods was 
conducted according to ISO 20776:2007. ISO 20776:2007 is an international standard 
for evaluation of performance of antimicrobial testing methods(International 
Organisation for Standardization, 2007). I intended to compare the susceptible, 
intermediate and resistant results of the Kirby-Bauer (disk diffusion test) and VITEK 
method in comparison with the E-test method (reference method). The comparison 
parameters included category agreement (CA), very major discrepancy (VMD), major 
discrepancy (MJD) and minor discrepancy (MD). Acceptable results are category 
agreement (CA) ≥90%, and a VMD and MD ≤ 3% as recommended by the ISO 
20776:2007(International Organisation for Standardization, 2007). However, according 
to CLSI M23-A2, acceptable results are <1.5% for very major errors, <3 % for major 
errors, and <10% for minor errors.  
 
Comparison formulas 
Categorical agreement (CA): agreement of antimicrobial susceptibility testing result 
between the comparison test and the reference test. The result is expressed as a 
percentage. 
 
(NCA: the number of isolates with the same categories (SIR) with the reference method; 
N:  the number of all tested isolates) 
 
 
 NCA x 100 
CA =   
        N 
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Very major discrepancy (very major error) (VMD): test result by the reference method 
interpreted as resistant and a comparative test result of susceptible. The result is 
expressed as a percentage. 
 
 
 
 
(NVMD: the number of tests that result in a VMD; NRREF: the number of resistant 
bacterial isolates as determined by the reference method) 
 
 
 
 
Major discrepancy (Major error) (MJD): Test results are resistance by the comparison 
test and susceptible by reference method. The result is expressed as a percentage. 
 
 
 
 
 
(NMD: the number of tests that results in a major discrepancy (MD); NSREF: the 
number of susceptible isolates as determined by the reference method) 
 
 
 NMD X 100 
MJD= 
     NSREF 
 
 NVMD X 100 
VMD= 
     NRREF 
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Minor discrepancy (MnD) (minor error): Test result by the reference method interpreted 
as resistant or susceptible and a comparison test result of intermediate; or a reference 
result interpreted as intermediate and a compared test result of resistant or susceptible. 
The result is expressed as a percentage. 
 
 
 
 
(NMD is the number of tests that result in an MD; N is the total number of isolates 
tested) 
  
 
 NMD X 100 
MnD= 
     N 
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Chapter 3 
Bloodstream infections at the Hospital for Tropical Diseases in Ho Chi 
Minh City from 2010 to 2014 
 
 Aims of Chapter 
The main objectives of this study were to identify and describe the major bacterial 
pathogens associated with BSI at HTD over a five-year period. Additionally, I sought to 
investigate trends in antimicrobial resistant profiles of the main pathogens, and to 
determine the source of infection (community or hospital) of isolates to identify the 
principal location associated with the acquisition of acquiring a bacterial infection 
associated with a multi-drug resistance. 
 
  Introduction 
In HTD, BSI is an important disease that requires close management and intensive 
treatment. Every year, approximately 7,000-8,000 blood cultures are performed in this 
hospital. In local general practice a blood culture is requested for every suspected case 
of BSI  alongside other general blood tests. Systematically, all HIV-infected cases have 
blood culture after admission. Identification and susceptibility result from blood culture 
play an important role in antimicrobial selection and therapy amendment in individual 
cases. Antibiograms at HTD are required to be reported annually but not for specific for 
BSI pathogens. Important antimicrobial resistance phenotypes such as ESBL, AmpC 
lactamases, MRSA, carbapenemase-resistance, vancomycin-resistant enterococcus, 
have been found in this hospital in recent years but their circulating and commonality 
have not been determined. This data chapter develops an understanding of BSI at HTD 
over a five-year period. Specially, I describe the characteristics of blood cultures, 
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including positive rate, contamination rate, and outcome. I additionally determine 
pathogenic organisms causing BSI in HTD in the context of proportion, initial infection 
source, ICU infection, and outcome categories. Lastly, I assessed the trend of the 
antimicrobial susceptibility patterns of common pathogens versus selected antimicrobial 
groups.  
 
 Results 
 Overall characteristics of blood culture in HTD 
Over the five years (2010-2014) of available data from HTD there were 47,304 blood 
samples submitted to the microbiology laboratory for culture (Table 3.1). The number 
of blood samples taken for culture were comparable in 2010 and 2011 (<9,000) but then 
increased to more than >9,000 (>10,000 in 2013) in the following years. Over this five-
year period, 3,852 samples exhibited growth, resulting in an overall prevalence of 
8.14% (3,852/47,304) positive blood cultures. From the 3,852 (8.1%) positive samples, 
3,287 (6.9% of 47,304) were considered to non-contaminant and 565 (1.2% of 47,304) 
were considered to be contaminant. Therefore, the median rate of non-contaminant 
positive blood cultures was 7.0% (range; 6.1-7.3); the lowest rate of positive blood 
cultures was in 2011 (541/8,781; 6.1%) and the highest rate was in 2012 (715/9,774; 
7.3%). A microbiology consultant and a clinician attending the affected patient made 
the final decision on every potentially contaminated blood culture. The most common 
contaminants in blood culture were Burkholderia cepacia (329/565; 58.2%) and 
coagulase-negative Staphylococcus (206/565; 36.5%). Notably, over two thirds 
(384/565; 68%) of the contaminated blood cultures were taken from patients on the 
HTD HIV ward. 
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 Bloodstream infections by ward 
HTD has 14 clinical wards, which include three ICUs wards (adult ICU, paediatric ICU, 
and central nervous system infection ICU), six adult general wards, four general 
paediatric wards, and one HIV ward. The prevalence of positive blood cultures in each 
of the 14 HTD wards over the study period is described in Table 3.2. The adult ICU and 
HIV ward accounted for the largest proportion of positive blood samples (23.8%; 
780/1,091 and 22.3%; 762/1,091; of all positive blood samples, respectively). The HIV 
ward additionally had the greater proportion of positive blood samples from all the 
wards in 2010 and 2011. However, from 2012 the adult ICU produced a greater 
proportion of positive blood than other wards. A third (1,092/3,287; 33%) of all positive 
blood culture originated from the three ICUs. 
 84 
Table 3. 1 The number and proportion of total blood cultures, positive blood cultures and 
contaminated blood cultures at HTD, 2010-2014 
Year 
 
No of 
admissions 
No of blood cultures 
collection (% 
admission) 
 
No of positive blood 
cultures (%admission) 
 
No of contaminated blood 
cultures (%collection) 
 
No of true positive 
blood cultures 
(%admission) 
 
2010 45,695 8,777 (19.2) 782 (1.7) 143 (1.6) 639 (1.4) 
2011 48,017 8,781 (18.3) 621 (1.3) 80 (0.9) 541 (1.1) 
2012 51,151 9,774 (19.1) 869 (1.7) 154 (1.6) 715 (1.4) 
2013 45,910 10,346 (22.5) 841 (1.8) 115 (1.1) 726 (1.6) 
2014 44,321 9,631 (21.7) 739 (1.7) 73 (0.8) 666 (1.5) 
Total 235,094 47,309 (20.1) 3,852 (1.6) 565 (1.2) 3,287 (1.4) 
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Table 3. 2 The number and proportion of positive blood cultures by ward at HTD, 2010-
2014 
 
Clinical ward 
No of admission No (%) of true  
positive cultures 
 % of true positive 
culture/admissions  
ICU wards 25,933 1,091 (33.2)  4.2 
Adult ICU 6,566 780 (23.8)  11.9 
Paediatric ICU 13,130 87 (2.6)  0.7 
Central nervous system ICU 6,237 224 (6,8)  3.6 
HIV ward 12,406 962 (22.3)  7.8 
Non- ICU adult ward 98,320 1,126 (34.9)  1.2 
Infection ward A 15,975 311 (9.5)  1.9 
Infection ward B 13,407 372 (11.3)  2.8 
Infection ward C 19,873 118 (3.6)  0.6 
Infection ward D 18,345 93 (2.8)  0.5 
Internal ward A 17,063 70 (3.1)  0.4 
Internal ward B 13,657 162 (4.9)  1.2 
Children Wards 93,555 108 (3.3)  0.1 
Children ward A 25,536 30 (0.9)  0.1 
Children ward B 21,613 25 (0.8)  0.1 
Children ward C 23,656 17 (0.5)  0.07 
Children ward D 22,750 36 (1.1)  0.2 
Total 217,808 3,287 (100)  1.5 
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In the non-ICU wards the majority of positive blood cultures originated from infection 
ward B, (11.3% (372/1,091) of all positive cultures) which receives patients with 
prolonged fever, and Infection ward A, (9.3%(311/1,091) of all positive cultures), 
which receives patients with severe hepatitis.  
 
 Outcome 
The characteristics of BSI stratified by ICU admission, outcome, and sex are presented 
in Table 3.3. The patients’ outcome was obtained from 2,572 cases, which accounted 
for 66.7% (2,572/3,287) of the total blood culture positive study population. Missing 
outcome data was due to unavailable information on the hospital database, mostly in 
2014 due to storage error (missing 96.4% (642/666) outcome data). For the purposes of 
this work, outcome was categorized as good (discharged with recovery), bad (death or 
discharged to die home (a local custom, called moribund)) or unknown (patient 
transferred to another hospital or self-discharges). I found that 1,667/ 2,572 cases 
(64.8%) had a good outcome and 619/2,572 cases (24%) had a bad outcome. The 
overall mortality rate for those with a positive blood culture was 3.4% (87/2,572); a 
further 20.6% (532/2,572) were recorded as moribund. The mortality rate (bad outcome) 
was 24.5% (155/633) in 2010, 25.8% (133/516) in 2011, 26.3% (183/696) in 2012, and 
20.5% (144/703) in 2013. 
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Table 3. 3 The number and proportion of positive blood cultures by aetiology of infection, outcome, and ICU hospitalization at HTD, 2010-2014. 
 Total 
N(%) 
Etiology of infection 
N=2,539 
Outcome 
N=2,572 
ICU admission 
N=2,325 
  
3,287 
CA 
2,129 
(83.9) 
HA 
410 
(16.1) 
OR p Good 
1,667 (64.8) 
Bad 
619 
(24.1) 
OR p Yes 
1,091 (46.9) 
No 
1,234 
(53.1) 
OR p 
Gender              
Male 2,102  1,374 (65.4) 275 (13.1) 0.97 0.3 1,037 (49.3) 443 (21.1) 17.3 <0.001 709 (33.7) 686 (32.6) 21.29 <0.001 
Age   2,129 410   1,667 619   1,091 1,234   
Age <5 years 
(baseline)  
141a  76 (53.8) 29 (20.6) 1 … 99 (70.2) 2 (1.4) 1 … 56 (39.7) 85 (60.3) 1 … 
Age 5-15 years  56b  
 
35 (62.5) 4 (7.1) 
 
4.9 0.03 30 (53.6) 5 (8.9) 8.1 0.05 30 (53.6) 26 (46.4) 3.3 0.07 
Age 16-60 years  2,476c 1,648 (66.6) 285 (11.5) 12.7 <0.001 1,205 (48.7) 542 (21.9) 39.2 <0.001 706 (28.5) 813 (32.8) 2.7 0.1 
Age >60 years 614d 370 (60.3) 92 (15.0) 3.0 0.08 333 (54.2) 70 (11.4) 15.6 <0.001 299 (48.7) 310 (50.5) 4.39 0.04 
 
Table shows aetiology of infection of 2,539 BSI cases, outcome at discharge of 2,572 BSI cases and of 2,325 cases stratified by ICU/non-ICU care. Pairwise 
comparison using X2 test, p<0.05 was considered as significant. CA: community-acquired infection, HA: hospital-acquired infection. ICU category was 
determined based on the site of the blood culture collection. 
aAge < 5 years: 36 missing in etiology, 40 missing in outcome group;b Age 5-15 years: 17 missing in etiology, 21 missing in outcome group; 
c Age 16-60 year: 543 missing in etiology, 729 missing in outcome group, 957 missing in ICU admission group;d Age >60 years: 152 missing in etiology 
group, 211 missing in outcome group, 5 missing in ICU admission group.  
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 Characteristics of patients with bloodstream infections 
In the 3,287 clinically relevant bloodstream infection episodes, 197 (6%) cases were in 
children aged <15 years, 2,476 (75.3%) were within those aged 15-60 years, and 614 
(18.7%) of cases were in patients aged >60 years. The mean age was of those with a 
clinically relevant bloodstream infection was 42 years old (IQR 29-56). In total 64% 
(2,102/3,287) of clinically relevant bloodstream infection episodes was in males. This 
distribution was more apparent in those aged under 60 years; 1,828 cases in males vs. 
845 cases in females. However, there were more female than male patients (340 cases 
vs. 274 cases, respectively) in the elderly age group (those aged >60 years). In the 2,539 
BSI with definable aetiology of infection, 16.1% (410 cases) was hospital-acquired 
infection. Patients aged between 5 and 15 years, 15 and 60 years and more than 60 years 
were more commonly associated with BSI in community (p<0.05) (Table 3.3).  
 
 Significant pathogens 
Bacteria and fungi pathogens were commonly isolated in bloodstream infection at HTD 
from 2010 to 2014. Overall, the proportion of bacteria isolation was four times higher 
than fungi; 2,650 cases (80.6%) vs. 637 cases (19.4%), respectively. The relative 
proportion of bacteria isolated from blood increased gradually every year (2010: 76%, 
2011: 80%, 2012 and 2013: 81%, 2014: 85%) (Figure 3.1).  
 
From the 2,650 bacterial pathogens isolated over the study period, Gram-negative 
bacilli were the most prevalent (1,748/2,650; 65.9%), followed by Gram-positive cocci 
(886/2,650; 33.4%), Gram-negative cocci (8/2,650; 0.3%), and Gram-positive bacilli 
(8/2,650; 0.3%) (Table 3.4)
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Figure 3. 1 The proportion of significant bacterial and fungal isolates in bloodstream 
infection at HTD from 2010 to 2014.  
 
Plot showed the number of cases that had blood culture grew bacteria (blue area) or fungi (red 
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Table 3. 4 The number and proportions of Gram-negative, Gram-positive, fungal 
pathogens isolated from bloodstream infections at HTD from 2010 to 2014 
 
a Data presented as actual counts and percentages (%), b Total number of positive blood cultures 
per year (plus additional organisms not included in the table). CNS: coagulase-negative 
Staphylococcus 
 
 
  
Pathogen a 2010 2011 2012 2013 2014 Total 
Gram negative bacteria       
Escherichia coli 
103 
(16.12) 
97 (17.92) 168 (23.50) 163 (22.45) 156 (23.42) 
687 (20.9) 
Klebsiella spp. 60 (9.38) 35 (6.46) 55 (7.69) 54 (7.44) 52 (7.81) 256 (7.9) 
Non-typhoid Salmonella 35 (5.48) 33 (6.09) 31 (4.48) 31 (4.96) 34 (5.10) 
 
164 (5.0) 
Salmonella Typhi 21 (3.28) 14 (2.58) 20 (2.80) 9 (1.24) 7 (1.05) 71 (2.7) 
Salmonella Paratyphi A 0 (0.00) 1 (0.18) 1 (0.14) 6 (0.83) 17 (2.55) 25 (0.8) 
Burkholderia pseudomallei 13 (2.03) 13 (2.40) 15 (2.10) 19 (2.62) 14 (2.10) 
 
74 (2.3) 
Burkholderia cepacia 0 (0.00) 15 (2.77) 10 (1.40) 1 (0.14) 6 (0.90) 32 (1.0) 
Acinetobacter 16 (2.50) 19 (3.51) 24 (3.36) 25 (3.44) 10 (1.50) 94 (2.9) 
Pseudomonas aeruginosa 14 (2.19) 9 (1.66) 18 (2.52) 12 (1.65) 14 (2.10) 67 (2.0) 
Aeromonas 11 (1.7) 15 (2.8) 14 (1.95) 26 (3.58) 25 (3.75) 91 (2.8) 
Gram positive bacteria       
Staphylococcus aureus 50 (7.82) 47 (8.69) 50 (6.99) 68 (9.37) 57 (8.56) 272 (8.3) 
CNS 39 (6.10) 6 (1.10) 3 (0.42) 3 (0.41) 5 (0.75) 56 (1.7) 
Streptococcus suis II 34 (5.32) 30 (5.54) 18 (2.51) 27 (3.71) 14 (2.1) 123 (3.7) 
Streptococcus pneumoniae 16 (2.50) 20 (3.69) 20 (2.80) 32 (4.41) 26 (3.90) 114 (3.5) 
Other Streptococci 44 (6.9) 29 (5.36) 60 (8.39) 41 (5.64) 51 (7.66) 225 (6.9) 
Fungi       
Cryptococcus neoformans 80 (12.51) 63 (11.64) 62 (8.67) 76 (10.47) 52 (7.81)       333 (10.1) 
Talaromycetes marneffei 70 (10.95) 41 (7.57) 73 (10.21) 53 (7.30) 48 (7.21) 285 (8.7) 
Total b 639 541 715 726 666 3,287 
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Figure 3. 2 The distribution of bloodstream pathogens during 2010-2014 period  
 
 
 
Hospital admission: 235022 
Blood cultures: 47,309 
True positive cultures: 3,287 
True positive culture rates: 6.9% 
 
Pie charts showing combined data from 2004--2008. Proportions correspond to the organisms 
represented in the chart only (total data is shown in Table 3.4) and are shaded by E.coli (red), 
Klebsiella ( green), nontyphoidal Salmonella and typhoidal Salmonella (marine), Pseudomonas 
and Acinetobacter and Aeromonas (peach), Gram-positive organisms( Streptococcus and 
Staphylococcus) (purple), fungi (C.neoformans and T.marneffei) (olive) and other bacteria 
(white blue). 
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All eight of the Gram-negative cocci were Neisseria meningitidis serogroup b, and the 
eight Gram-positive bacilli included five Listeria cytomonogenes, one Corynebacterium 
bovis, one Pleistophora spp. and one Nocardia spp.  
 
3.3.5.1 Gram-negative organisms  
The Gram-negative bacilli were the most common group of pathogenic bacteria isolated 
(Figure 3.3). This group was comprised of the Enterobacteriaceae and the non-
Enterobacteriaceae. E. coli was the most common bacterium isolated from blood in this 
hospital every study year, with a mean isolation rate of 20.9% (687/3,287) of all 
pathogens across the fours year (Figure 3.2). There was an increase in the number 
isolated every year apart from 2011 over the study period (Figure 3.3). I additionally 
found that BSI associated with E.coli were significantly more commonly associated 
with community-acquired infections than hospital-acquired infections (p<0.01). Further, 
E.coli BSI were significantly more associated with the general wards than the ICUs, and 
more commonly resulted in good outcome (p<0.001) (Table 3.5).  
 
The second most common pathogen was Klebsiella spp. in which K. pneumoniae 
predominated (254/256, 99.2%). The number of Klebsiella remained relatively 
consistent annually, and the proportion was three time less than E.coli (Table 3.4 % 
Figure 3.2). There was no significant association of Klebsiella bloodstream infection 
arising with community or hospital acquired infections or outcome (Table 3.5, Figure 
3.3). 
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Figure 3. 3 The distribution of pathogens isolated from bloodstream infections by year 
(2010 -2014) at Hospital for Tropical Diseases.  
 
 
Data is presented in real numbers (A) and percentages (B) for the main groups of pathogens 
causing BSI annually. Orange: Enterobacteriaceae; light green: filamentous fungi, green: non-
Enterobacteriaceae; blue-green: unclassified organism; marine-blue: Staphylococci; purple: 
Streptococci; pink: yeast. 
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Table 3. 5 Causative pathogens by etiology of infection, outcome and ICU.  
Pathogen Total 
N(%
) 
 Etiology of infection 
N=2,539 
 Outcome 
N=2,572 
 ICU admission 
N=2,325 
  CA 
2,129 
( 83.9) 
HA 
410 
(16.1) 
X2 p Good 
1,667 
(64.8) 
 
Bad 
619 
(24.1) 
X2 p Yes 
1,091 
(46.9) 
No 
1,234 
(53.1) 
X2 p 
E.coli 687 465 (21.8) 67 (16.3) 6.3 0.01 395 (23.7) 96 (15.5) 17.9 <0.001 213 
(19.5) 
394 
(31.9) 
46.1 <0.001 
Klebsiella 252 164 (7.7) 30 (7.3) 0.07 0.78 124 (7.4) 46 (7.4) 0.01 0.92 71 (6.5) 24 (1.9) 31.1 <0.001 
S.Typhi 96 64(3.0) 6(0.7) 3.1 0.8 69 (4.1) 0 (0) 26.4 <0.001 4 (0.4) 91 (7.4) 72.6 <0.001 
Salmonella spp.  164 118 (5.5) 9 (2.2) 8.1 0.004 77 (4.6) 34 (5.5) 0.75 0.38 32 (2.9) 34 (2.8) 0.07 0.79 
Acinetobacter 101 25 (1.2) 60 (14.6) 192 <0.001 52 (3.1) 25 (4.0) 1.2 0.27 71 (6.5) 24 (1.9) 1.2 <0.001 
P.aeruginosa 67 29 (1.4) 20 (4.9) 14.6 <0.001 22 (1.3) 20 (3.2) 9.1 0.002 34 (3.1) 12 (1) 13.7 <0.001 
Aeromonas 91 58 (2.7) 6 (1.5) 2.2 0.13 39 (2.3) 20 (3.2) 1.4 0.23 49 (4.5) 33 (2.7) 5.6 0.01 
S.pneumoniae 114 77 (3.6) 7 (1.7) 3.9 0.05 61 (3.7) 15 (2.4) 2.1 0.14 46 (4.2) 51 (4.1) 0.01 0.92 
S.suis 123 104 (4.9) 2 (0.5) 16.6 <0.001 96 (5.8) 4 (0.6) 28.2 <0.001 93 (8.5) 29 (2.4) 44.4 <0.001 
Other 
Streptococcus 
225 150 (7) 17 (4.1) 4.7 <0.001 105 (6.3) 20 (3.2) 8.2 0.004 62 (5.7) 145 
(11.8) 
26.2 <0.001 
Enterococcus 38 14 (0.7) 15 (3.7) 27.4 <0.001 18 (1.1) 9 (1.5) 0.5 0.46 18 (1.6) 14 (1.1) 1.1 0.28 
S.aureus 272 170 (8) 41(10) 1.8 0.17 108 (6.5) 57 (9.2) 5.0 0.025 97 (8.9) 95 (7.7) 1.1 0.29 
Fungi 637 464 (21.8) 39 (9.5) 32.6 <0.001 292 (17.5) 196 (31.1) 53.8 <0.001 75 (6.9) 44 (3.6) 13.0 <0.001 
 
Table showed comparison data for 12 main pathogens in bloodstream infection by etiology of infection (2,539 cases), available outcome on discharge 
(2,572 cases) and by ICU/non-ICU care (2,572 cases). Pairwise comparison using X2 test, p<0.05 was considered as significant. 
ICU category was determined based on the site of the blood culture collection. 
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However, Klebsiella was more commonly associated from patients in the general wards 
than in the ICU wards (71/1,091 vs 24/1,234; p<0.001)( Table 3.5). 
 
Over the period of investigation 260 Salmonella were isolated, this included 96 S. Typhi 
and 164 non-typhoidal Salmonella (NTS). Typhoid fever, associated with S. Typhi, was 
found to be associated with a good outcome (full recovery on discharge) and less likely 
to arise in patients in the ICU (p<0.001) (Table 3.5). Notably, the number of NTS was 
greater that the number of S. Typhi. Further, and in comparable fashion to Klebsiella 
spp., the annual number of NTS isolated was relatively consistent (Figure 3.4). A 
notable characteristic of NTS cases is that 61.4% (97/158) of infections originated from 
HIV-infected patients. While S. Typhi exhibited an annual decline in number of 
isolations from 2010 to 2014, there was increase in the number of S. Paratyphi A (which 
causes a clinically indistinguishable disease from S. Typhi) isolated over the same 
period (Figure 3.4). None of those with a S. Typhi infection were HIV-infected.  
 
Less common Gram-negative bacteria isolated from blood cultures were the non-
fermenting bacilli. These included Acinetobacter spp., Pseudomonas aeruginosa, 
Burkholderia pseudomallei, and Burkholderia cepacia. A high proportion of 
Acinetobacter spp. and Pseudomonas aeruginosa (70.3% (71/94) and 50.7% (34/67), 
respectively) originated from the ICUs as apposed to the general wards (p<0.001). 
Acinetobacter spp. (most commonly A. baumanii) was the most frequently isolated non-
fermenting rod (94/3,287; 2.9% of all BSI) and were more commonly associated with 
hospital-acquired infections and critical care (p<0.001) (Table 3.5). 
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Figure 3. 4 Time trends of the Gram-negative bacteria isolated from blood at HTD 2010-2014 
 
Data was presented as percentage or actual count.  
Klebsiella and Klebs: Klebsiella spp.; NT Sal.: Non-typhoidal Salmonella; S.Par.A: Salmonella Paratyphi A; Acin: Acinetobacter spp. ; Pseud. : 
Pseudomonas aeruginosa. 
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P. aeruginosa was also more commonly associated with hospital-acquired infections 
and those undergoing critical care (p<0.001) (Table 3.5). Additionally, P. aeruginosa, 
but not Acinetobacter spp., were more likely to be associated with a bad outcome 
(p=0.002). There was no significant increase or decline in the trend of Acinetobacter 
spp., Pseudomonas aeruginosa, Burkholderia pseudomallei, or Burkholderia cepacia 
over the study period (Figure 3.4) 
 
3.3.5.2 Gram-positive organisms 
The Gram-positive organisms represented 30% of all bacterial pathogens and 24.1% of 
all bloodstream isolations (Table 3.4, Figure 3.5). The most commonly isolated Gram-
positive organisms were Staphylococcus aureus, Streptococcus suis, and Streptococcus 
pneumoniae, corresponding with 8.27% (272/3,287), 3.74% (123/3,287) and 3.47% 
(114/3,287) of all positive blood cultures, respectively (Table 3.4; Figure 3.5). The other 
Streptococci (including S. agalactiae, S .pyogenes, S. salivarius, and S. gordoni) 
represented only 6.85% (225/3,287) of all positive blood cultures. S. aureus and S 
.pneumoniae had showed an annual increasing trend over the five-year study period, 
whereas the coagulase negative Staphylococcus and other Streptococcus showed a 
decreasing trend over the same period (Figure 3.5); these changes with time were not 
significantly different. Over the study period there were 38/ 3,287 cases (1.2%) of 
enterococcus bloodstream infection. These infections were more likely to be associated 
with hospital-acquired infections than community-acquired infection (p<0.001) (Table 
3.5). However, there was no difference in outcome or ICU admission in these 
Enterococci BSI (p=0.46 and p=0.28) (Table 3.5). 
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Figure 3. 5 Time trends of the Gram-positive bacteria isolated from blood at HTD 2010-2014 
 
 
Data was presented as percentage or actual count.  
Str.pneu: Streptococcus pneumoniae; Str.spp.: Other Streptococcus spp. (except S.pneumoniae) 
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3.3.5.3 Fungi 
I found that Cryptococcus neoformans and Talaromyces marneffei (formerly known as 
Pennicillium marneffei) were the second and third most common pathogens isolated in 
the hospital over the period of investigation, (Table 3.4, Figure 3.2), representing 10.1% 
(333/3,287) and 8.7% (285/3,287) of the total positive blood cultures, respectively. 
Despite being the second and third most commonly isolated pathogens, these organisms 
did not exhibit an increasing or decreasing trend over the five-year period. Candida 
were infrequently isolated, with only 19 cases throughout the five years. 
 
 Source of infection 
Clinical data, describing a potentially associated source of infection were available for 
321 infections only. The most common causes of primary infection were respiratory 
tract infections (174/321; 54.2%), followed by urinary tract infections (65/321; 20%), 
gastrointestinal infections (63/321; 19.7%), and wound infections (19/321, 5.9%) (Table 
3.6). 
 
Among the 174 BSI associated with respiratory tract infections, S. pneumoniae was the 
most common pathogen isolated, representing 18% (31/174 cases) of all BSI associate 
with respiratory tract infections. All respiratory tract infection associated bacteraemia 
cases caused by S. pneumoniae were associated with community-acquired infections 
and had a good outcome on discharge. Notably, E.coli and Salmonella were the second 
and the third more common organisms isolated from blood in those with a 
corresponding respiratory tract infection (Table 3.6). S.aureus and K. pneumoniae were 
cultured from blood of 13 and 12 individuals who had community-acquired 
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pneumoniae. Among the 13 S.aureus cases, five had a good outcome, one case was 
discharged to die at home, and the remainder transferred to other hospitals.   
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Table 3. 6 Infection source associated with bacteraemia in 321 patients attending HTD 
 
 
 
 
 
 
 
 
* Data obtained from 321 patients with available source of BSI.
Infection source Number of pathogens* 1st 2nd 3rd 4th 5th 
Respiratory 174 
S. pneumoniae 
(31; 18%) 
E. coli 
(25; 14%) 
Salmonella 
(17;10%) 
S.aureus 
(13; 8%) 
Klebsiella 
(12; 7%) 
Urinary tract 
infection 
65 
E.coli 
(46;71%) 
Klebsiella 
(7; 11%) 
Streptococcus 
(4; 2%) 
Salmonella 
(3; 2%) 
S.aureus 
(2; 1%) 
Gastrointestinal 63 
E.coli 
(18; 29%) 
Salmonella 
(12; 19%) 
Klebsiella 
(4; 6%) 
Campylobacter 
(3; 5%) 
Many 
organism 
Skin and soft 
tissue 
19 
S.aureus 
(8; 42%) 
Klebsiella (3; 16%), Streptococcus (3; 16%), coagulase negative 
Staphylococcus (3, 16%) 
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Members of Enterobacteriaceae (E.coli, Klebsiella, and Salmonella) were the most 
common organisms associated with BSI from those who also had urinary tract 
infections (UTI) and gastroenteritis. E.coli was isolated from blood of 71% (46/65) of 
cases with UTI/bacteraemia and almost 29% (18/63) of the cases with 
gastroenteritis/bacteraemia. Of those patients with an UTI/bacteraemia the majority 
were community acquired (46/65; 74%) and had good outcome (33/46; 72%). In those 
with gastroenteritis/bacteraemia the proportion of was 29% (18/63); 78% (14/18) of 
these were community-acquired infections and 78% (14/18) had a good outcome. 
Notably, there were three gastroenteritis/bacteraemia caused by Campylobacter, a 
microaerophilic organism isolated from an aerobic blood culture vial. The patients with 
a Campylobacter bacteraemia additionally had hepatitis and diarrhoea on admission. 
Lastly, S.aureus (42%; 8/19) was an important cause of bacteraemia in those with 
wound infections and skin abscesses; five out of eight were associated with community-
acquired infections and had a good outcome (67%). 
 
 Antimicrobial susceptibility profiles 
3.3.7.1 Gram-positive bacteria 
Antimicrobial susceptibility testing was performed on isolation and the resulting data 
have been analysed for main antimicrobials used to treat Gram-positive infections. The 
resulting data were categorized into two groups: non-susceptible (resistant and 
intermediate resistance) and susceptible. Firstly, I examined the time trends for the 
Staphylococci, Streptococci, and Enterococci over the five-year period for the three 
main clinically relevant antimicrobials: penicillins, fluoroquinolones (ciprofloxacin or 
levofloxacin when available), and vancomycin (Figure 3.4). Overall, there was no 
significant change in the dynamics of susceptibility against these antimicrobials apart 
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from the enterococci, which had an increase in resistance against fluoroquinolones and 
an increase in susceptibility for penicillin.  
 
The S.aureus isolated over the study period (n=272) were characterized with high 
proportion of resistance against penicillin; 99% (269/272) of S.aureus isolated from 
blood were resistant to penicillin. Besides three main antimicrobial listed above, 
available susceptible results for S.aureus were also found from clindamycin, co-
trimoxazol and rifampicin. Non-susceptibility to other anti-Staphylococcal agents such 
clindamycin, ciprofloxacin, and co-trimoxazole were 72,0% (196/272), 44.5% 
(121/272), and 39.3% (107/272), respectively.  Methicillin resistant S.aureus (MRSA) 
accounted for 45.6% (124/272) of all isolated S.aureus during 2010-2014 (ranging from 
38.2% to 57.3% per year). Moreover, MRSA were associated with high rate of non-
susceptibility against of common antimicrobials. MRSA were significantly more likely 
to be non-susceptible to clindamycin, ciprofloxacin, and co-trimoxazole than in 
methicillin-susceptible S.aureus (MSSA) (p<0.001 for clindamycin and ciprofloxacin, 
p=0.003 for trimethoprim-sulfamethoxazol). Non-susceptibility against to rifampicin 
was less common, arising on only 16/272 infections (5.9%).  There were no S.aureus 
isolated that were non-susceptible to vancomycin, the maximum MIC against 
vancomycin (by E-test) over the study period was 2.0µg/ml. 
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Figure 3. 6 Annual non-susceptibility patterns of the three main Gram-positive species to 
penicillin, vancomycin, and fluoroquinolones at HTD, 2010-2014.   
 
Data presented in percentage on X- axis; estimated total count every year was presented by the 
size of the dot. Enterococcus sp. : red line (dot); Staphylococcus spp. : green line (dot); 
Streptococcus sp.: blue line (dot)..
 105 
 
S. pneumoniae was the most resistant antimicrobial member of the Streptococci. Very 
high non-susceptibility rates were recorded against erythromycin, clindamycin, and co-
trimoxazole, identified in 87.7% (100/114), 80.7% (92/114) and 79.8% (91/114) of 
organisms, respectively. In contrast, 91% (104/114) S. pneumoniae were susceptible to 
penicillin. The MIC50 and MIC90 against penicillin were 0.25 µg/ml and 0.75 µg/ml, 
respectively. All S. pneumoniae were susceptible to vancomycin. S. suis was also 
commonly isolated from febrile patients, however this organism was susceptible to all 
clinically relevant antimicrobials, including penicillin, ceftriaxone, and vancomycin. 
The MIC50 and MIC90 against penicillin for S. suis were 0.03 µg/ml and 0.06 µg/ml, 
respectively, which were lower than those recorded for the pneumococci. The MIC50 
and MIC90 against ceftriaxone in the isolated S. suis were also low (0.01 µg/ml and 0.1 
µg/ml, respectively). However, in a comparable fashion to S. pneumoniae, S. suis 
exhibited a high rate of non-susceptibly against macrolides; 48% (59/123) were non-
susceptible to erythromycin and 41% (50/123) were non-susceptible to clindamycin. 
The isolated beta hemolytic Streptococci included S. agalactiae (52.3%; 34/65), S. 
pyogenes(32.3%; 31/65),  S. dysgalactiae (15.4%; 10/65). These organisms were all 
susceptible to penicillin, ceftriaxone, vancomycin, and rifampicin. However, 80% 
(52/65) of the beta-hemolytic Streptococci were non-susceptible to tetracycline. The 
non-susceptibility rate to erythromycin, levofloxacin, and co-trimoxazole were 47% 
(31/65), 25% (16/25) and 15.4% (10/65), respectively. 
 
From the 38 isolated enterococci, 66% (25/38) were non-susceptible to 
fluoroquinolones (either ciprofloxacin or levofloxacin). None of the enterococci were 
susceptible to erythromycin, only 5/38 (13.1%) cases were susceptible to tetracycline. 
The overall resistance rate to penicillin and ampicillin was 31.6% (12/38) and 34.2% 
(13/38), respectively. Among all the enterococcus species, E. faecium was the species 
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with the broadest range of resistance to antimicrobials with 82% (9/11) of organisms 
being resistant to ampicillin, and 73%(8/11) being resistant to penicillin. Resistance 
against vancomycin was found only in one E. faecium isolate, this isolate had MIC 
against vancomycin of >256µg/ml, and was non-susceptible to all other antimicrobials 
tested, apart from linezolid. Notably, E. faecalis were more susceptible to beta-lactams 
than E. faecium, with only 31.8% (7/22) and 22.7% (5/22) of organisms being resistant 
to penicillin and to ampicillin, respectively. However, all E. faecalis were non-
susceptible to tetracycline and erythromycin; none were resistant to vancomycin, all had 
MICs <2µg/ml. 
 
3.3.7.2 Gram-negative bacteria 
Antimicrobial susceptibility testing was performed on isolation and the resulting data 
analysed for the main antimicrobials used to treat Gram-negative infections. The 
resulting data were categorized into non-susceptible (resistant and intermediate 
resistance) and susceptible as before. I examined the time trends for Acinetobacter spp., 
E. coli, K. pneumoniae, Pseudomonas spp., and Salmonella spp. over the five-year 
period against carbapenems, fluoroquinolones, and third generation cephalosporins 
(Figure 3.6). Over this period the general trend was a decrease in susceptibility to all 
these commonly used antimicrobials. The proportion of non-susceptibility against third 
generation cephalosporins increased from 40.8% (42/103) in 2010 to 60.8% (95/156) in 
2014, with a median annual increase of 4% (Figure 3.6). Comparatively, the proportion 
of E. coli that were non-susceptible to fluoroquinolones also increased annually, rising 
from 42.7%(44/103) in 2010 to 54.5% (85/156) in 2014. There was also an increasing 
trend of non-susceptibility to carbapenems from 1.0% (1/103) in 2010, to 3.8% (6/156) 
in 2014. The majority of E. coli isolates that had decreased susceptibility to 
carbapenems were intermediately resistant or resistance to ertapenem, a first generation 
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carbapenem. However, there was no antimicrobial non-susceptible profile for E.coli that 
was associated with poor outcome (p>0.05)(Table 3.7). Extended spectrum beta 
lactamase (ESBL) activity was recorded in 42.4% (291/687) of all isolated E. coli. 
AmpC lactamase activity was recorded in 0.8% (6/687) of all isolated E. coli. 
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Figure 3. 7 Annual non-susceptibility patterns of the five main Gram-negative species to 
carbapenems, fluoroquinolones, and third generation cephalosporins at HTD, 2010-2014. 
 
 
 Data presented in percentage on X- axis; estimated total count every year was presented by the 
size of the dot. Acinetobacter spp. : red line (dot); : olive line (dot); Klebsiella spp. : green line 
(dot); Pseudomonas spp.: blue line (dot); Salmonella spp.: purple line (dot) 
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Table 3. 7 Susceptibility profile of 491 E.coli against 3rd cephalosporin, carbapenem and 
fluoroquinolone in different outcome groups 
Outcome 3rd cephalosporin 
n (%) 
Carbapenem 
n (%) 
Fluoroquinolone 
n (%) 
 S 
395 (80.4) 
NS 
96 (19.6) 
S 
395 (80.4) 
NS 
96 (19.6) 
S 
375 (76.4) 
NS 
116 (23.6) 
Good 213 (53.9) 50 (52.1) 386 (97.8) 92 (95.8) 200 (53.3) 64 (55.2) 
Bad 182 (46.1) 46 (47.9) 9 (2.3) 4 (4.2) 175 (46.7) 52 (44.8) 
X2 0.1 1.07 0.03 
p 0.7 0.3 0.86 
 
Data obtained from 491 E.coli that had available antimicrobial profile for investigated 
antimicrobials. Pairwise comparison using X2 test, p<0.05 was considered as significant. 
S: susceptible; NS: non-susceptible 
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In comparison to E. coli, the isolated Klebsiella were less commonly resistant to third 
generation cephalosporins and fluoroquinolones. The annual prevalence of resistance 
against third generation cephalosporins ranged from 10% to 18%, while the annual 
prevalence of resistance against fluoroquinolones ranged from 7% to 22%. However, 
comparable to E. coli, the isolated Klebsiella had an annual increase in resistance to 
carbapenems; none of the Klebsiella were resistant to carbapenems in 2011 and 5.7% 
(3/52) were resistant in 2014. 
 
Salmonella 
Among the 96 S. Typhi isolated, an MDR phenotype (resistance to ampicillin, 
chloramphenicol, and trimethoprim-sulfamethoxazole) was recorded in 13 (14%) 
isolates, this proportion became fewer with time. Almost half (42/96; 44%) S. Typhi 
were non-susceptible to nalidixic acid. However, all isolated S. Typhi were susceptible 
to fluoroquinolones and third generation cephalosporins. The HTD microbiology 
laboratory did not test susceptibility for ampicillin and chloramphenicol routinely for 
the NTS; therefore data was not available for these two antimicrobials. Overall, 
resistance against third generation cephalosporins was rare with only 4/126 (3%) of 
NTS not susceptible to ceftriaxone. Non-susceptibility to the fluoroquinolones, 
ciprofloxacin and to ofloxacin was identified in 26/126 (21%) and 6/126 (5%) of 
organisms, respectively. Four NTS organisms were non-susceptible to both 
ciprofloxacin and ofloxacin. 
 
Acinetobacter 
The isolated Acinetobacter spp. generated a similar susceptibility pattern for 
cephalosporins, carbapenems, and fluoroquinolones. The non-susceptible trend tended 
to increase from 2011 to 2013 then decline in 2014. Morever, Acinetobacter was the 
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most non-susceptible organism against many antimicrobial classes (3rd cephalosporin, 
carbapenem, fluoroquinolone…) found in bloodstream infections. 43% (43/94) 
Acinetobacter had non-susceptible profile to three main classes: 3rd cephalosporin 
(ceftazidime), fluoroquinolone (either ciprofloxacin or levofloxacin) and carbapenem 
(imipenem and/or meropenem), and only susceptible to colistin. Ceftazidime 
nonsusceptibility was recorded in 48/94 (47.9%) cases while cefepime nonsusceptibility 
was in 50 cases (53%).  Non-susceptibility to imipenem and meropenem were high at 
56.4%( 53/94) and 44.7% (42/94).  Trimethoprim-sulfamethoxazole was ineffective in 
48%(48/94) of Acinetobacter. 
 
Pseudomonas 
Pseudomonas were the only Gram-negative organisms that increased in the proportion 
of non-susceptible isolates to multiple agents over the five-year period. Non-susceptible 
pseudomonas to ceftazidime and carbapenem increased from 0% (0/18) in 2012 to 
50%(7/14) in 2014. 17.4% (12/69) MDR Pseudomonas (mostly P. aeruginosa) were 
isolated in 2013 and 2014 (4 isolates in 2013 and 8 isolates in 2014). 
 
  The aetiology of common organism and common resistant mechanism 
Community or nosocomial 
The six most common BSI pathogens were stratified by their association with 
community or hospital acquired infection. Acinetobacter and Pseudomonas were 
significantly more associated with hospital acquired BSI than community acquired BSI 
(p<0.001) (Table 3.5). In contrast, E. coli, Salmonella, Streptococcus, and S.aureus 
were significantly more associated with community acquired BSI than in hospital 
acquired BSI (p<0.05 for and Salmonella, p<0.001 for Streptococcus and S.aureus) 
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(Table 3.5). Klebsiella were the only common pathogens that were not significantly 
associated with community acquired or hospital-acquired BSI (Table 3.5). 
 
Common resistant mechanisms  
I next analysed the prevalence of ESBL in the Enterobacteriaceae and MRSA, the two 
most clinical relevant resistant mechanisms associated with community/hospital-
acquired infections. ESBL activity was determined in 178/1,583 (9.4%) of the 
community-acquired BSI organisms and 45/441 (9.8%) of the hospital-acquired BSI 
organism. Therefore, the ESBL activity rate was not significantly difference between 
two groups (p=0.72, Fisher exact test). However, MRSA was found more commonly 
associated with hospital-acquired BSI than in community-acquired BSI (5.5% vs. 3.5%, 
respectively) ((p=0.06, Fisher exact test). 
 
 Seasonal variation 
In the south of Vietnam, there are two main seasons, a rainy season and dry season. The 
rainy season runs from April to October every year while dry season is in the 
intervening months. I analysed the seasonal distribution of two key organisms (E.coli 
and Salmonella). I observed that E. coli, the most common BSI pathogen had two 
seasonal peaks, one in April and one in September. This observation equated with more 
BSI associated with E.coli at the beginning and at the end of the rainy season. I found 
that BSI caused by Salmonella typically peaked between January March, July and 
October every year and declined at the end of the year. Therefore, the peak of 
Salmonella BSI infection mostly happened during rainy season (from April to October) 
( Figure 3.8 and Figure 3.9). 
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Figure 3. 8 Seasonal variation of E.coli in bloodstream infection in HTD during 2010-2014.  
 
 
Plot showing incidence of bloodstream infection due to E.coli among all pathogens every month 
during 2010-2014 period. 
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Figure 3. 9 Seasonal variation of Salmonella bloodstream infection in HTD during 2010-
2014.  
 
 
Plot showing incidence of Salmonella bloodstream infection among all pathogens every month 
during 2010-2014 period. 
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 Discussion 
In HTD, the annual positive rate of blood culture over the defined study period was 7% 
(6.1%-7.3%) which was lower than other hospitals in Asia and other continents (Ahmed 
et al., 2017; Crump et al., 2015; Orsini et al., 2012; Phetsouvanh et al., 2006; Sang Oh 
et al., 2015) . An explanation for lower culture frequency may include; only one blood 
vial was collected per episode, under filled blood bottle for culture, and the pre-
consumption of antimicrobials. Many studies have shown that sensitivity of  blood 
culture can reach up to  60% if more than 20ml of blood in inoculated into the 
bottle(Art, 2016) or at least recommended to use more than one bottle for blood 
culturing from adult patients(Lee et al., 2007). Additionally, although there was no 
information recorded about pre-antimicrobial consumption, I predict a high proportion 
of cases that receiving an antimicrobial before blood culturing, which is the most likely 
explanation for the low rate of positive blood cultures. Recent guidelines have 
suggested that using resin-media, which can absorb antimicrobials in the blood, and 
collecting enough blood volume can improve the rate of pathogens recovery from blood 
culture. Moreover, applying molecular method to improve the diagnostic rate and 
identify common resistant mechanisms may also be a promising solution. 
 
The low overall contamination rate of blood culture was low (1.2% (565/ 47,309)), 
which reflected good blood collection technique of the nursing staff in this hospital. 
However, there may have been potential errors on the decision of contamination 
because judgment was made through agreement between laboratory staff and an 
attending doctor based on the result of one blood culture sample for each infection 
episode. I strongly recommended that a set of two blood culture collections should be 
performed routinely in HTD, each culture from a different venous site so that 
contamination can be ruled out.  
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One distinctive contaminant in HTD was organisms belonging to the Burkholderia 
cepacia complex which accounted for 58% (329/565) of all contaminants. The decision 
of defining Burkholderia cepacia was for every individual case because this group of 
organisms can be defined as a pathogen in some situations, such as with the 
contamination of intravenous fluids (Doit et al., 2004; T. Singhal et al., 2015). I this 
context, there were 32 B. cepacia cases which were considered as to be associated with 
BSI, because they were collected from culture of HIV infected patients or those 
admitted to the ICU. It is known that B. cepacia complex has the capacity to survive in 
some disinfectants, therefore correct blood collection techniques should be re-taught 
annually for ICU staff and those working with HIV infected patients. Some skin 
preparation techniques, such as the initial specimen diversion technique, has been 
shown to reduce contamination by up to 30% in a study from Canada(Binkhamis and 
Forward, 2014). 
 
Coagulase negative Staphylococcus (CNS) were the second most common contaminant 
in HTD with rate of 36.5% (206/565) of all contaminated blood cultures. Most of these 
contaminated cultures were taken from the children’s ward and HIV ward. CNS is a 
common contaminant of blood culture in many reports(Gregson and Church, 2007; 
Kanoksil et al., 2013; Kiertiburanakul et al., 2012).  
 
In this study, one third of BSI (33.2%, 1,091/2.587) originated from the ICU wards and 
one fifth (22%, 962/2,587) were from HIV-ward. These two wards possessed the 
highest proportion of BSI in HTD over the five-year investigation. In many BSI studies, 
critical care units account for very high proportion of BSI because they receive severely 
ill patients, patients with underlying diseases, or those with the potential risk of 
hospital-acquired infections (Barnett et al., 2013; Timsit et al., 2014). In the epidemic 
areas a high prevalence of HIV infection, such as Southeast Asia and Africa, a large 
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proportion of BSI originated from HIV-infected patients. My study found that 22% 
(952/2,587) BSI was were HIV-seropositive patients, which was considerably lower 
than data obtained from a meta-analysis from Africa (53.5%, 1,217/2,273)(Reddy et al., 
2010). An explanation for this observation for is the availability of antiretroviral therapy 
and better nutrition care in Vietnam than in many African countries. 
 
I found that fatality rate in this study was 24% (619/2,572), which included death in the 
hospital and moribund. A recent publication originating from a tertiary hospital for 
infectious diseases in Northern Vietnam showed a higher fatality rate of 28.9% 
(138/477) of BSI during 2011-2013 (Dat et al., 2017).  However, a study of BSI from an 
African hospital, which included HIV and non-HIV infected patients had lower fatality 
rate of 14% in 2009. Notably, this study demonstrated a significantly reduction of 
mortality rate from 39% in 1997 to 14% in 2009 (p<0.001), after the introductions of 
ARTs (Feasey et al., 2014).  Although there was a decline in fatality outcome in HTD 
from 26.3% (183/696) in 2012, to 20.5% (144/703) in 2013, this declining trend was not 
as pronounced as in the African hospital study and ARTs were available in Vietnam 
during the entire study period.  
 
In my study, patient population had median age of 42 (IQR 29-56) years which was 
younger than BSI population in the north of Vietnam (48; IQR 36-60)(Dat et al., 2017). 
However, an even younger population admitted to hospital due to BSI was found in 
Southeast Asia: mean age 31 years old (IQR 27-38)(Jay K Varma et al., 2010) ; and 
Africa, 38 years old (IQR 14-96) in Tanzania(John A. Crump et al., 2011). These 
countries are all under-developed nations with an on-going HIV epidemic.  In contrast, 
BSI surveillances in developed countries generally has an older patient population 
(Skogberg et al., 2012; Wisplinghoff et al., 2003; Yahav et al., 2016). In comparison to 
this study, healthcare-associated and nosocomial BSI have been found more common in 
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older patients (Kaye et al., 2014; Mayr et al., 2014; Yahav et al., 2016). The elderly 
have been identified as being at risk of nosocomial infection in the guidelines for 
management of BSI (P. Dellinger et al., 2013). My study emphasizes the importance of 
clinical assessment for nosocomial BSI in patients aged over 60 years who are admitted 
in HTD. 
Males were the predominant sex in my study (63.9%; 2,102/3,287). Similar findings 
have been reported in studies of BSI in Vietnam, Asia, and other developing countries 
(Dat et al., 2017; Vlieghe et al., 2012)(Wisplinghoff et al., 2004)(Kiertiburanakul et al., 
2012). 
One limitation of my study was that data about age and sex of all patients in hospital 
during 2010-2014 were unable obtained. Therefore, it was impossible to clarify the 
differences of age and sex distribution between BSI patients with other types of hospital 
admission. 
 
The pathogen type in BSI is largely dependent on the characteristics of the patient 
population within the hospital. HTD is a non-surgery hospital which received both HIV 
and non-HIV infected patients. Therefore, fungi accounted for 19.4% (637/3,287) of 
total BSI in HTD; 87% of these 637 cases originated from HIV-infected patients. 
Fungal infections in HTD have been intensely researched at OUCRU for several years, 
mainly focusing on Cryptococcus neoformans and Talaromyces marneffei (Ho Dang 
Trung et al., 2012; Le et al., 2011). The proportion of fungi in BSI at HTD Vietnam was 
lower than that found (24%) fungi in a cohort study about BSI in a similar hospital in 
Thailand (Kiertiburanakul et al., 2012). I found that bacteria were the most common 
group of BSI pathogens at HTD accounting for 80.6% (2,650/3,287) of all infections; 
Gram negatives were a higher proportion than Gram positives (66.4% (890/2,650) vs. 
33.6% (1,760/2,650)). Dat et al. performed a BSI study in the north of Vietnam that 
showed a similar proportion of Gram-negative (69%) and Gram-positive (31%) as 
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found here.  The proportion of Gram-negative bacteria in my study was lower than other 
studies in Southeast Asia. BSI in Thailand was associated with 72% Gram-negative and 
28% Gram-positive bacteria (Kiertiburanakul et al., 2012); Cambodia was 78.9% Gram-
negative and 21.1% Gram-positive organism (Vlieghe et al., 2013); Laos was 77.2% 
Gram-negative and 22.8% Gram-positive bacteria (Phetsouvanh et al., 2006) . However, 
a meta-analysis of 61,327 BSI cases in Africa, found a lower proportion of Gram 
negative than reported here: 58.2% Gram-negative and 33.4% Gram-positive bacteria 
(Reddy et al., 2010).  
 
In this study, I found E.coli was the largest cause of BSI, which is comparable to many 
other studies of septicaemia globally (Deen et al., 2012; Kang et al., 2012; Kanoksil et 
al., 2013; Serefhanoglu et al., 2009). E.coli was also the only bacteria that exhibited an 
increasing trend in the period 2010-2014. This increase may be explained by the an 
additional increase in the number of patients with severe hepatitis and ascites admitted 
to this hospital; E.coli was the most common pathogen causing septicaemia in this 
patient group. Additionally, I found a higher proportion of NTS than S. Typhi between 
2010-2015. This is different from a similar study conducted at HTD 1990s and 2000s in 
which S. Typhi was the predominant bloodstream pathogen (Nga et al., 2012). In 
Africa, NTS have been found to be more common in HIV-infected patients than in 
immunocompetent hosts (Biggs et al., 2014; Feasey et al., 2012). 
 
Worryingly, I report a high proportion of MRSA and ESBL-producing bacteria 
associated with community and hospital acquired infections. In the recent HTD 
antimicrobial guidelines, third generation cephalosporins and oxacillin are the drug of 
choice for community infections for Gram-negative bacterial infections and 
Staphylococcus aureus, respectively. This study suggests that clinicians should request 
blood and other infected samples for culture so that resistant organism can be intensified 
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and treatment can be modified as quickly as possible. Moreover, the HTD antimicrobial 
guidelines should be revised frequently with the updated antimicrobial susceptibility 
data. 
 
Although there was only a single VRE isolated over this five-year period, the presence 
of this dangerous pathogen in a hospital setting in Vietnam in concerning. Since the 
discovery of VRE in 1987, this organism has spread internationally (Willems et al., 
2005). There are very few antimicrobials that are able to treat VRE, these include the 
expensive treatments, linezolid, teicoplanin, and daptomycin. Thus, I suggest that 
infection control practices should be applied to minimize the spread of VRE and other 
MDR bacteria. 
 
Notably, Acinetobacter and Pseudomonas were the only two organisms that were found 
to be significantly more common in hospital-acquired infections than community- 
acquired infections (p<0.05). High resistance levels to several broad-spectrum 
antimicrobials used in the ICUs characterized these organisms. Resistance to third 
generation cephalosporins, carbapenems, and fluoroquinolones here were as high as 
numbers reported in Asia, Europe and USA (Al-Mously, 2013; Arnoni et al., 2007; 
Kang et al., 2003; Mudau et al., 2013; Wisplinghoff et al., 2004). I would like to 
emphasize the significant of the high prevalence of resistance to common antimicrobials 
because the last drug against in HTD is now colistin.  I suggest that an antimicrobial 
stewardship and better infection control measures should be applied more strictly at 
HTD. These measures are particularly important in the ICU ward to minimize the 
spread of these MDR bacteria within the ward and to other parts of the hospital.  
 
 I observed an increased trend of AMR, which was particularly apparent for ESBL 
producing E.coli. The proportion of ESBL producing E.coli increase and there was no 
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association between infections arising in the hospital or the community. These data 
suggest that the largest reservoir of MDR is in the community, which is very alarming 
for the large population of HCMC. The data presented in this chapter have been used to 
build the first ever antimicrobial treatment guidelines in HTD. The first version was 
published in 2015, and contained recommendations for antimicrobials for community 
and hospital-acquired infections, including BSI. The suggested empirical antimicrobial 
therapy for BSI was determined from the common pathogens and their susceptibility 
patterns identified from this study. Moreover, this work continued and a new revision 
will be released at the end of 2017.  
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 Two cases of non-toxigenic Vibrio cholerae non-O1, non-O139 bacteremia in 
Ho Chi Minh City 
 Case one 
A 63-year-old female patient was admitted to HTD in June 2013.  She recalled a four-
week history of fatigue with the loss of appetite, and she had developed jaundice with 
fever in the week prior to admission. The patient had a history of hypertension, but no 
previous history of liver disease. On admission, she was fully conscious, afebrile and 
hemodynamically stable, her respiratory rate was 20 breaths per minute. She had severe 
icterus, palmar erythema, peripheral edema, and her liver and spleen were not palpable. 
She had detectable ascites (Grade 2) but without abdominal tenderness or portal vein 
thrombosis. The patient’s initial laboratory results are shown in Table 3.1 and her viral 
hepatitis serology results were as follows; antiHAV (IgM) - negative, antiHBV - 
negative, antiHBc (IgM) - negative, antiHCV - negative, and HBsAg - positive, with a 
quantitative HBV PCR blood result of 1 x106 copies/ml, (Abbott Real-time HBV Kit, 
USA). The initial prescribed treatments were entecavir (0.5mg once a day), rabeprazol 
(20mg twice a day), BDD (25mg thrice a day), furosemide (25mg once a day), and 
losartan (50 mg once a day). On the third day of admission, the patient’s temperature 
peaked at 40oC with associated chills, nausea and dizziness, but without diarrhea or 
abdominal pain. Her procalcitonin was elevated at 0.72 ng/ml. A bacterial infection was 
suspected, and 2g/day of intravenous ceftriaxone was added to the medications. An 
aerobic BACTEC bottle was taken for blood culture and incubated in a BACTEC 9240 
system. It became positive after 12 hours. A Gram stain on the positive BacT/Alert 
revealed small curved Gram-negative bacilli, which were sub-cultured onto blood and 
MacConkey agar plates. The colonies displayed hemolysis on the blood agar plates and 
were oxidase positive. API20E and VITEK2 identification (bioMerieux, France) 
confirmed the organism to be Vibrio cholerae. Slide agglutination tests with polyvalent 
O1 and O139 antisera were negative. The isolate was resistant to trimethoprim-
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sulfamethoxazole and tetracycline and susceptible to chloramphenicol, ofloxacin, 
ciprofloxacin, azithromycin, and ceftriaxone. The patient was became afebrile after two 
days of ceftriaxone, yet the antimicrobial was continued, with the other treatments, for 
an additional eight days. The patient was ultimately discharged after 24 days of 
hospitalization. 
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Table 3. 8  Initial laboratory test results of two patients with Vibrio cholerae non-O1, non-O139 
bacteremia 
 
Laboratory test Normal range Patient 1 Patient 2 
White cell count (x103 cells/µl) 6-10 7.37 1.75 
1.750 
Polymorphonuclear cell (%) 49.6-71.3 58.4 83.2 
Lymphocyte (%) 27.8-42.2 34.4 14.2 
Monocyte (%) 0.2-4.3 18.2 0.8 
Red cell count (×106 cells/µl) 4.7-5.4 4.0 3.9 
Platelet (×103 cells/µl) 201-324 160 37 
AST (UI/l) <37 2983 121 
ALT (UI/l) <40 3004 56 
Total bilirubin (µmol/l) 0-17 334.5 2.1 
Direct bilirubin (µmol/l) 0-4.3 272 3.2 
Albumin (g/l) 35-50 27.9 29.6 
Prothrombin time (s) 11-13.5 23.9 18.1 
TP (%) 70-130 35 55 
International Normalized Ratio 0.85-1.15 2.22 1.48 
 
AST: aspartate aminotransferase, ALT:  alanine  aminotransferase, TP: prothrombin time
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 Case two 
In July 2013 a 73-year-old man was admitted to HTD with fever and confusion. He had 
been diagnosed with severe cirrhosis due to hepatitis C infection in a private healthcare 
facility four years previously, and was actively receiving an unspecified treatment 
regime. He had been unwell for four days with fever and constipation. Initial 
examination on the day of admission to hospital revealed the man to be thin, pale, and 
icteric, with peripheral edema and spider angiomata. His pulse was 97 bpm, with a 
blood pressure of 140/80 mmHg, and a respiratory rate of 24 breaths per minute. He 
was febrile with a temperature of 39oC.  His mental state was confused, somnolent and 
he had amnesia. A chest X-ray suggested the patient had pneumonia and an abdominal 
examination showed marked ascites with tenderness. An abdominal ultrasound revealed 
large amount of ascitic fluid and splenomegaly. A bacterial infection was suspected; 
therefore the patient was prescribed 2g/day of intravenous ceftriaxone, along with 
metronidazole (250 mg/day), furosemide (25 mg/day), and lactulose. 
 
A yellow sample of ascitic fluid was drawn, which was rivalta test negative, and 
negative for bacteria by Gram staining on microscopy. The fluid had 629 
leucocytes/mm3 (86% neutrophils and 14% lymphocytes), 1,000 erythrocytes/mm3, 9 
g/L of protein, and 5.8 g/L of albumin. The ascitic fluid was cultured on blood agar and 
MacConkey agar and an aerobic BacT/Alert tube was taken for blood culture. Gram-
negative curved bacilli were from both the blood and the ascitic fluid isolated after 
overnight incubation. The organism in both samples was identified as V. cholerae and 
neither agglutinated with O1 and O139 antisera. Antimicrobial susceptibility testing 
demonstrated the organism was susceptible to all antimicrobial tested (ampicillin, 
chloramphenicol, ciprofloxacin, ceftriaxone, ofloxacin, trimethoprim-sulfamethoxazole, 
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and tetracycline). The patient became afebrile after two days of ceftriaxone, but was 
transferred to another hospital for surgical intervention after being diagnosed with 
bleeding of the upper gastrointestinal tract. 
 
For confirmation of the microbiological identification, DNA preparations from the 
isolates from both patients were subjected to established PCR amplification methods 
targeting the rRNA intergenic spacer region of V. cholerae (Chun et al., 1999), the 
cholera toxin (CT) gene ctxA, the O1 O-antigen, and the O139 O-antigen (Choopun et 
al., 2002). A toxigenic V. cholerae strain previously cultured from stool of diarrheal 
patient was used as a control for the assays. All three of the isolates (two from blood 
and one from ascitic fluid) were PCR amplification positive for the rRNA intergenic 
spacer, confirming their microbiological identification as V. cholerae. All of isolates 
were PCR amplification negative for the O139 antigen, the O1 antigen, and the ctxA 
toxin gene. Hence we concluded the isolates to be non-toxigenic, non-O1, non-O139 V. 
cholerae. 
  
 Discussion of Vibrio cholerae infections  
There are over 200 different reported serogroups of V. cholerae (Chatterjee and 
Chaudhuri, 2003), but not all are capable of causing cholera. In fact, only CT producing 
V. cholerae strains belonging to the serogroups O1 and O139 are associated with 
epidemic cholera (Mutreja et al., 2011; Reidl and Klose, 2002). However, other 
serogroups usually referred as non-O1 and non-O139 strains are occasionally reported 
to cause systematic infections. Patients with chronic syndromes, such as cirrhosis, 
hematologic abnormalities, renal dialysis, organ transplants, and immunosuppression 
appear to be at incased risk of V. cholerae non-O1, non-O139 infections (Couzigou et 
al., 2007; Hou et al., 2011; Phetsouvanh et al., 2008; Stypulkowska-Misiurewicz et al., 
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2006; Trubiano et al., 2014). Previous, retrospective studies originating from Taiwan 
(Hou et al., 2011) and Thailand (Wiwatworapan and Insiripong, 2008) have described 
patients with cirrhosis and non-toxigenic Vibrio cholerae non-O1, non-O139 
septicemia. Spontaneous peritonitis has also been observed in patients with Vibrio 
cholerae non-O1, non-O139 septicemia (Ferreira et al., 2012). The more typical 
manifestations of this infection are ascites, fever, jaundice, diarrhea, skin lesions, and 
gastrointestinal bleeding (Ferreira et al., 2012; Ko et al., 1998), and we observed the 
majority of these symptoms in the patients in this report. However, we observed no skin 
lesions or cellulitis. It has been reported that non-O1, non-O139 V. cholerae infections 
are associated with consumption of, or contact with, raw seafood, which is a similar risk 
factor for the related Vibrio species V. paraheamolyticus (Su and Liu, 2007). However, 
is also noteworthy that neither of the cases described here reported contact with, or 
consumption of, seafood.   
 
The management of Vibrio cholerae non-O1, non-O139 infections differs substantially 
from epidemic diarrhea. The role of antimicrobials in severe cholera is not as critical as 
fluid and electrolyte replacement. In contrast, antimicrobials are essential for the 
management of extra-gastrointestinal Vibrio infections, however there are currently no 
standard guidelines for treating this disseminated infection. Therefore, assessing the 
antimicrobial susceptibility pattern of the infecting Vibrio spp. is paramount for 
tailoring treatment. Currently Vibrio cholerae non-O1, non-O139 from many locations 
are still reported to be susceptible to beta lactams, fluoroquinolones, trimethoprim-
sulfamethoxazole, tetracycline, and chloramphenicol (1,3,8,9,10). It has been suggested 
that third generation cephalosporins or fluoroquinolones are the most suitable agents for 
treating V. cholerae septicemia. Indeed, ciprofloxacin seems to be associated with a 
favorable outcome, and we can report here that both patients in this report recovered 
from the bloodstream infection quickly with a good clinical response after ceftriaxone.  
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 Outbreak of human Brucellosis in Vietnam 
 Background 
Brucellosis is a collective term for infections caused by small Gram-negative 
coccobacilli belonging to genus Brucella. This genus incorporates the well-described 
animal pathogens Brucella melitensis, Brucella abortus, Brucella ovis, Brucella suis, 
and Brucella canis, which are associated with disease in goats, cattle, sheep, pigs, and 
dogs, respectively. Brucella are facultative intracellular pathogens, and are sequestered 
by monocytes and macrophages, spreading throughout the body to the liver, spleen, 
lymph nodes, and bone marrow (de Figueiredo et al., 2015). These pathogens are 
synonymous with an aggressive disease syndrome in animals causing abortion, 
stillbirth, and the delivery of weak offspring. The organisms replicate to high 
concentrations in the affected tissues and are transmitted through contact with the 
placenta, fetus, fetal fluids, and vaginal discharge. Notably, goats can shed B. melitensis 
in vaginal discharge for up to three months after abortion and organisms can be shed in 
milk for the lifetime of an infected animal (Tittarelli et al., 2005). 
 
Many Brucella species have zoonotic potential and can be transmitted from animals to 
humans. Brucellosis in humans is typically contracted by contact with infected animals 
or through the ingestion of animal products prepared from infected animals. In 
symptomatic cases, disease presentation is highly variable and may arise rapidly or 
progressively. Classically, brucellosis in humans is a sub-acute, non-specific febrile 
disease characterized by high temperatures, headaches, malaise, night sweats, and body 
aches (Jia et al., 2017). Some individuals recover quickly, while others develop more 
persistent, long-term complications including arthritis, spondylitis, endocarditis, 
dermatitis, and chronic fatigue, and neurological complications (Jia et al., 2017). The 
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disease is treated using antimicrobials; however, relapses are common, even after 
apparent bacteriological cure.  
 
 Brucella outbreak 
From 14th June 2016 to 18th January 2017, ten febrile patients attending HTD had a 
positive blood culture containing Gram-negative coccobacilli. These organisms were 
sub-cultured onto sheep chocolate blood agar and subjected to biochemical 
identification and antimicrobial susceptibility testing. The organisms stained red using a 
modified cold Ziehl-Neelsen stain, and were identified as Brucella spp. on a VITEK2 
system (BioMerieux, France). All organisms were susceptible to amikacin, 
ciprofloxacin, gentamycin, doxycycline, imipenem, rifampicin, and trimethoprim 
sulphate. Nucleic acid was extracted from organisms and subjected to Bruce-ladder 
multiplex PCR to identify the infecting species (Lopez-Goni et al., 2008); all produced 
an identical collection of amplicons indicative of B. melitensis. We next performed 
MLVA-16 (Multiple Locus VNTR Analysis) on the ten Brucella isolates (Maquart et 
al., 2009), which is comprised of three panels, panel 1 (8 minisatellite loci), panel 2A (3 
microsatellite loci), and panel 2B (5 microsatellite loci). Panel 1 allows clustering the 
different Brucella species while panels 2A and 2B provide finer resolution 
characterization. The MLVA profiles of the Vietnamese isolates were compared with a 
global collection of various Brucella species (Figure 3.9). The organisms were all 
confirmed as B. melitensis and produced independent VNTR profiles falling into four 
subgroups, clustering with organisms originating from Southern Europe, the Middle 
East, and China.   
 
The presumptive diagnoses of the brucellosis patients prior to bacterial culture and 
identification were sepsis (patients 1 and 2), non-specific viral infection(3), dengue(4), 
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tuberculosis(5 and 7), and non-specific inflammatory disease(6); patients 8, 9, and 10 
were correctly diagnosed with brucellosis after laboratory diagnosis of the first seven 
patients. These infections were additionally confirmed using Rose Bengal agglutination 
with titers in plasma ranging from 1/4 to 1/256. Differential blood counts were largely 
unremarkable but almost all patients had elevated AST, ALT, and GGT; several patients 
had elevated CRP and procalcitonin indicating systemic inflammatory response (Table 
3.8).
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Figure 3. 10 The MLVA genotypes of ten human Brucella melitensis cases in southern 
Vietnam 
Circular tree representing the global population structure of the genus Brucella using Multiple 
Locus VNTR Analysis-16 (MLVA-16) analysis. Nine different Brucella species (labeled) are 
shown and associated with main branches; B. melitensis forms the majority of the tree. The ten 
Vietnamese isolates are on black branches within the B. melitensis population 
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Table 3. 9  The clinical characteristics of ten human Brucella melitensis cases in southern Vietnam 
 
 
 
 
 
 
 
 
 
 
 
* * relapse † Normal ranges (results outside normal range in bold, NR; not recorded) AST: 10-40 IU/L, ALT: 5-30 IU/L, GGT: 5-30 IU/L, CRP (C reactive 
protein): 0-10mg/L, and PCT (Procalcitonin): <0.15 ng/ml
Patient 
number 
Date of hospital 
admission 
Age 
(years) 
Sex 
Potential  
exposure 
Rose Bengal 
titre 
Days in 
hospital 
Days of 
fever 
AST† 
(IU/L) 
ALT† 
(IU/L) 
GGT† 
(IU/L) 
CRP† 
(mg/L) 
PCT† 
(ng/mL) 
1 06/06/2016 47 Male Goat keeper/ate goat blood 1/32 16 37 38 35 51 NR 5.04 
2 08/26/2016 80 Male Goat keeper 1/8 21 60 78 64 114 31 2.06 
3 08/31/2016 78 Male Goat keeper 1/64 14 8 69 39 431 NR 0.13 
4 09/25/2016 37 Female Ate undercooked goat meat 1/4 15 6 26 26 NR NR NR 
5 05/15/2016 40 Male Goat keeper/had sick animals 1/32 30 14 44 34 235 NR 0.89 
 09/26/2016*     15 120 67 61 131 36 0.34 
6 10/30/2016 35 Female Goat keeper 1/16 20 20 295 405 70 64 NR 
7 11/23/2016 50 Male Goat keeper 1/32 8 35 67 61 145 NR 0.12 
8 11/16/2016 35 Male Goat/sheep keeper 1/64 8 30 28 37 167 52 NR 
9 12/28/2016 27 Female Goat keeper 1/16 12 10 515 58 31 7 NR 
10 01/18/2017 60 Male 
Veterinarian vaccinating 
goats/sheep 
1/256 11 14 55 57 235 NR NR 
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Figure 3. 11 The locations of ten human Brucella melitensis cases in southern Vietnam 
Map of southern Vietnam showing the locations of provinces where the ten cases of brucellosis 
originated between June 2016 and January 2017. The solid circle shows the location of the 
Hospital for Tropical Diseases in Ho Chi Minh City.  
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On review of the medical histories, all patients had reported exposure to goats prior to 
the febrile episodes; eight kept goats, two had consumed goat meat, and one was a 
veterinarian who had been vaccinating goats. The ten cases originated from four 
provinces, with the primary cases occurring in Binh Phuoc and Tay Ninh near the 
Cambodian border, and later detection in the south (Ho Chi Minh City and Long An) 
(Figure 3.10). All patients, apart from patient 5 (ceftriaxone 2g/day for seven days) 
received doxycycline (200mg/day for six weeks) with gentamycin (240 mg/day for 
seven days). All patients recovered without relapse with the exception of Patient 5, who 
was treated with imipenem (2g/day), gentamycin (240mg/day) for seven days and 
doxycycline (200mg/day) for six weeks. Patient 5 made a complete recovery without 
additional relapse.  
 
Discussion for Brucella outbreak 
B. melitensis is a known zoonotic pathogen that can cause an invasive febrile disease in 
humans exposed to infected animals(Moreno and Moriyon, 2002). Brucellosis infection 
in human have been reported from other countries in Southeast Asia such as Thailand, 
Malaysia(Hartady et al., 2014; Manosuthi et al., 2004).  Diagnosing brucellosis in 
humans is complicated by its non-specific presentation and may not be included in a 
differential diagnosis. The lack of a confirmatory diagnosis with appropriate 
antimicrobial therapy can lead to lasting physical effects through chronic infections. 
Persistent intracellular infection is associated with chronic arthritis, endocarditis and 
neurobrucellosis. Lewis et al had described B.melitensis as a rare cause of prosthetic 
joint infection from traveller returning from Thailand and other Asia region(Lewis et al., 
2016). Here we have reported the first identified cases of human brucellosis caused by 
B. melitensis in Vietnam. The organisms were susceptible to the advocated 
antimicrobial agents, again highlighting the importance of pathogen isolation and 
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identification. By performing MLVA genotyping, we found that the organisms fell into 
four different subgroups, suggesting that these organisms circulate widely in goats in 
southern Vietnam and were not part of an isolated outbreak. Therefore, we suggest that 
patients with non-specific febrile disease in Vietnam and comparable locations in 
Southeast Asia reporting contact with goats, sheep, and cattle receive a blood culture 
and a Rose-Bengal test. If the diagnosis is strongly suspected, empirical doxycycline 
can be given. 
 
Vietnam is a hotspot for zoonotic infections and brucellosis is an important disease 
globally, stemming from the circulation of undiagnosed sick animals coming in contact 
with humans. About fifty years ago, there was report about Brucella infection among 
human and big cattle in the north of Vietnam which suggests the long-term presence of 
this bacteria in this country(Quy Nguyen-Phu, 1966). Given the distribution of these 
cases now and the collective exposure to goats, these findings suggest that these 
organisms are circulating widely in the goat population, which predicts that human 
cases may become increasingly common. We recommend that sick animals with a 
suspicion of brucellosis and their owners be screened in the identified provinces to 
assess the magnitude of the problem. This type of screening requires an interaction 
between the Departments of Preventative Medicine and Animal Health. Our work 
indicates the importance of zoonotic infections in Vietnam and highlights the need for 
sustained surveillance in human and animal populations. 
 
  
 136 
Chapter 4 
The phenotypic and genotypic characteristics of ESBL and AmpC producing 
organisms associated with bacteraemia in Ho Chi Minh City, Vietnam 
 
 Aims of chapter 
Here I aimed to evaluate conventional methods to detect ESBL and AmpC activity in 
comparison with the molecular method. Therefore, I performed multiplex PCR for 
several ESBL genes and AmpC genes on clinical isolates from HTD in HCMC with 
suspected ESBL and AmpC activity. Based on the molecular test results, I will 
additionally be able to determine the common ESBL and AmpC genes associated with 
BSI in this major healthcare facility in southern Vietnam. This work has been published 
at BMC antimicrobial resistance and infection control. 
 
 Introduction 
AMR has become an increasing problem in global health. Resistance against 
antimicrobials used for the empirical therapy of invasive infections is particularly 
alarming, especially given that the provision of effective antimicrobials rapidly 
improves the likelihood of a better outcome. To limit the possibility of poor outcomes, 
broad-spectrum antimicrobials, such as third generation cephalosporins, have become 
the most commonly empirical drugs to treat non-specific febrile diseases. However, the 
sustained use of the drugs in hospital settings has meant an increase in resistance to 
these antimicrobials, which somewhat ironically may lead to a poor outcome. The 
situation has been internationally recognised and the WHO have identified seven 
bacteria as the most important cause of AMR infections in hospitals and the community. 
This list includes E. coli and K. pneumoniae, which are commonly found to be resistant 
to third-generation cephalosporins (WHO, 2013).  
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As previously discussed, resistance to third-generation cephalosporins is mediated by a 
class of serine hydrolases known as ESBLs, which act by cleaving the -lactam ring, 
thereby rendering the drug inactive (Bradford, 2001). With the increasing threat of 
treatment failure, monitoring ESBL producing organisms in sentinel locations is 
imperative for surveillance and improved infection control measures. 
 
Routine susceptibility testing is usually capable of detecting the presence of ESBL 
activity, however false positives can occur. This lack of sensitivity is associated with the 
plasmid-mediated ampicillinases, AmpC. AmpC genes also confer resistance to many 
-lactams and β-lactam/β-lactamase inhibitor combinations, the latter of which render 
ESBL producing bacteria susceptible. AmpC genes are generally chromosomally 
located, however plasmid associated variants of the enzymes have become increasingly 
recognised. This observation is significant as these ampicillinases can be easily 
disseminated through horizontal gene transfer (Doi and Paterson, 2007). There are 
currently no standardised CLSI guidelines for AmpC detection, however several 
methods have been proposed to aid in the accurate detection of AmpC β-lactamases 
(Black et al., 2005; Gupta et al., 2014; George A. Jacoby, 2009). These phenotypic tests 
primarily use a cephalosporin with a β-lactamase inhibitor (e.g. clavulanate) or non-β-
lactamase inhibitors (e.g. boronic acid) and can be combined with molecular detection 
of the AmpC β-lactamases using multiplex PCR (Pérez-Pérez and Hanson, 2002). 
However, due to overexpression of AmpC genes, bacteria carrying an ESBL gene may 
test negative for ESBL production and subsequently interpretations of phenotypic 
AmpC methods (Song et al., 2005; Steward et al., 2001; Thomson, 2001) which can be 
catastrophic for treatment outcomes. The accurate testing and interpretation of AmpC 
and ESBL activity is vital for healthcare professionals to provide effective and 
appropriate treatment management.  
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Here, I aimed to assess the distribution of AmpC and ESBL genes in organisms 
associated with bloodstream infections between January 1st 2011 and December 31st 
2013 at HTD in HCMC, Vietnam. My data highlights the need for routine AmpC and 
ESBL gene surveillance in hospitals in low-middle income countries to ensure effective 
infection control measures and report on the incidence of drug resistant bacteraemia. 
 Results  
 Gram-negative organisms with reduced susceptibility against third-
generation cephalosporins isolated from bloodstream infections at the Hospital for 
Tropical Diseases 
Between January 2011 and December 2013, 1,690 non-contaminant bacteria were 
isolated from the blood of febrile patients attending HTD in HCMC. The overall 
isolation rate of from blood during this period was 5.6% (1,690/30,185); 1,017 of these 
were Gram-negative (excluding Pseudomonas spp. and Acinetobacter spp.). Ceftriaxone 
(or an alternative parenteral third-generation cephalosporin) was (and remains) the 
empirical therapy for suspected bacteraemia in this healthcare facility. Therefore, all 
Gram-negative organisms isolated from blood were routinely screening for 
susceptibility against third-generation cephalosporins. In total, nearly a third 
(304/1,017) were found to exhibit reduced susceptibility against third-generation 
cephalosporins, with >90% (n=280) of these exhibiting resistance to ceftriaxone and 
nearly 3% (n=8) being intermediate according to current CLSI susceptibility 
breakpoints (Clinical and Laboratory Standards Institute, 2010). 
 
The 280 non-duplicate organisms with reduced susceptibility to third-generation 
cephalosporins were subjected to phenotypic screening using the double disk diffusion 
method for ESBL activity, and to detect a zone of reduced inhibition between the third-
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generation cephalosporin and imipenem, indicative of AmpC activity (Figure 4.1). In 
total 172/1,017 (16.9%) isolates were phenotypically ESBL positive and 63/1,017 
(6.2%) were phenotypically AmpC positive, 5/1,017 (0.5%) exhibited phenotypic 
evidence of both ESBL and AmpC activity. E. coli was the most common bacterial 
species exhibiting ESBL activity, accounting for >90% (162/177) of this group of 
ceftriaxone resistant organisms (Figure 4.2). Approximately 40% (25/63) of the AmpC 
producing organisms were Aeromonas spp.; E. coli was the second most abundant 
species amongst the AmpC producers with 21/6 (>30%) identified. The remaining 
organisms exhibiting AmpC activity belonged to a range of species, including 
Enterobacter spp. (8/63), K. pneumoniae (7/63), and Morganella morganii (2/63). 
 
 Molecular analysis of ESBL and AmpC genes conferring resistance to third-
generation cephalosporins 
PCR amplification was performed on nucleic acid extracted from the 177 ESBL (172 
ESBL and 5 producing both ESBL and AmpC) exhibiting phenotypic ESBL activity to 
identify four ESBL gene groups (blaTEM , blaSHV, blaOXA, and blaCTX-M). 67/177 (38%) 
isolates had only one ESBL gene in which blaCTX-M was the most prevalent in 63/177 
(36%). There were 106/177 (60%) isolates had combination of two or more ESBL 
genes, in which the blaCTX-M and blaTEM complex was the most common combination 
(67/177; 38%) (Table 4.5).  These PCR amplifications demonstrated that blaCTX-M was 
the most prevalent ESBL gene family in these organisms, testing positive in 168/177 
(95 %) nucleic acid extractions. Subsequent sequencing of the blaCTX-M PCR amplicons 
revealed that blaCTX-M-15 (n=84) was the most common ESBL gene subtype. Other 
ESBL gene subtypes detected included blaCTX-14 (n=40), blaCTX-24 (n=6), blaCTX-27 
(n=48), and blaCTX-55 (n=12) (Table 4.1). Of the five isolates exhibiting both an ESBL 
and an AmpC phenotype, only two had genetic determinants that may induce an AmpC 
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phenotype, namely, blaCIT (CMY-42) and blaEBC. Two blaCTX-M variants (blaCTX-M-15 
and blaCTX-M-27) were identified in these organisms as the genes most likely to confer 
resistance against third generation cephalosporins (Table 4.2).  
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Figure 4. 1 Representative results of the double disk diffusion test (A) for ESBL 
production and the AmpC disk test (B)  
 
 
Abbreviations. AMC: amoxicillin, CTX: cefotaxime, CAZ: ceftazidime, CRO: ceftriaxone, 
CLA: clavulanate, FEP: cefepime, FOX: cefoxitin, IPM: imipenem.  
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Figure 4. 2 The distribution of ESBL or AmpC producing bacteria isolated during the 
period of 2011-2013  
 
Bar chart indicates the number and type of ESBL or AmpC producing bacteria isolated. 
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PCR amplification of nucleic acid extracted from the 63 organisms with indicative 
AmpC activity only found that blaCIT was the most common gene associated with this 
phenotype and resistance to third generation cephalosporins; this variant was detected in 
18/63 (29%) of the isolates (Table 4.3). Sequencing of the AmpC amplicons determined 
that approximately half (11/18; 61%) of the isolates harboured the blaCMY-2 subtype; the 
remainder (7/18; 39%) carried the blaCMY-42 gene. Notably, more than half (34/63; 54%) 
of the organisms conferring an AmpC phenotype did not generate a PCR amplicon for 
any of the six AmpC genetic markers that were screened. The majority of the organisms 
exhibiting AmpC activity but not generating any detectable PCR amplifications were 
Aeromonas spp. The remainder of the AmpC producing organisms harboured either 
blaDHA (9/64; 14%) or blaEBC (2/64; 3%) genes. Almost half (27/63; 43%) of the AmpC 
producing isolates also generated a PCR amplicon for an ESBL gene. The most 
commonly detected ESBL gene in these phenotypic AmpC organisms was the blaTEM 
gene, found in 17/27 (30%) of these isolates (Table 4.4). One E. coli isolate harboured 
three different -lactamase genes, blaCTX-M, blaTEM, and blaOXA. 
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Table 4. 1 The distribution of -lactamase genes identified in 177 ESBL producing 
bacteria  
Gene E. coli 
Klebsiella 
spp. 
Enterobacter 
cloacae 
Salmonella 
cholerasuis 
Total* 
blaCTX-M 157 9 1 1 168 (95%) 
blaTEM 70 7 1 1 79 (45%) 
blaOXA 
 
33 
 
 
2 
 
 
1 
 
 
- 
 
36 (20%) 
blaSHV 1 4 - - 5 (3%) 
Not detected 3 1 - - 4 (2%) 
 
* The proportion of bacterial species harbouring a particular ESBL gene is expressed as a 
percentage of the total bacteria possessing an ESBL phenotype (n=177). 
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Table 4. 2 The Genetic determinants associated with the five ESBL and AmpC producers  
Strain Organism ESBL gene AmpC gene 
E063 E. coli blaCTX-M-27 blaCIT* 
E080 E. cloacae blaCTX-M-15, blaOXA, blaTEM blaEBC# 
E081 E. coli blaCTX-M-27 - 
E113 K. pneumoniae blaCTX-M-15, blaOXA, blaTEM - 
E126 E. coli blaCTX-M-27 - 
 
*CMY-42 was the blaCIT variant identified by DNA sequencing. # The blaEBC variants includes 
(MIR-1 and ACT-1) 
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Table 4. 3  The distribution of -lactamase genes within the AmpC producing bacteria  
Gene Aeromonas spp. E. coli 
Klebsiella 
spp. 
Enterobacter 
spp. 
M. morganii Total* 
blaCIT - 18 - 1 - 18 (29%) 
BlaDHA - 1 6 - 2 9 (14%) 
BlaEBC - - - 2 - 2 (3%) 
Not 
detected 
25 3 1 5 - 34 (54%) 
 
*The proportion of bacterial species harbouring a particular AmpC gene is expressed as a 
percentage of the total bacteria possessing an AmpC phenotype (n=63). 
 
 
 
 
 
 147 
 
 Hospital and community-acquired third-generation cephalosporin resistant 
infections 
E.coli and Aeromonas spp. were the most common bacterial species identified as being 
either ESBL or AmpC producing, respectively. Ninety-seven percent (157/162) of the 
E. coli isolates with an ESBL phenotype harboured a blaCTX-M gene. Of these, 135 were 
associated with a CAI and 22 were associated with a HAI. Hypothesising that 
organisms associated with HAI would have a broader range of AMR, I additionally 
aimed to compare the antimicrobial susceptibility profiles of organisms associated with 
CAIs and HAIs. However, after investigating resistance to a range of different 
antimicrobial classes in the ESBL producing organisms, I found no significant 
difference between the antimicrobial susceptibility profiles of organisms associated with 
CAI or HAI (p>0.05; student t-test) (Figure 4.3). I additionally compared the 
antimicrobial susceptibility phenotypes between the E. coli associated with CAI and 
HAI for the isolates that were phenotypically AmpC positive; there was no significant 
difference between these groups (p>0.05; student t-test) (Figure 4.4). Lastly, I 
investigated the clinical source of the AmpC producing Aeromonas spp. in CAI and 
HAI. I found that the AmpC expressing Aeromonas spp. were significantly associated 
(p<0.001; student t-test) with liver cirrhosis/hepatitis in both CAI and HAI (Figure 4.5). 
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Table 4. 4 The distribution of the 68 AmpC producing bacteria harbouring an additional 
ESBL gene 
Gene 
Aeromonas 
spp. 
E. coli 
Klebsiella 
spp. 
Enterobacter spp. M. morganii Total* 
BlaCTX-M  
3 
 
  
3 
(4%) 
blaTEM - 15 
 
- 1 
 
1 
 
17 
(25%) 
blaSHV - - 4 
 
1 
 
- 5 
(7%) 
blaOXA - 2 
 
- - - 2 
(3%) 
blaOXA & blaTEM - 1 
 
1 
 
- - 2 
(3%) 
blaOXA, blaTEM & 
blaCTX-M 
- 1 
 
1 1 - 3 
(4%) 
Not detected** 25 
 
2 
 
2 
 
6 
 
1 
 
36 
(53%) 
 
*The proportion of all bacterial species with AmpC phenotype (n=68) gene is expressed as a 
percentage of the total bacteria possessing harbouring an additional ESBL gene. **These 
samples had an ESBLs phenotype but no detectable ESBL gene 
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Table 4. 5 The distribution of several ESBL genes in 177 ESBL producing bacteria  
Genes Number of isolates (%) 
No ESBL gene 4 (2.3%) 4 (2.3%) 
Single genes blaCTX-M 63 (35.6%) 67 (37.8%) 
blaTEM 2 (1.1%) 
blaSHV 2 (1.1%) 
blaOXA 0 (0%) 
Multiple-
genes 
blaCTX-M and blaTEM 67 (37.9%) 106 (59.9%) 
blaCTX-M and blaOXA 27 (15.3%) 
blaCTX-M and blaSHV 2 (1.1%) 
blaTEM and blaOXA 1 (0.6%) 
blaCTX-M , blaTEM and blaOXA 8 (4.5%) 
blaCTX-M , blaTEM and blaSHV 1 (0.6%) 
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Figure 4. 3 A comparison of antimicrobial susceptibility profiles between CAI and HAI of 
the 177 ESBL producing E. coli 
 
 
The AMR phenotype of the ESBL producing E. coli (n=157) from HAI (n=135) or CAI (n=22) 
was scored for resistance to each drug and this was expressed as a percentage relative to the 
number of organisms in each group (CAI or HAI). No significant differences (p>0.05) were 
found in antimicrobial resistance phenotype between CAI and HAI. 
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Figure 4. 4 Comparison of antimicrobial susceptibility profiles between CAI and HAI of 
63 AmpC producing E. coli 
 
The AMR phenotype of the AmpC producing E. coli (n=17) from HAI (n=4) or CAI (n=13) 
was scored for resistance to each drug and this was expressed as a percentage relative to the 
number of organisms in each group (CAI or HAI). No significant differences (p>0.05) were 
found in antimicrobial resistance phenotype between CAI and HAI. 
AMK: amikacin, AUG: amoxicillin-clavulanate, CIP: ciprofloxacin, ETP: ertapenem, FOX; 
cefoxitin, IMP: imipenem, MEM: meropenem, OFX: ofloxacin, SXT: trimethoprime-
sulfamethoxazole, TCC: ticarcillin-clavulanate, TZP: piperacillin-tazobactam. 
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Figure 4. 5 The distribution of bacteremia infections where Aeromonas spp. was isolated from 
community (CAI) and hospital (HAI) patients 
 
 
 
 
From 63 AmpC producing bacteria isolates, 25 were found to be Aeromonas spp. Indicated 
below the CAI/HAI designation, are the infections the patients presented at the point of sample 
collection. We found cirrhosis/hepatitis to be significantly associated (p<0.001) infection by 
Aeromonas spp. 
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 Discussion 
With the ever-increasing reports of ESBL producing Gram-negative bacteria in clinical 
settings, identifying these organisms is imperative for monitoring and the provision of 
efficacious treatments. Although antimicrobial susceptibility profiling is still the most 
commonly used method, interpretation of AmpC production data can sometimes prove 
problematic and may lead to under-reporting or misdiagnosis as an ESBL phenotype 
(Hanson, 2003). This scenario could potentially lead to treatment failure due to 3rd 
cephalosporin. Here, I aimed to investigate the prevalence and diversity of ESBL and 
AmpC producing isolates from HTD from organisms isolated from bloodstream 
infections only over a three-year period. 
 
CTX-M type ESBLs are the most prevalent enzymes that are reported, with over 170 
different subtypes assigned (Lahey Clinic, 2016; Pitout and Laupland, 2008). This 
investigation identified that these enzymes were largely associated with E. coli isolates 
originating from the community. This was not unexpected, as a previous study from the 
same region found that healthy individuals had a high carriage rate of ESBL producing 
Enterobacteriaciae in their gastrointestinal microbiota (Vien et al., 2009). Furthermore, 
I found no statistical significance in overall AMR carriage between CAI and HAI in E. 
coli harbouring an ESBL or AmpC phenotype. This observation is important and 
suggests equilibrium in the circulating AMR organisms in the community and clinical 
setting with the potential to cause disease in this location. I additionally identified that 
approximately half of the AmpC producing organisms additionally harbour an ESBL 
gene. The presence of a co-producing ESBL may affect AmpC susceptibility 
interpretation (Hanson, 2003; Song et al., 2005; Thomson et al., 2004), therefore the 
treatment of infections caused by suspected AmpC producing organisms with cefepime 
requires additionally microbiological assessment . 
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No plasmid associated resistance genes were detected for the most prevalent AmpC 
producing organism identified in this study, Aeromonas spp. I therefore speculate that 
the AmpC phenotype in these organisms was mediated by a chromosomally located 
AmpC gene (George A. Jacoby, 2009; Philippon et al., 2002). Notably, when assessing 
the clinical presentations associated with the AmpC producing Aeromonas spp., these 
organisms were found to be associated with cirrhosis/hepatitis. Aeromonas spp. are 
commonly identified as the agent of bacteraemia in cirrhosis patients, and commonly 
has a higher mortality rate than infections caused by alternative pathogens (Lau et al., 
2000; Llopis et al., 2004). The high prevalence of Aeromonas spp. mediated cirrhotic 
infections suggests the spread of this bacterial organism within immunocompromised 
chronic liver patients in HCMC, a potential association that requires longitudinal 
surveillance. 
 
I observed a high prevalence of AmpC and ESBL expressing organisms associated with 
both CAI and HAI in HCMC. AmpC producing Aeromonas spp. appear to potentially 
be associated with bacteraemia in cirrhosis/hepatitis patients. With febrile disease 
presentations, it is routine clinical practice to prescribe a broad-spectrum antimicrobial, 
generally a third-generation cephalosporin, to increase the likelihood of a better clinical 
outcome (Kollef, 2003, 2008). However, my data suggest this approach may not be 
optimum and the use of third-generation cephalosporins in monotherapy should be 
assessed carefully when there is a clinical suspicion of bacteraemia, irrespective of 
whether this is a suspected CAI or HAI. 
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Chapter 5 
Invasive non-typhoidal Salmonella infections in Asia: clinical observations, disease 
outcome and dominant serovars from an infectious disease hospital in Vietnam  
 
 Aims of chapter 
I hypothesise that the epidemiology of invasive NTS infections is ecologically different 
to that of sub-Saharan Africa, and I predict due to improved access to hospital care, 
antiretroviral drugs and nutrition that mortality is low and limited to a few specific risk 
factors such as liver damage. To address this hypothesis I conducted a retrospective 
analysis on all NTS patients hospitalised at HTD in HCMC over a four-year period. 
Data was collected from records, entered into a custom designed database and stratified 
by HIV status, age, sex, nutrition, treatment, hospital stay, complications, 
gastrointestinal complaints, and outcome. Data was described and then analysed to 
assess risk factors such as poor outcome, such as prolonged hospital stay, relapse, 
complications, co-morbidities and death. This was the first such study of its type 
originating from outside sub-Saharan Africa and was published in PLoS Neglected 
Tropical Diseases in 2016. 
 
 Introduction 
Salmonella bacterial infections in humans can cause a range of syndromes. A subset of 
the >2,500 described serovars of Salmonella subspecies I can cause typhoidal illness, 
including S. Typhi and the various S. Paratyphi pathovars (Popoff et al., 2004). 
However, the great majority of Salmonella infections in humans do not generally cause 
systemic disease and are referred to as NTS. NTS organisms include S. Typhimurium, 
S. Dublin and S. Enteritidis, which are characterized by their wide host range and their 
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ability to induce self-limiting diarrhea in humans (Crump et al., 2015). However, in 
addition to the common diarrheal clinical syndrome induced by NTS organisms in 
humans, invasive (bloodstream) NTS (iNTS) disease also occurs in specific populations 
(Crump and Heyderman, 2015; Feasey et al., 2012). iNTS disease, which is most 
commonly caused by the Salmonella serovars Typhimurium and Enteritidis (Feasey et 
al., 2015; Kariuki and Onsare, 2015), is associated with an aggressive systemic 
infection that can resemble typhoid fever (Crump et al., 2015; J. A. Crump et al., 2011; 
Crump and Heyderman, 2015). In sub-Saharan Africa, the disease has a high mortality 
rate (20-25%) and infection is most common in children with malaria, malnourished 
children and HIV-infected adults (Feasey et al., 2012). There are an estimated 1.9 
million cases of iNTS disease in Africa annually, with and incidences rate of 227 per 
100,000 population overall (Ao et al., 2015) and 175-388 and 2,000-7,500 per 100,000 
population in children 3-5 years of age and HIV-infected individuals, respectively 
(Bassat et al., 2009; Berkley et al., 2005; Enwere et al., 2006; Feasey et al., 2012; 
Gordon et al., 2008; Oosterhout et al., 2005; Reddy et al., 2011).  
 
NTS are a common cause of diarrhea in Asia, and previous work has shown that NTS 
are responsible for approximately 4% of pediatric hospitalized diarrhea in HCMC 
(Thompson et al., 2015). In a retrospective study of blood cultures conducted between 
1994 and 2008 at the HTD in HCMC it was observed that S. Typhi was the predominant 
cause of culture positive bacteremia (66%) until 2002 (Nga et al., 2012).  After this 
period there was significant annual decline in the isolation rate of S. Typhi and a 
concurrent increase in organisms associated with the HIV epidemic, including NTS. 
The isolation rate of NTS increased from 1% (n=47) of total bacteremia cases between 
1994-2001 to 4% (n=146) of cases from 2002-2008. Whilst the increase in burden was 
modest in comparison to sub-Saharan Africa these data support a longitudinal shift in 
the etiology of bloodstream infections in southern Vietnam.  
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There is a paucity of data regarding iNTS infections from Asia, with limited reports 
from Taiwan (Chen et al., 2012), India (Menezes et al., 2010), Thailand (Hendriksen et 
al., 2012; Kiratisin, 2008) and the aforementioned study in Vietnam (Nga et al., 2012). 
It is apparent that the burden of iNTS in sub-Saharan Africa is not mirrored in Asia. 
However, iNTS disease is present in Asia but there are no or few data regarding clinical 
symptoms, disease outcome, patient demographics or the infecting serovars. By 
accessing available clinical data and bacterial isolates I sought to retrospectively 
investigate the clinical and microbiological manifestations of iNTS in a major infectious 
disease hospital in southern Vietnam.  
 
 Results 
 The demographic and laboratory features of invasive non-typhoidal 
Salmonella infections 
Between January 2008 and June 2013 there were 142 culture confirmed bloodstream 
infections caused by an NTS bacterium at HTD. Hospital records were obtainable for 
102/142 (72%) iNTS cases. The median patient age was 33 years (IQR: 28 to 41 years) 
(Table 5.1). Eight of the 102 (8%) iNTS cases were children (<16 years) of which five 
(5% of total) were infants (<12 months). The majority of patients (61/102; 60%) were 
from HCMC, with the remainder residing in the surrounding provinces. The median 
duration of illness (including fever and other symptoms) prior to hospital admission was 
13 days (IQR 1-60 days). Patients were more commonly male (72/102; 71%) and three 
quarters (71/94; 76%) of adults (>16 years) reported that they were unemployed upon 
admission. A third (31/102; 33%) of cases reported a history of intravenous drug use, 
which was more common in men (26/65, 40%) than women (5/30, 17%) (p=0.019, 
Fisher’s exact test). 
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HIV testing was performed for all patients diagnosed with iNTS infections; CD4 counts 
were not routinely measured. Seventy-two (71%) of the iNTS cases were HIV-infected: 
71 adults (76% of 94 adults) and one infant (13% of all 8 children). Only 16/72 (22%) 
of the adult HIV-infected iNTS patients were on active antiretroviral therapy (ART) 
prior to this episode of bacteremia, and 6/72 (8%) of the HIV-infected iNTS patients 
were taking trimethoprim-sulfamethoxazole for Pneumocystis jiroveci pneumonia 
prophylaxis on admission. A history of long-term steroid use was reported in 4/30 
(13%) of the iNTS cases testing negative for HIV infection. 
 159 
Table 5. 1  The clinical characteristics of invasive non-typhoidal Salmonella disease 
stratified by HIV status and outcome 
Characteristic 
Total HIV status Fatal a 
 Infected Uninfected Yes No 
n=102 n=72 n=30 n=26 n=66 
Male sex 72 (70.6) 54 (75.0) 18 (60.0) 18 (69.2) 44 (66.7) 
Age 33 (28-41) 31.5 (28-37) 44 (25-69) 33.5 (29-37) 33 (27-44) 
Reported Injected drug user 31/95 (32.6) 31/65 (47.7) 0 (0) 12/25 (48) 15/60 (25) 
Immunosuppression      
 
HIV infection 72 (70.6) 72 (100) 0 (0) 24 (92.3) 39 (59.1) 
 
On ART (HIV infected) 16/72 (22.2) 16/72 (22.2) 0/20 (0) 8/24 (33.3) 7/39 (17.9) 
 
Hepatitis 27 (27.0) 20/70 (28.6) 7 (23.3) 8/25 (32.0) 17 (25.8) 
Symptoms and signs on admission      
 
Abdominal pain 23 (22.5) 14 (19.4) 9 (30.0) 5 (19.2) 17 (25.8) 
 
Ascites 8 (7.8) 8 (11.1) 0 (0) 2 (7.7) 4 (6.1) 
 
Cough 44 (43.1) 35 (48.6) 9 (30.0) 14 (53.8) 26 (39.4) 
 
Diarrhea 42 (41.2) 28 (38.9) 14 (46.7) 11 (42.3) 26 (39.4) 
 
Fever 76/97 (78.4) 49/69 (71) 27/28 (96.4) 15/24 (62.5) 54/63 (85.7) 
 
Hepatomegaly 25 (24.5) 21 (29.2) 4 (13.3) 4 (15.4) 18 (27.3) 
 
Oral candidiasis 36 (35.3) 35 (48.6) 1 (3.3) 11 (42.3) 21 (31.8) 
 
Pallor 
56/101 
(55.4) 
38/71 (53.5) 18 (60.0) 15 (57.7) 35 (53.0) 
 
Pneumonia 72 (70.6) 56 (77.8) 16 (53.3) 19 (73.1) 45 (68.2) 
 
Septic Shock 6 (5.9) 4 (5.6) 2 (6.7) 4 (15.4) 2 (3.0) 
 
Splenomegaly 16 (15.7) 15 (20.8) 1 (3.3) 3 (11.5) 10 (15.2) 
 
Tachypnea 29 (28.4) 19 (26.4) 10 (33.3) 13 (50.0) 15 (22.7) 
 
Throat lesions 45 (44.1) 40 (55.6) 5 (16.7) 13 (50.0) 26 (39.4) 
Coinfections 16 (15.7) 16 (22.2) 2 (6.7) 6 (23.1) 10 (15.2) 
 
T. marnefeii  9 (8.8) 9 (12.5) 0 (0) 2 (7.7) 7 (10.6) 
 
Other b 7 (6.9) 7 (9.7) 0 (0) 4 (15.4) 3 (4.5) 
Serovar      
 
S. Enteritidis 43/89 (48.3) 30/63 (47.6) 13/26 (50.0) 12/22 (54.5) 26/57 (45.6) 
 
S. Typhimurium 23/89 (25.8) 22/63 (34.9) 1/26 (3.8) 7/22 (31.8) 11/57 (19.3) 
 
S. Choleraesuis 11/89 (12.4) 9/63 (14.3) 2/26 (7.7) 1/22 (4.5) 10/57 (17.5) 
 
Other 12/89 (13.5) 2/63 (3.2) 10/26 (38.5) 2/22 (9.1) 10/55 (18.2) 
 
a) 10 patients missing outcome status; b) Includes Cryptococcus neoformans, Streptococcus 
pneumoniae and Escherichia coli isolates cultured from either blood or cerebrospinal fluid 
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Table 5.1 describes the clinical characteristics of the patients. The most common 
clinical features were fever (76/97, 78%) (≥38.0oC) and pallor (56/101, 56%). Almost 
half of the cases (45/102) had oropharyngeal lesions, including ulcers and candidiasis; 
these symptoms were chiefly restricted to the HIV-infected group. Notably, 
gastrointestinal symptoms such as diarrhea (42/102, 41%) and abdominal pain (23/102, 
23%), which are synonymous with the archetypal, non-invasive manifestation of NTS 
infection, were uncommon. However, comorbidities such as hepatitis (induced by 
hepatitis B, C or alcohol abuse) and pneumonia (caused by PCP or Mycobacterium 
tuberculosis) were recorded in 27% (27/102) and 71% (72/102) of patients, 
respectively. Furthermore, 16/102 (16%) patients had an additional pathogen identified 
in their bloodstream (BS) or cerebrospinal fluid (CSF): 9 Talaromyces marnefeii (BS), 4 
Cryptococcus neoformans (CSF), 2 Escherichia coli (BS) and 1 Streptococcus 
pneumoniae (BS). None of these additional BS or CSF infections were identified in 
children. Septic shock was diagnosed in 6/102 (6%) cases; hypovolemic shock (due to 
fluid loss) was diagnosed in 2/102 (2%); a secondary infection was identified in only 
1/6 (17%) patient with septic shock. Furthermore, 2/8 (25%) of the paediatric patients 
were diagnosed with hand-foot and mouth disease prior to the isolation of an NTS 
organism from the blood.  
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Table 5. 2 Laboratory results of invasive non-typhoidal Salmonella disease stratified by 
outcome 
Laboratory test 
Normal 
range 
Total cases 
(n=102) 
Fatal (n=26) Nonfatal (n=66) 
p value a 
Median 
(IQR) 
Median (IQR) Median (IQR) 
White blood cells (103 cells/µl) 3.7-11.7 
5.1 (3.1-
10.8) 
4.5 (2.9-6.5) 6.9 (3.0-11.1) 0.210 
Neutrophils (%) 39.6-78.4 
82 (66.1-
87.5) 
84.7 (74.05-88) 77.6 (63.8-85.3) 0.479 
Lymphocytes (%) 14.1-52.8 
11.2 (4.8-
19.2) 
8.05 (4.8-18.4) 12.4 (5.6-20.3) 0.261 
Platelets (109 cells/µl) 172-440 
142 (58-
258) 
90 (59-153) 178 (64-269) 0.042 
Hemoglobin (g/dL) 12.0-17.2 
10.2 (7.9-
12) 
8.1 (6.95-10.1) 10.8 (8.9-12.5) 0.001 
Hematocrit (%) 34.8-50.9 
30.1 (23.6-
36.1) 
25.2 (20.8-30.4) 31.9 (26.8-37.6) 0.002 
AST (U/L) 5-30 
100.4 (52.4-
189) 
109 (52.4-320) 90.5 (48-133) 0.094 
ALT (U/L) 5-30 47 (26-93) 36 (22-74) 47 (27.5-84.4) 0.547 
Creatinine (µmol/L) 80-130 68 (57-107) 74.5 (49.5-172) 68 (55-87) 0.303 
Sodium (mmol/L) 135-145 
130 (126-
134) 
130.9 (125-135.5) 130 (127-134) 0.900 
Potassium (mmol/L) 3.5-5.0 3.7 (3.3-4.5) 4.3 (3.6-4.8) 3.6 (3.1-3.9) 0.003 
 
a) Derived using Kruskal-Wallis test; normal values derived from minimum and maximum 
adult values (>18 years) listed in (Farinde, 2016; Virginia Commonwealth University, 2010)
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 Outcome of invasive non-typhoidal Salmonella infections 
Overall 66/102 (65%) patients improved or recovered before hospital discharge; four 
(4%) died in hospital and 22 (22%) were discharged to die at home; the remaining 10 
patients had an outcome that was non-assessable (five left against medical advice, two 
were unchanged and three transferred hospitals). One child (1/8, 12%), who was HIV-
uninfected, died. The overall mortality rate was 26/92 (28%), of which 24 (92%) were 
HIV-infected. A total of 23% (6/26) of fatal cases had a secondary infection in 
bloodstream or central-spinal fluid. The median time to death in hospital was one day 
(IQR: 1-2 days) while median length of hospital stay for patients not discharged to die 
at home was 10 days (IQR: 3-15 days).  
 
Hematology parameters for the 102 patients stratified by outcome are shown in Table 
5.2. Notably, total white cell count was generally non elevated (median 5.1 (IQR: 3.1-
10.8) x 103 cells/µl) but characterized by a high proportion of neutrophils: 82% (IQR: 
66.1-87.5). The platelet count was lower in fatal cases than nonfatal cases but this was 
not statistically significant. Fatal cases were significantly more likely to have higher 
potassium, lower haemoglobin, and lower hematocrite levels (Table 5.2). Additionally, I 
performed univariable and multivariable logistic regression analyses to assess the 
clinical and laboratory variables that were associated with death (Table 5.3). Though 
HIV positivity, age and infecting serovar were associated with death in the univariable 
analysis, after controlling for confounding only HIV positivity remained independently 
associated with an increased risk of fatality (Table 5.3). 
 
 The treatment of invasive non-typhoidal Salmonella infections 
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The vast majority of iNTS patients received an antimicrobial (100/102; 98%) (Table 
5.4). The most commonly used antimicrobial was ceftriaxone; 89/100 (89%) patients 
received this drug in mono or combination-therapy. A fluoroquinolone (levofloxacin, 
ciprofloxacin or ofloxacin) was used in 22/100 (22%) of cases, again either used in 
monotherapy or in combination with ceftriaxone (Table 5.4). Switching to an alternative 
antimicrobial (imipenem or meropenem) occurred on two occasions, of which one 
patient had a positive outcome and one was fatal. Trimethoprim-sulfamethoxazole was 
used in early therapy in 25/101(25%) iNTS; ceftriaxone was later added to this regime. 
Patients who were additionally diagnosed with Talaromyces marneffei or Cryptococcus 
neoformans in their BS or CSF were also treated with antifungal drugs. There was no 
significant difference in disease outcome with differing antimicrobial treatment 
regimens (Table 5.4). The median time from hospitalization to the use of an 
antimicrobial was 2.9 days (IQR 0-3 days); patients with a fatal outcome received an 
antimicrobial significantly earlier than those with non-fatal disease with a median of 
two days after hospitalization in the fatal group compared to 3.5 days in the non-fatal 
group (p=0.01; Kruskal-wallis test). 
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Table 5. 3 Covariates associated with fatal outcome in 102 patients with invasive non-
typhoidal Salmonella disease 
Characteristic  
 
Univariable Multivariable 
OR 95%CI p aOR 95%CI p 
Male sex 1.13 0.42-2.99 0.813 0.82 0.23-2.95 0.757 
Age category (yr) a       
 <10 0.75 0.07-7.88 0.811 0.94 0.06-14.3 0.967 
 21-30 1.75 0.44-6.88 0.423 0.31 0.05-1.85 0.198 
 31-40 4.32 1.20-15.6 0.025 0.86 0.15-5.0 0.866 
 >40 1.00 - - 1.00 - - 
HIV  8.31 1.8-38.1 0.006 7.89 1.10-56.3 0.039 
Hepatitis 1.36 0.50-3.71 0.552 0.89 0.23-3.44 0.862 
Serovar       
 S. Enteritidis 3.08 0.76-12.4 0.114 2.91 0.65-12.9 0.161 
 S. Typhimurium 4.24 0.91-19.8 0.066 3.24 0.54-19.5 0.198 
 Other 1.00 - - 1.00 - - 
 
OR: odds ratio; CI: confidence interval; aOR: adjusted odds ratio 
a) No patients aged 10-20 years 
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Table 5. 4 The characteristics of antimicrobial treatment for invasive non-typhoidal 
Salmonella patients 
Antimicrobial prescribed 
Count Treatment, days FCT, days a 
n/Total (%) n Median (IQR) n Median (IQR) 
Any 100/102 (98) 98 7 (3-10) 51 3 (2-8) 
Ceftriaxone 89/100 (89) 89 7 (4-10) 47 3 (2-7) 
 Monotherapy 34/100 (34)     
 Combination 55/100 (55)     
Fluoroquinolone 22/100 (22) 22 10 (7-14) 11 5 (2-10) 
 Monotherapy 7/100 (7)     
 Combination 15/100(15)     
Combination therapy 53/100 (53)     
 CRO-FLQ 16/100 (16) 15 10 (7-12) 9 4 (2-5) 
 CRO-SXT 25/100 (25) 25 6 (2-10) 6 2 (2-5) 
 Other 12/100 (12)     
Switched to a broader spectrum 4/101 (4)     
 
FCT: fever clearance time; a) non-fatal cases only; CRO-FLQ: ceftriaxone-fluoroquinolone; 
CRO-SXT: ceftriaxone- trimethoprim-sulfamethoxazole 
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5.3.1. Serovars associated with invasive non-typhoidal Salmonella infections  
I perform MLST on the complete collection of 142 available iNTS isolates cultured at HTD 
between January 2008 and June 2013; the resulting minimum spanning tree of these data is 
shown in Figure 5.1. I was able to identify 17 different serovars by MLST that were associated 
with iNTS disease in this population. The most common serovars causing invasive disease were 
S. Enteritidis (ST11) and S. Typhimurium (STs 19, 34 and 1544), which were responsible for 
63/147 (43%) and 44/147 (30%) of all cases, respectively. S. Typhimurium was identified more 
frequently in HIV-infected patients (Table 5.1) (p=0.003, Fisher’s exact test). The remaining 
organisms (n=40) were a combination of less commonly isolated Salmonella serovars including 
S. Choleraesuis (n=14), S. Stanley (n=3) and S. Weltevreden (n=1) (Figure 5.1), which were 
generally identified in nonfatal cases. 
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Figure 5. 1 Salmonella serovars associated with invasive disease  
 
 
Minimum spanning tree of 142 iNTS isolates created using seven allele MLST profiling. The 
sequence type (ST) of each allele profile is shown along with the inferred serovar. Clonal 
complexes (S. Typhimurium, S. Enteritidis, S. Cholerasuis and S. Paratyphi B [tartrate positive]) 
are highlighted. The size of each ST group corresponds with the number of isolates with the 
same ST profile (scale shown), and the branches are labeled by the number of variable alleles 
between STs. 
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Figure 5. 2 The antimicrobial susceptibility profiles of invasive Salmonella 
 
 
Bar graph showing the proportion of organisms (red, S. Typhimurium; blue, S. Enteritidis and 
grey, others) exhibiting resistance against   ampicillin (AMP), amoxicillin/clavulanate (AMC), 
ceftazidime (CAZ), ceftriaxone (CRO), chloramphenicol (CHL), ciprofloxacin (CIP), 
gentamicin (GEN), nalidixic acid (NAL), ofloxacin (OFX) and trimethoprim-sulfamethoxazole 
(SXT). Asterisks signify statistically significant differences in the proportion of organisms 
exhibiting resistance to the individual antimicrobial (p<0.05, Fisher’s exact test). 
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I next compared antimicrobial susceptibility profiles between S. Enteritidis, S. 
Typhimurium and the remaining serovars (Figure 5.2). The susceptibility profiles varied 
between the three different etiological groups and I found that S. Typhimurium were 
significantly more likely to exhibit resistance against ampicillin, amoxicillin, 
Chloramphenicol, and trimethoprim-sulfamethoxazole than S. Enteritidis and the 
remaining serovars (p<0.05 for all pairwise comparisons, Fisher’s exact test) (Figure 
5.1). Further, >50% of S. Typhimurium isolates were resistant to 6/10 antimicrobials 
tested (including ciprofloxacin and gentamicin); the same was true for 2/10 tested 
antimicrobials with the S. Enteritidis isolates and 5/10 antimicrobials with the other 
iNTS isolates. The majority of iNTS were susceptible to both azithromycin and third 
generation cephalosporins, with the exception of a single Extended Spectrum Beta 
Lactamase (ESBL) producing S. Choleraesuis. After PCR amplification and sequencing 
I found this particular S. Choleraesuis isolate to harbor a blaCTX-M-55 ESBL gene (see 
chapter 4). Despite differences in AMR profiles I found no significant difference in 
mortality between those infected with S. Typhimurium and S. Enteritidis (p=0.431, 
Fisher’s exact test). Lastly, isolates from HIV–infected patients were significantly more 
likely to exhibit reduced susceptibility against trimethoprim-sulfamethoxazole (28/62 
45%) compared to HIV-uninfected patients (6/28, 21%) (p=0.037, Fisher’s exact test). 
 
 Discussion 
NTS pathogens are a leading cause of community acquired bloodstream infections in 
parts of sub-Saharan Africa (Crump and Heyderman, 2015; Feasey et al., 2012). In sub-
Saharan Africa the disease is concentrated in children and HIV-infected adults and 
complicated by the recent emergence and dominance of ST313, a multidrug resistant 
(MDR) variant of S. Typhimurium (Okoro et al., 2012). It was not known whether 
similar epidemiological patterns and iNTS sequence types existed in Asia. I can report 
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that iNTS infections are not as common in this setting in comparison to parts of sub-
Saharan Africa, but similarly the disease is associated with immunocompromised adults 
and primarily caused by the serovars S. Enteritidis and S. Typhimurium.  
 
Recent evaluations in sub-Saharan Africa have highlighted that the emergence of iNTS 
has been largely driven in adults by the HIV epidemic, while malnutrition and malaria 
infection are heavily associated with iNTS in children (Crump and Heyderman, 2015; 
Feasey et al., 2012). The overall incidence of iNTS infections in Southeast Asia is 
limited compared to that of Africa (Gordon, 2011; Khan et al., 2010), though similar to 
the African context we confirm that HIV infection is the primary risk factor for iNTS 
disease in adults in Vietnam. The overall prevalence of HIV infection is low in Vietnam 
(0.5%) (UNAIDS, 2014), yet it is known that disease is common in adults using 
intravenous drugs (Go et al., 2011). Indeed, HIV positive individuals in this study were 
likely to be male between the ages of 28-37 years. Therefore, iNTS disease should be 
considered as a possible aetiology for febrile HIV-infected individuals. 
As HIV was identified as main risk factor for iNTS diseases, I assume that HIV 
individuals should have convenient immune factors to NTS infection. In this case, 
bacterial killing assay is the appropriate method for better understanding of immune 
response to NTS in these immunocompromised patients(Gupta-Wright et al., 2017). 
Protocols for such assay in Salmonella including S.Typhi, S.Paratyphi, S.Typhimurium 
and S.Enteritidis had been developed for vaccine research(Boyd et al., 2014). My study 
had both HIV-infected iNTS and non-HIV infected iNTS patients. Using bacterial 
killing assay to compare the functioning of immune response in different groups of 
iNTS patients is a promising study in the future. 
 
Through MLST testing I found that approximately 75% of iNTS organisms were either 
S. Enteritidis or S. Typhimurium, which is consistent with the organisms causing iNTS 
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disease in Africa (Feasey et al., 2015; Kariuki and Onsare, 2015), and the predominant 
organisms found in non-invasive NTS infections in this setting (Thompson et al., 2013). 
Although S. Typhimurium isolates were more likely to exhibit resistance against 
antimicrobials than other serovars, I did not identify the MDR S. Typhimurium clone 
ST313, which appears to have replaced resident NTS strains in sub-Saharan Africa 
(Okoro et al., 2012). The sequence types identified here setting, namely S. Enteritidis 
ST11 and S. Typhimurium ST19 and ST34, have been found in invasive infections in 
Africa previously (Ikumapayi et al., 2007; Kariuki and Onsare, 2015; Kingsley et al., 
2009; Okoro et al., 2012) while S. Typhimurium ST1544 has recently been isolated 
from food samples from China (Yang et al., 2015). I additionally identified 14 S. 
Choleraesuis isolates, a serovar known to be associated with the consumption of pork 
products (Chiu et al., 2004), and previously shown to be a cause of bacteremia in 
Taiwan (Jean et al., 2006). I surmise that it is likely that organisms causing 
gastroenteritis in immunocompetent individuals may be comparable to those causing 
iNTS disease in immunocompromised patients in Vietnam. Continuing efforts to 
improve food safety and hygiene may have a positive effect on reducing both non-
invasive and iNTS disease in this setting, though such interventions are costly and may 
be difficult to sustain in an industrializing setting like Vietnam (Unnevehr and Jensen, 
1999). 
 
Over one quarter of patients with iNTS disease either died in hospital or were 
discharged to die at home with family. This mortality rate is similar to the African 
context and confirms the severity of this infection in an immunocompromised 
population. The primary risk factor for death in our population was HIV infection, 
confirming trends identified in adults in sub-Saharan Africa (Crump and Heyderman, 
2015; Feasey et al., 2012). Though I did not have CD4 cell counts available, iNTS 
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disease is known to be a major risk factor for death in patients with advanced HIV 
disease (M. Gordon et al., 2002). As only 22% of HIV-infected patients were on active 
ART at the time of admission, improving access to ART would likely prevent the 
number of iNTS cases in Vietnam. 
 
The majority of patients received ceftriaxone either in mono or combination therapy. 
Current susceptibility profiles confirm this is an appropriate choice, however high 
existing resistance against a variety of antimicrobials including ampicillin, 
chloramphenicol, and ciprofloxacin signal the propensity for Salmonella to acquire a 
variety of resistance mechanisms. High levels of antimicrobial resistance in S. 
Typhimurium is cause for concern, particularly as HIV-infected patients were most 
often diagnosed with this serovar and the presence of resistance could further 
complicate management. Attempting to identify whether such antimicrobial resistance 
is related to food consumption and the excessive use of antimicrobials in animal 
husbandry known to occur in Vietnam is warranted (Carrique-Mas et al., 2015). 
Furthermore, the significant elevation of trimethoprim-sulfamethoxazole resistance 
amongst HIV-infected patients suggests that pneumocystis prophylaxis with the drug 
leads to colonization by resistant organisms. These data indicate that reduced 
antimicrobial susceptibility may not purely arise in animals in zoonotic pathogens, 
further work regarding the use of specific antimicrobials is animals is justified. 
 
Our study has limitations. First, children with HIV are generally referred to one of two 
large local pediatric hospitals so it is likely the burden of iNTS disease in children 
substantially underestimated. Though HIV is a risk factor for iNTS in children in Kenya 
(Muthumbi et al., 2015), malnutrition and malaria infection are also important risks in 
children in the sub-Saharan African context (Berkley et al., 2005; Graham et al., 2000); 
future work in an Asian context should examine the epidemiology of pediatric iNTS 
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more thoroughly. Secondly, this retrospective analysis for risk of death may be biased 
by misclassification as we coded patients who were taken home by family members as 
fatal, though I did not have a confirmed death report from these individuals. 
Notwithstanding these limitations of a retrospective study this work provides the largest 
description to date of iNTS patients to date in Southeast Asia and highlights important 
similarities and differences between the African and Asian settings. I suggest that 
continued surveillance, including sequence typing/whole genome sequencing, should be 
performed to monitor for emergence or introduction of MDR strains or strains with any 
apparent enhanced virulence phenotype, such as ST313 (Nguyen et al., 2013). 
 
I conclude that iNTS disease is a severe infection in Vietnam, with a mortality rate 
(26%) similar to that of sub-Saharan Africa. I also highlight HIV infection as the major 
risk for both infection and death in this setting. Though the sequence types of iNTS 
organisms identified in this study are common globally, I suggest continued 
surveillance to monitor for the presence of MDR sequence types, such as ST313, which 
has not, as of yet, been identified in Asia.  
  
 174 
Chapter 6 
A descriptive study of antimicrobial resistance in Salmonella spp. and a 
comparison between differing susceptibility testing methods  
 Aims of chapter 
This study has two main aims. The first aim was to examine the trend of antimicrobial 
susceptibility of all Salmonella spp. isolated from blood cultures within an eight-year 
period (2008-2015) at HTD. The data presented in chapter 3 demonstrated that there 
was notable change in type of Salmonella associated with bacteraemia in HTD between 
2010 and 2014. I observed an increase number in NTS BSI, as opposed S. Typhi being 
the predominant serovar (Nga et al., 2012). Moreover, there was an increase in AMR in 
Gram-negative bacilli associated with BSI (as described in chapter 3); this was 
predominantly associated with beta-lactams and fluoroquinolones. These two 
antimicrobial groups are the first line therapeutics for typhoid and NTS infections in 
HTD. Therefore, in this study, I will describe the susceptibility trends for antimicrobials 
for Salmonella BSI by the E-test method and the disk diffusion method. Based on the 
MIC of each antimicrobial obtained by E-test, the MIC50 and MIC90 will be determined 
for defined antimicrobials in Salmonella population. The distribution of MICs is 
valuable for epidemiology investigation and empirical treatment guidelines. 
 
I additionally aimed to identify the most appropriate antimicrobial testing method for 
Salmonella. The E-test method is considered as the best antimicrobial susceptibility 
method for clinical microbiology but it is expensive. The disk diffusion method is 
historically the most common approach but it is unable to produce MIC values. 
Additionally, new automatic antimicrobial susceptibility testing machines, such as 
VITEK, have become increasingly popular Vietnam. In this study, I compare the 
accuracy and agreement level of three antimicrobial susceptibility testing methods (E-
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test, VITEK, and disk diffusion) for common antimicrobials used to treat infections 
caused by Salmonella sp. Data were analysed according to ISO 20776:2007 and CLSI 
M100: 2016 guidelines. 
 Results 
 Salmonella organisms and prevalence 
Among 317 Salmonella isolated over the study period, 117 (36.9%) were S. Typhi, 23 
(7.3%) were S. Paratyphi A, 8 (2.5%) were S. Paratyphi B, and 168 (53%) were NTS 
(Figure 6.1).  It was notable that the number of S. Typhi being isolated steadily 
decreased over this period. NTS were more commonly isolated than S. Typhi from 
2009, with the exception of a fall in NTS cases in 2013. 2013 was the time that HTD 
stopped receiving all HIV patients, and only received moderate or severe cases. The rise 
of NTS cases in 2014 was associated with hepatitis in non-HIV infected patients.  
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Figure 6. 1 Trend of different types of Salmonella associated with bacteraemia at HTD 
over an 8-year period (2008-2015) 
 
 
 
Line chart describing the actual number of Salmonella isolated per year divided into three main 
groups: Salmonella Typhi (blue line), Salmonella Paratyphi (including serotype A, B and C) 
(orange line) and nontyphoidal Salmonella (grey line). 
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 Trends of antimicrobial susceptibility by E-test method 
The trends of antimicrobial susceptibility of 332 Salmonella isolates are shown in 
Figure 6.2. The (fluoro)quinolone (nalidixic, ofloxacin, and ciprofloxacin) were the 
antimicrobials to which the organisms were least susceptible (annual susceptibility rate 
<50%), followed by the beta-lactam, ampicillin (55.2%). Susceptibility against 
chloramphenicol increased over the study period. Third generation cephalosporins 
(ceftriaxone) and azithromycin exhibited the highest susceptible rate across all 
Salmonella (>90%)  (Figure 6.2). The older generation antimicrobials (ampicillin, 
trimethoprim-sulfamethoxazole and chloramphenicol) exhibited a similar trend: 
decreased susceptibility from 2009 to 2011, then regaining susceptibility after this 
period. 
 
The distribution of MIC50 and MIC90 in common antimicrobials used to treat infections 
caused by Salmonella spp. is shown in Table 6.1.  I found that nalidixic acid; an early 
generation of fluoroquinolones, was the least susceptible antimicrobial against 
Salmonella. The proportion of resistant organisms against nalidixic was 55.2% 
(175/317). MIC testing showed that 50% (158/317) of Salmonella had an azithromycin 
MIC value of 256µg/ml, this was most apparent in the S. Typhi and the NTS. Moreover, 
resistance was observed for approximately 10% of the fluoroquinolones (35/317; 11% 
for ofloxacin and 30/317; 9.5% for ciprofloxacin). Ciprofloxacin had lower MIC50 and 
MIC90 values than ofloxacin in both the S. Typhi and the NTS strains. The MIC90 value 
for ciprofloxacin was ≤0.75 µg/ml in the Salmonella population, which implicated the 
majority of organisms in the susceptible and intermediate range.  
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Figure 6. 2 Susceptibility trends of several antimicrobials for 332 Salmonella isolated from 
blood between 2008 and 2015 
 
 
AMP: ampicillin; NA: nalidixic acid; OFX : ofloxacin; CIP: ciprofloxacin; CRO: ceftriaxone; 
 AZM: azithromycin; SXT: trimethoprim-sulfamethoxazole: Susceptible by using E-test method 
; C: chloramphenicol ( susceptibility was performed by the disk diffusion method) 
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Table 6. 1 MIC and susceptibility pattern of 317 Salmonella isolates by E-test method  
 
 
 
 
 
 
 
 
*MIC: minimum inhibition concentration. SXT: trimethoprim -sulfamethoxazole 
 
 
MIC50 (MIC90) (µg/ml) 
 Nalidixic acid Ofloxacin Ciprofloxacin Azithromycin SXT Ampicillin Ceftriaxone 
Salmonella Typhi (n=117) 256 (256) 0.75 (1.0) 0.38 (0.75) 8.0 (12.0) 0.023 (32.0) 0.75 (256) 0.25 (0.25) 
Salmonella Paratyphi (n=32) 4.0 (256) 0.19 (2.0) 0.064 (0.5) 8.0 (16.0) 0.094 (0.12) 1.5 (256) 0.25 (0.25) 
        
Nontyphoidal Salmonella 
(n=168) 
256 (256) 0.5 (2.0) 0.125 (0.5) 6.0 (8.0) 0.19 (32.0) 256 (256) 0.12 (0.19) 
All Salmonella  (n=317) 256 (256) 0.5 (1.5) 0.125 (0.5) 6.0 (12.0) 0.094 (32) 256 (256) 0.19 (0.25) 
MIC range 0.5-256 0.016-32 0.004-32 1.5-256 0.008-32 0.25-256 0.016-32.0 
Resistance proportion % 55.2 11 9.5 1.3 21.8 42 1.6 
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I found that resistance against ampicillin was high at 42% (133/317), which made 
ampicillin the second most common antimicrobial that Salmonella were resistant to over 
the 8-year period.  All three of the subgroups of Salmonella had high ampicillin MIC90 
value at 256 µg/ml. However, Salmonella had high susceptibility to ceftriaxone. Low 
MIC50 and MIC90 value at <0.25 µg/ml for ceftriaxone were observed in majority of 
Salmonella strains. Only five isolates were found to be resistant to ceftriaxone, all of 
which were isolated after 2011. One ceftriaxone-resistant organism was S. Typhi, the 
remainder belonged to NTS group. 
 
Azithromycin, the oral azalide drug maintained its susceptibility for Salmonella over the 
8 years. Resistance was identified in only four Salmonella, whose MIC value were 
>32µg/ml. All MIC90 in all Salmonella subgroups was less than or equal to the 
susceptible cut-off (<16 µg/ml). The NTS organisms had lower MIC50 than S. Typhi 
(6.0µg/ml vs. 8.0µg/ml). 
Approximately, 22% (69/317) of Salmonella isolates were resistant to trimethoprim- 
sulfamethoxazole (SXT) as determined by E-test method. The SXT MIC50 value in the 
NTS group was 0.19 µg/ml, the highest MIC50 of this drug in all species. 
 
 Multidrug-resistant Salmonella 
53/332 Salmonella was categorized as being multi-drug resistant (MDR; resistant to 
ampicillin, chloramphenicol, and SXT). There was an increasing trend of MDR 
isolation from 8.5% (4/47) to 38.5% (20/52) during 2008 -2011 (Table 6.2). After 2011, 
the MDR rate declined unevenly and varied between 5% and 13%. More than 70% of 
MDR strains were NTS. MDR S. Typhi was recorded for 12 isolates only all were 
cultured before 2012. 
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Table 6. 2 The prevalence of MDR Salmonella from 2008-2015 
Year 2008 2009 2010 2011 2012 2013 2014 2015 Total 
No of MDR strains 4 7 10 20 5 1 4 2 53 
% of MDR 8.5 18.4 21.7 38.5 11.1 5.5 7.3 12.5 16.7 
MDR ST (%) 3 0 2 5 2 0 0 0 12(22.6) 
MDR SP (%) 0 0 1 1 0 0 0 0 2(3.8) 
MDR NTS (%) 1 7 7 14 3 1 4 2 39 (73.6) 
 
*MDR: multi-drug resistant (co-resistant against ampicillin, chloramphenicol and trimethoprim-sulfamethoxazole); 
 ST: Salmonella Typhi; SP: Salmonella Paratyphi; NTS: nontyphoidal Salmonella 
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 A comparison of three antimicrobial testing methods 
I compared three commonly used clinical antimicrobial testing methods: E-test, an 
automated VITEK system, and disc diffusion to test seven antimicrobials against all 317 
Salmonella. The seven-selected antimicrobials were ampicillin, ceftriaxone, nalidixic 
acid, ofloxacin, ciprofloxacin, azithromycin, and trimethoprim-sulfamethoxazole. They 
are all appropriate antimicrobials for Salmonella infections. Chloramphenicol was not 
selected as it is not incorporated into a VITEK screening card and the chloramphenicol 
E-test is not available in Vietnam. Because nalidixic acid, ofloxacin and azithromycin 
were not represented on the VITEK AST GN67 card, a comparison between VITEK 
method and E-test was not possible for these antimicrobials. Table 6.3 shows a 
comparison result for all Salmonella isolates collected over 8 years. Table 6.4, Table 
6.5, and Table 6.6 describe a comparison for the various Salmonella subgroups (S. 
Typhi, S. Paratyphi (A, B, and C), and NTS, respectively).  
 
For nalidixic acid, categorical agreements (susceptible, intermediate, and resistant) 
between E-test and disk diffusion method was found at high rate (>90%; 286/317) for 
all Salmonella. The S. Paratyphi isolates had highest agreement rate at 97% (31/32) for 
nalidixic acid by the two methods. The S. Typhi and NTS subgroups had approximately 
90% category agreement by MIC E-test and disk diffusion. Minor error was very low 
(1/317, 0.3%), which occurred the in S. Paratyphi organisms only. The major error for 
nalidixic acid was as high as 13.4% (19/142) which was higher than the acceptable rate 
(<3%). 18/19 organisms that had major error in nalidixic acid were mainly in the NTS 
group. Very major error rate of disk diffusion method was 6.3% (11/175) of organisms 
in comparison with MIC E-test method), which was also higher than acceptable value 
(<1.5%). 10/11 strains that were susceptible to nalidixic acid by disk diffusion and 
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resistant by MIC E-test (very major error) were all S. Typhi. S. Paratyphi and NTS had 
very low very major errors for nalidixic acid in comparison with disk diffusion and MIC 
E-test. 
 
Ofloxacin had low overall categorical agreement (126/317; 39.7%) between E-test and 
disk diffusion method for the Salmonella isolates in this study. Minor error ranged from 
48% -60% in different Salmonella groups. However, there was no major error, which 
means all resistant strains against ofloxacin by disk diffusion, were also resistant by 
MIC E-test. In contrast, very major error was found to be very high (88%). 5/5 (100%) 
S. Typhi, 3/5 (60%) S. Paratyphi and 23/25 (92%) NTS strains were susceptible by MIC 
E-test method but found to be non-susceptible by disc diffusion method. 
 
I found that the automated susceptibility card AST GN69 failed to differentiate between 
ciprofloxacin susceptible and intermediate organisms. The lowest dilution of 
ciprofloxacin was 0.5µg/ml on the VITEK card, which covered the susceptible (<0.06 
µg/ml) and intermediate range (0.12-0.5 µg/ml). Therefore, the minor error and the very 
major error rate were not obtainable. However, I could assess the major error rate by 
assessing resistance to ciprofloxacin by MIC VITEK but susceptible by E-test. A major 
error was found on only NTS organism. In a comparison between MIC E-test and disk 
diffusion for ciprofloxacin, categorical agreement was low at 54% (171/317). The disk 
diffusion method provider a high minor error (41.2%, 141/317) and very major error 
(20%, 6/30) rate. Minor error of ciprofloxacin was detected in all Salmonella groups, 
while the major error arose in 6 NTS organisms only. 
 
Ampicillin, an older generation antimicrobial used to treat Salmonella, exhibited good 
agreement between the different antimicrobial testing methods. MIC VITEK showed 
good categorical interpretation agreement (> 99%) with the MIC E-test method for 
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every Salmonella group. There was only one NTS organism that was identified as 
resistant to ampicillin by VITEK method but susceptible by E-test method. Moreover, 
the ampicillin testing result by disk diffusion also exhibited a good correlation with the 
E-test method. Categorical agreement for ampicillin was 97.8% (310/317) for disk 
diffusion and E-test methods. Very major error was found only in one NTS isolated 
while a major error was in recorded for three S. Typhi and one NTS isolate. In general, 
ampicillin had good interpretation agreement between disk diffusion and MIC VITEK 
method. Ceftriaxone demonstrated a comparable result to ampicillin. The MIC VITEK 
methods produced identical results in comparison with E-test for ceftriaxone. 315/317 
(99.4%) of the Salmonella isolated had the same interpretation result by disk diffusion 
and MIC E-test for ceftriaxone. 
 
Azithromycin was compared by the MIC E-test method and the disk diffusion method 
only. 292/317 (92%) organisms had a good correlation by these two testing methods. 
Although azithromycin had very few minor and major errors (only one for each error), 
there was more major error (23/317; 7.4%) when compared to the disk diffusion 
method. 13/23 cases with a major error were NTS, 6 were S. Typhi and four were S. 
Paratyphi.  
 
SXT was tested by all three methods. VITEK proved to be a good testing method for 
Salmonella with 97.5% (309/317) in agreement with the E-test method. There were six 
minor errors (mostly NTS), one major, and one very major error. With the VITEK 
method, disk diffusion method had 95.6% (303/317) agreement with VITEK 
interpretation. Minor and major errors were under the specified cut-offs.  However, 3/73 
(4.3%) organisms produced a susceptible result by disc diffusion but were susceptible 
by E-test method (interpreted as very major error); these were all S. Typhi. 
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 Table 6. 3 Comparison between antimicrobials testing methods for 317 Salmonella isolated during 2008-2015  
 
NO(%) OF ISOLATES  NO.(%) OF ISOLATES 
 
Susceptible Intermediate Resistant Categorical agreement 
with E-test method 
Minor error Major 
error 
Very major 
error 
Nalidixic acid* 
E-TEST 142 (44.8) 0 175 (55.2) 
    
DISK DIFFUSION 133 (42) 1 (0.3) 183 (57.7) 286 (90.2) 1 (0.3) 19 (13.4) 11 (6.3) 
Ofloxacin* 
E-TEST 123 (38.8) 159 (50.2) 35 (11) 
    
DISK DIFFUSION 311 (98.1) 3 (0.95) 3 (0.95) 126 (39.7%) 160 (50.5) 0 31 (88.6) 
Ciprofloxacin 
E-TEST 116 (36.6) 171 (53.9) 30 (9.5) 
    
VITEK2 NA** NA** 51 (55.4) NA** NA** 0 NA** 
DISK DIFFUSION 194 (61.2) 91 (28.7) 32 (10.1) 171(53.9) 140 (41.2) 0 6 (20) 
Ampicillin 
E-TEST 184 (58) 0 133 (42) 
    
VITEK2 183 (57.7) 0 134 (42.3) 316 (99.7) 0 1 (0.5) 0 
DISK DIFFUSION 179(56.5) 2 (0.6%) 136 (42.9) 310 (97.8) 2(0.6) 4 (2.2) 1 (0.8) 
Ceftriaxone 
E-TEST 312 (98.4) 0 5 (1.6) 
    
VITEK2 312 (98.4) 0 5 (1.6) 317 (100) 0 0 0 
DISK DIFFUSION 311 (98.1) 1 (0.3) 5 (1.6) 315 (99.4) 1 (0.3) 1 (0.3) 0 
Azithromycin* 
E-TEST 312 (98.4) 1 (0.3) 4 (1.3) 
    
DISK DIFFUSION 290 (91.5) 0 27 (8.5) 292 (92.1) 1 (0.3) 23 (7.4) 1 (25) 
Trimethoprime-sulfamethoxazole 
E-TEST 242 (76.3) 6 (1.9) 69 (21.8) 
    
VITEK2 244 (77%) 6 (1.9) 67 (21.1) 309 (98) 6 (1.9) 1 (0.4) 1 (1.4) 
DISK DIFFUSION 242 (76.3%) 2 (0.6) 73 (23) 303 (96) 8 (2.5) 3 (1.2) 3 (4.3) 
*VITEK results were unavailable for nalidixic acid, ofloxacin and azithromycin. 
**Interpretation result in ciprofloxacin susceptible (<0.06 µg/ml) and intermediate (0.12-0.5 µg/ml) were not available (minimum VITEK MIC for 
ciprofloxacin was <0.5µg/ml). Bold number implicated the value that was higher than accepted range.
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Table 6. 4 Comparison between antimicrobials testing methods for 117 Salmonella Typhi isolated during 2008-2015 
 
NO.(%) OF ISOLATES NO.(%) OF ISOLATES 
  Susceptible Intermediate Resistant Categorical agreement 
with E-test method 
Minor error Major 
error 
Very major 
error 
Nalidixic acid* 
E-TEST 41 (35) 0 76 (65) 
    
DISK DIFFUSION 50 (42.7) 0 67 (57.3) 106 (90.5) 0 1 (2.4) 10 (13.1) 
Ofloxacin* 
E-TEST 42 (35.9) 70 (59.8) 5 (4.3) 
    
DISK DIFFUSION 117 (100) 0 0 42 (35.9) 70 (59.8) 0 5 (100) 
Ciprofloxacin 
E-TEST 40 (34.19) 59 (50.4) 18 (15.4) 
    
VITEK2 NA** NA** 33 (56.9) NA** NA** 0 NA** 
DISK DIFFUSION 20 (17.1) 71 (60.7) 26 (22.2) 75 (64) 42 (35.9) 0 0 
Ampicillin 
E-TEST 99 (84.6) 0 18 (15.4) 
    
VITEK2 99 (84.6) 0 18 (15.4) 117 (100) 0 0 0 
DISK DIFFUSION 94 (80.3) 2 (1.7) 21 (18) 112 (95.7) 2 (1.7) 3 (3) 0 
Ceftriaxone 
E-TEST 117 (100) 0 0 
    
VITEK2 117 (100) 0 0 117 (100) 0 0 0 
DISK DIFFUSION 117 (100) 0 0 117 (100) 0 0 0 
Azithromycin* 
E-TEST 116 (99.1) 1 (0.9) 0 
    
DISK DIFFUSION 110 (94) 0 7 (6) 110 (94) 1 (0.9) 6 (5.1) 0 
Trimethoprime-sulfamethoxazole 
E-TEST 99 (84.6%) 0 18 (15.4) 
    
VITEK2 99 (84.6%) 0 18 (15.4) 115 (98.3) 0 1 (1%) 1 (5.6) 
DISK DIFFUSION 102 (87.2%) 0 15 (15.4) 114 (97.4) 0 0 3 (16.7) 
*VITEK results were unavailable for nalidixic acid, ofloxacin and azithromycin. 
**Interpretation result in ciprofloxacin susceptible (<0.06 µg/ml) and intermediate (0.12-0.5 µg/ml) were not available  
(minimum VITEK MIC for ciprofloxacin was <0.5µg/ml). Bold number implicated the value that was higher than accepted range. 
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Table 6. 5 Comparison between antimicrobials testing methods for 32 Salmonella Paratyphi isolated during 2008-2015  
NO.(%) OF ISOLATES NO.(%) OF ISOLATES 
  Susceptible Intermediate Resistant Categorical agreement 
with E-test method 
Minor error Major error Very major 
error 
Nalidixic acid* 
E-TEST 23 (71.9) 0 9 (28.1) 
    
DISK DIFFUSION 22 (68.8) 1 (3.13%) 9 (28.1) 31 (96.9) 1 (3.1) 0 0 
Ofloxacin* 
E-TEST 18 (56.3) 9 (28.1) 5 (15.6) 
    
DISK DIFFUSION 29 (90.6) 1 (3.13) 2 (6.3) 19 (59.4) 10 (31.3) 0 3 (60) 
Ciprofloxacin 
E-TEST 21 (65.6) 9 (28.1) 2 (6.3) 
    
VITEK2 NA** NA** 5 (83) NA** NA ** 0 NA** 
DISK DIFFUSION 28 (87.5) 2 (6.3) 2 (6.3) 25 (78.1) 7 (21.9) 0 0 
Ampicillin 
E-TEST 26 (81.3) 0 6 (18.8) 
    
VITEK2 26 (81.3) 0 6 (18.8) 31(96.7) 0 0 0 
DISK DIFFUSION 26 (81.3) 0 6 (18.8) 32 (100) 0 0 0 
Ceftriaxone 
E-TEST 30 (93.8) 0 2 (6.3) 
    
VITEK2 30 (93.8) 0 2 (6.3) 32 (100) 0 0 0 
DISK DIFFUSION 30 (93.8) 0 2 (6.3) 32 (100) 0 0 0 
Azithromycin* 
E-TEST 31 (96.9) 0 1 (3.1) 
    
DISK DIFFUSION 27 (84.4) 0 5 (15.6) 28 (87.5) 0 4 (12.9) 0 
Trimethoprime-sulfamethoxazole 
E-TEST 28 (87.5) 1 (3.1) 3 (9.4) 
    
VITEK2 29 (90.6) 0 3 (9.4) 31 (96.9) 1 (3.1%) 0 0 
DISK DIFFUSION 29 (90.6) 0 3 (9.4) 31 (96.9) 1 (3.1%) 0 0 
*VITEK results were unavailable for nalidixic acid, ofloxacin and azithromycin. 
**Interpretation result in ciprofloxacin susceptible (<0.06 µg/ml) and intermediate (0.12-0.5 µg/ml) were not available  
(minimum VITEK MIC for ciprofloxacin was <0.5µg/ml). Bold number implicated the value that was higher than accepted range.
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Table 6. 6 Comparison between antimicrobials testing methods for 168 non-typhoidal Salmonella isolated during 2008-2015 
 
NO.(%) OF ISOLATES NO.(%) OF ISOLATES 
  Susceptible Intermediate Resistant interpretive agreement 
with the E-test method 
Minor error Major error Very major error 
Nalidixic acid* 
E-TEST 78 (46.4) 0 90 (53.6) 
    
DISK DIFFUSION 61 (36.3) 0 107 (63.7) 150 (89.3) 0 18 (23.1) 1 (1.1) 
Ofloxacin* 
E-TEST 63 (37.5) 80 (47.6) 25 (14.9) 
    
DISK DIFFUSION 165 (98.2) 2 (1.2) 1 (0.6) 65 (38.7) 80 (47.6) 0 23 (92) 
Ciprofloxacin 
E-TEST 76 (45.2) 86 (51.2) 6 (3.6) 
    
VITEK2 NA*** NA*** 13 (46.4) NA** NA** 1 (1.3) NA** 
DISK DIFFUSION 146 (86.9) 18 (10.7) 4 (2.4) 71 (42.3) 91 (54.2) 0 6 (100) 
Ampicillin 
E-TEST 59 (35.1) 0 109 (64.9) 
    
VITEK2 58 (34.5) 0 110 (65.5) 167 (99.4) 0 1 (1.7) 0 
DISK DIFFUSION 58 (34.5) 0 110 (65.5) 167 (99.4) 0 1 (1.7) 0 
Ceftriaxone 
E-TEST 166 (98.8) 0 2 (1.2) 
    
VITEK2 166 (98.8) 0 2 (1.2) 168 (100) 0 0 0 
DISK DIFFUSION 164 (97.6) 1 (0.6) 3 (1.8) 166 (98.8) 1 (0.6) 1 (0.6) 0 
Azithromycin* 
E-TEST 165 (98.3) 0 3 (1.8) 
    
DISK DIFFUSION 153 (91) 0 15 (8.9) 154 (91.7) 0 13 (7.9) 1 (33.3) 
Trimethoprime-sulfamethoxazole 
E-TEST 115 (68.5) 5 (3) 48 (28.6) 
    
VITEK2 116 (69.1) 6 (3.6) 46 (27.4) 163 (97) 5 (3) 0 0 
DISK DIFFUSION 111 (66.1) 2 (1.2) 55 (32.7) 160 (95.2) 7 (4.2) 1 (0.9) 0 
*VITEK results were unavailable for nalidixic acid, ofloxacin and azithromycin. 
**Interpretation result in ciprofloxacin susceptible (<0.06 µg/ml) and intermediate (0.12-0.5 µg/ml) were not available  
(minimum VITEK MIC for ciprofloxacin was <0.5µg/ml). Bold number implicated the value that was higher than accepted range. 
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 Discussion 
This study was the first study to assess the performance of common AST methods for 
bacteria in Vietnam. This work was focussed on Salmonella, a commonly isolated 
member of the Enterobacteriaceae, which can cause typhoid fever or BSI. 
 
Decreased susceptibility against fluoroquinolone has been reported in developed and 
developing countries. Decreased susceptibility to ciprofloxacin rose from 35% in 2001 
up to 70% in 2007 in the United Kingdom(Crump et al., 2015) . A very high prevalence 
(15%-46%) of reduced susceptibility to ciprofloxacin was identified in NTS isolated in 
Southeast Asia; Thailand reported 31% resistance against ciprofloxacin in NTS 
isolates(Wannaprasat et al., 2011).  In this study, I found that fluoroquinolones 
(including nalidixic acid, ofloxacin, and ciprofloxacin), a key group of drugs for 
Salmonella infection had low susceptibility rate in this study, using CLSI 
interpretations. The resistance rate against nalidixic acid was 55.2% (35/317); 11% 
(35/317) for ofloxacin, and 9.5% (30/317) for ciprofloxacin. A previous study 
investigating AST profiles of S. Typhi between 2008-2009 in Vietnam showed that 
nalidixic acid resistant was 19.6%, but there was no resistance against ciprofloxacin 
(Chiou et al., 2014). My data between 2008 and 2014 demonstrates the rise of 
fluoroquinolone resistance in Salmonella in Vietnam, which has followed the same 
trend as in other countries. This observation suggests a requirement to evaluate the 
clinical effect of fluoroquinolones for treating Salmonella infections.  
 
Reduced susceptibility against fluoroquinolones is associated with specific 
chromosomal mutations in NTS. Resistance to ciprofloxacin was associated with a 
mutation in the gyrA gene in isolates from the Congo; mutations in gyr, par and snr 
genes in Bangladesh, and   gyrA and par genes in the US(Chiou et al., 2014; Lunguya et 
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al., 2013). In Vietnam, nalidixic resistance due to mutations in gyrA had been reported 
in S. Typhi from 1993(Wain et al., 1997). Recently, plasmid mediated-fluoroquinolone-
resistant genes (qnrS, qnrB and qnrS), had been described in Enterobacteriaceae 
isolated from faecal samples from Vietnamese children in 2012(Vien et al., 2012).  It 
would be interesting to identify the mechanism of fluoroquinolone resistance in 
Salmonella isolates associated with BSI in this location.  
 
A multinational study from Asia (Korea, Thailand and Taiwan) revealed that NTS had 
decreased susceptibility against ciprofloxacin with MIC50 (0.12 µg/ml) and MIC90 (1-4 
µg/ml)(Lee et al., 2009). The NTS organisms in my study had the same MIC50 (0.12 
µg/ml) and lower MIC90 (0.25 µg/ml) to ciprofloxacin than this previous study. Another 
recent study originating from the Middle East and central Asia found decreased 
susceptibility of ciprofloxacin in S. Typhi (Rahman et al., 2014), which was comparable 
to the S. Typhi isolates in this study (MIC50/MIC90: 0.38/0.75 µg/ml). 
However, the MIC50 (256 µg/ml) and MIC90 (256 µg/ml) for ampicillin in my study 
were higher than other countries in Asia (MIC50 0.5-1.0 µg/ml, MIC90 >126 µg/ml). 
This result suggests the threat of potential MDR NTS epidemic in Vietnam. However, 
the ceftriaxone MIC50 (0.12 µg/ml) and MIC 90 (0.19 µg/ml) in my study was equivalent 
to that from other Asian nations(Lee et al., 2009). In my study, 53/317 Salmonella 
isolates were MDR, in which 74% (39/53) were NTS. A study from Malawi found that 
59% of NTS in BSI had an MDR phenotype (Feasey et al., 2015)  .  One notable finding 
was that MDR S. Typhi was isolated before 2013 only. This marked a significant shift 
of the S. Typhi antimicrobial profile, because 70% of S. Typhi were MDR between 
1993 and 1994 (Hoa et al., 1998). 
 
Here I did not use the broth micro dilution method (BMD), which is the standard 
method for MIC testing; I alternatively used E-test, a clinical AST method as a 
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standard. BMD is not a practical method for a clinical microbiology laboratory and a 
good agreement between E-test and BMD has been shown in many studies. In early 
1990s, Baker et al. reported good categorical agreement of >92% between E-test and 
BMD for fluoroquinolones and beta-lactams for Gram-negative rods (Baker et al., 
1991). Even for colistin or other polymyxins, E-test exhibited nearly 90% agreement 
with the reference BMD method (Heijden et al., 2007) . 
 
It was not possible to procure a VITEK AST card that contained all the required 
antimicrobial for Salmonella susceptibility testing, especially nalidixic acid, 
chloramphenicol and azithromycin. Therefore, testing these three antimicrobials was not 
possible by automated VITEK methods. Further, the VITEK AST card did not have the 
interpretation cut-off for the range 0.06-0.5 µg/ml for ciprofloxacin, therefore I was 
unable to determine whether Salmonella isolates with MIC <0.5 µg/ml for ciprofloxacin 
were resistant or intermediate. However, I found very good correlation % between 
VITEK result and E-test for all tested beta-lactams.  Trimethoprim-sulfamethoxazole 
also had a good correlation between E-test and VITEK. In my opinion, the VITEK AST 
GN 69 card did not appropriately test Salmonella due to limited antimicrobials and 
provide insufficient interpretation for ciprofloxacin, although it did have a good 
performance for beta-lactams and trimethoprim-sulfamethoxazole.  
 
Poor categorical agreement between disk-diffusion and E-test result was found for the 
fluoroquinolones. Low categorical agreement was caused by high minor errors of 50.5% 
(160/317) for ofloxacin and 41.2% (140/317) for ciprofloxacin. Since minor error could 
possibly result from the technical practice, repeated testing should be performed for 
ofloxacin and ciprofloxacin by disk diffusion method. Moreover, I also found a high 
rate of very major error for these two antimicrobials in the NTS isolates, which means 
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disk diffusion test failed to identify resistance in these group. I recommend that 
ofloxacin and ciprofloxacin should be tested by E-test for better precision for NTS. Disk 
diffusion provided good ability, in comparison with E-test for beta-lactams, 
azithromycin and SXT. This means that disk diffusion, a simple and manual technique, 
is a reliable testing method for these antimicrobials for Salmonella. In Vietnam, except 
for some central microbiology laboratories, disk diffusion is still the method of choice 
for antimicrobial susceptibility testing. With my results, I propose that clinical 
microbiology laboratories should continue to use the disk-diffusion method to test beta-
lactams, azithromycin, and SXT. 
 
I additionally found that chloramphenicol and trimethoprim -sulfamethoxazole regained 
their effectively in the latter stages of the study. The appearance of five Salmonella 
organisms exhibiting resistance to ceftriaxone highlights the emergence of NTS 
organism with ESBL activity. Therefore, chloramphenicol and SXT could be 
considered to treat Salmonella infections for the purpose of limiting the usage of third 
generation cephalosporins. 
 
In conclusion, the MIC VITEK and disk diffusion exhibited good performance for 
testing beta-lactams, ampicillin and ceftriaxone. MIC E-test and disk diffusion methods 
gave a good comparison result for SXT, but gave some very major errors for S. Typhi 
only. Azithromycin had good categorical agreement between disk diffusion test and 
MIC E-test. Problematic agreement or several errors were found with the quinolones 
(nalidixic acid, ofloxacin, ciprofloxacin). The VITEK automatic susceptibility testing 
system did not appropriately test for Salmonella as it was unable to generate breakpoints 
for ciprofloxacin, it was missing nalidixic, ofloxacin and azithromycin, although it had 
good performance with beta-lactams. The disk-diffusion method is likely the most 
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reliable method for testing beta-lactams, azithromycin and trimethoprim-
sulfamethoxazole. 
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Chapter 7 
Conclusion and future research direction 
After performing my PhD research on BSI in HTD, I have outlined some conclusions 
and final thoughts: 
1. BSIs in HTD were associated with both bacterial and fungal pathogens. 
 
BSIs associated with bacteria were the most predominant (80.6%). Gram-
negative bacteria were the most relevant (1,748/2,650; 65.9%), followed by 
Gram-positive cocci (886/2,650; 33.4%). Members of Enterobacteriaceae, 
including E.coli, K. pneumoniae, S. Typhi, and the NTS were the most common 
Gram-negative causes of bacterial BSI in this hospital during 2010-2015. I 
report a high proportion of MRSA and ESBL-producing bacteria associated with 
both community and hospital acquired infections. I also highlight the circulation 
of MDR Pseudomonas and Acinetobacter in hospital acquired BSI in HTD. 
Therefore, antimicrobial treatment guidelines in HTD should be revised 
periodically to adapt to a new era with a high rate of antimicrobial resistance. C. 
neoformans and T. marneffei (both fungal pathogens) were found in HIV-
seropositive patients only. Therefore, fungal agents should be considered 
primarily when investigating BSI in this particular patient group.  
 
2. I found that ESBL and AmpC lactamases were the two most common beta-
lactamases produced by Gram-negative bacilli in BSI in this hospital.  Common 
ESBL genes were bla CTX-M, bla CIT, and blaOXA, while common AmpC genes 
were blaCIT, blaDHA, and blaEBC.  I also discovered a large proportion of 
organisms harbouring more than one ESBL gene, or ESBL and AmpC genes in 
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combination. Alarmingly, these resistance genes could be commonly found in 
both HAI and CAI BSI, which implicates the common circulation of resistant 
organisms in the community. These data emphasize the need for national 
surveillance for antimicrobial resistance and the implementation of antimicrobial 
stewardship in Vietnam immediately. 
 
3. I found that NTS have replaced S. Typhi to be the most common Salmonella 
pathogens associated with BSI in HTD. The most common hosts for NTS were 
immunocompromised patients, particularly those infected with HIV or with 
cirrhosis. I conclude that iNTS disease is a severe infection in Vietnam, with a 
mortality rate (26%) comparable to that observed in parts of sub-Saharan Africa. 
I also highlight HIV infection as a major risk for both infection and death with 
iNTS in this setting. Although the sequence types of iNTS organisms identified 
in this study were common globally, I suggest continued surveillance to monitor 
for the presence of MDR sequence types, such as ST313, which has not, as of 
yet, been identified in Asia. I propose that HIV-infected hosts have a limited 
protective immune response to NTS.  Using bacterial killing assays to compare 
the functional immune response in HIV infected and uninfected iNTS patients 
would be the next logical progression to these finding. 
 
4. Lastly, by assessing the antimicrobial resistance profiles of 317 Salmonella via 
differing testing methods, I found that the Salmonella isolated here exhibited 
decreased susceptibility against the fluoroquinolones, which is the drug of 
choice to treat these infections. This observation suggests a requirement to 
evaluate the clinical effects of fluoroquinolones for treating Salmonella 
infections. I also report some problems in using the VITEK automatic 
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antimicrobial susceptibility system to screening susceptibility in Salmonella. E-
test remains the best method for susceptibility testing, while the disc diffusion 
methods has a good performance for beta-lactams, azithromycin, and SXT. 
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Appendix A: Protocol for Study 15EN 
Project: 
The bacterial etiology and antimicrobial susceptibility profile of bloodstream infections 
at the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam 
 
Principal Investigators:  
Dr Nguyen Phu Huong Lan (Lead Investigator HTD) bshuonglan@gmail.com 
Dr Stephen Baker (Lead Investigator OUCRU-VN) sbaker@oucru.org 
 
Other Investigators:  
Dr Nguyen Van Vinh Chau (HTD) 
Tran Thi Ngoc Dung (OUCRU-VN) 
  
Collaborating Institutions and Departments: 
The Hospital for Tropical Diseases microbiology laboratory, HCMC, Vietnam 
Oxford University Clinical Research Unit, HCMC Vietnam  
 
Proposed Start Date:  
February 2014 
1. Introduction 
This retrospective investigation is designed to study the aetiology, microbial population 
structure, antimicrobial susceptibility patterns, and antimicrobial susceptibility genes of 
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the bacteria causing bloodstream infections (bacteremia) at the Hospital for Tropical 
Diseases (HTD) in Ho Chi Minh City (HCMC), Vietnam. The main aims of this study 
are, i) to define the major causes of bacteremia in this setting, ii) investigate 
antimicrobial susceptibilities of the bacteria causing bloodstream infections and iii) 
investigate the pool of antimicrobial resistance genes in these organisms. We 
hypothesize that there is an emerging problem with antimicrobial resistance, particularly 
to third generation cephalosporins and carbapenems (Hoang et al., 2013; Thi Khanh 
Nhu et al., 2010; Trang et al., 2013), in this group of organisms. We hope that by 
studying and defining the antimicrobial susceptibility patterns we are be able to develop 
an improved approach to managing bacteremia and we will use these data to initiate 
prospective studies of antimicrobial resistance in patients with suspected bacteremia.  
 
This project will be a follow on from previously published studies of bloodstream 
infections at HTD(Baker et al., n.d.; Le et al., 2011; Nga et al., 2012; Wain et al., 1998). 
 
2. Background 
3. Aims and outcomes 
3.1. Scientific rationale 
There are limited contemporary data on the bacterial cause of bloodstream infections at 
HTD. We think that there is a dramatic surge in multi-drug resistant Gram-negative 
organisms and the emergence of Methicillin sensitive Staphylococcus aureus (MRSA). 
Therefore, to understand this important cause of morbidity and to best inform 
antimicrobial treatment regimes we aim to describe the bacterial etiology of 
bloodstream infection from 2010 to 2013 and investigate the circulation of antimicrobial 
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resistance genes through conventional molecular analysis, susceptibility testing, and 
genome sequencing. 
 
3.2. Aims 
This is a retrospective hospital study aiming to understand the cause of bacteremia and 
their associated antimicrobial susceptibility profiles at HTD. Our main interest lies in 
studying the Gram-negative organisms and MRSA and Methicillin sensitive 
Staphylococcus aureus (MSSA) causing bloodstream infections (Thwaites, 2010). 
However, to put these organisms into the context of bacteremia at HTD, and other 
locations, we will study all cause bacteremia retrospectively through patient records 
from HTD and the HTD microbiology laboratory. This study will be performed with a 
corresponding set of routine data and archived strains that is available over the last 4 
years, i.e. from 2010 to 2013. We aim to investigate the major causes of bacteremia at 
HTD, their distribution by ward, their association with HIV, their antimicrobial 
susceptibility patterns, their content of antimicrobial resistance genes, their population 
structure, and their accessory genome structure. 
 
3.2. Primary outcomes 
1. A dataset describing etiology of bacteremia, with a corresponding strain collection, 
from 2010-2013 at HTD in HCMC. 
2. An analysis of antimicrobial susceptibility profiles of the agents of bacteremia 
investigating study time trends and emerging resistance patterns. 
3. A molecular analysis of the agents of bacteremia studying the distribution of the main 
antimicrobial resistance gene groups.  
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4. Genome sequences of pivotal strains from within this collection to study the 
population structure, the antimicrobial resistance gene pool, and other horizontally 
transferred DNA between bacteria causing bloodstream infections. 
 
3.2. Secondary outcomes 
1. An analysis of antimicrobial resistance profile and gene distribution by hospital ward 
to add insight into the circulation of bacteria causing nosocomial (hospital associated) 
infections. 
2. An in depth screen of genes catalyzing resistance to the beta-lactams (specifically 
third generation cephalosporins and carbapenems) as these are the major agents to treat 
bacteremia at HTD. 
 
3.3. Future outcomes after analyses 
1. A comprehensive understanding of the microbiological and genetic makeup and the 
temporal and phylogenetic relationships of bacteria causing bloodstream infections at 
HTD. 
2. A baseline of data permitting prospective studies aimed at to detecting bacteremia 
cases more rapidly (i.e. by PCR on blood).   
3. A baseline of data permitting prospective studies to detect patients early with multi-
drug resistance infections of those with infections with bacteria containing 
ESBL/AMPC lactamase genes. 
4. A data resource that will be made available to clinicians working at HTD managing 
bloodstream infections. 
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5. A measure of evolutionary rate, antimicrobial resistance development and the role of 
the accessory genome in the local evolution of the causes of bacteremia at HTD 
 
4. Research plan 
4.1. Study design 
This is a retrospective, descriptive study conducted on data and strains collected over a 
four-year period from patients with bacteremia at HTD, activities will be broadly 
similar to those described previously (Nga et al., 2012).  
 
4.2. Study sites 
1. The Hospital for Tropical Diseases 
2. Oxford University Clinical Research Unit 
 
4.3. Required data and samples 
1. Available routine microbiology laboratory data on bacteremia at HTD from 2010-
2012 inclusive. These data will include: 
i. Data on all cause bacteremia from 2010-2013 – e.g. etiology, date of isolation, ward, 
sex, HIV status and outcome 
ii. Antimicrobial susceptibility patterns from all bacterial isolates   
2. Access to all stored bacterial isolates that correspond to available data on bacteremia 
at HTD from 2010-2013. After re-culturing and identification these bacteria will be 
used for: 
i. Additional antimicrobial susceptibility phenotyping 
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ii. Molecular analysis for antimicrobial susceptibility genes 
iii. Genome sequencing of pivotal strains (defined by antimicrobial susceptibility data) 
iv. Additional bacterial phenotyping to investigate novel mechanisms of pathogenicity 
and anti microbial resistance identified by genome sequencing 
  
5. Methods 
5.1. Inclusion criteria 
The analyzed data will be retrospective and the inclusion criteria for analysis will be 
every patient at HTD with a positive bacterial culture from a blood sample from the 1st 
January 2010 to 31st December 2013. 
    
5.2. Exclusion criteria 
There will be no exclusion criteria.  
 
5.3. Study population 
Systematic criteria concerning which patients should have blood cultures performed are 
not defined at HTD. However, in general, we consider that a blood culture is initiated by 
am admitting clinician in patients in whom a bloodstream infection is suspected on the 
basis of a fever (>38 ◦C) or the evidence of sepsis on the basis of the presence of two or 
more of the following features: fever (>38 ◦C) or sub-normal temperature (<36 ◦C); 
tachycardia (exact level according to age); tachypnea (exact level according to age); an 
elevated white cell count (>12,000 cells/mm3) or depressed white cell count (<4,000 
cells/mm3) (Nga et al., 2012). We have no reason to believe there has been a systematic 
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change in the application of these criteria during the selected time course of the 
proposed study. Therefore, all patients with or without HIV admitted to the hospital 
who had a blood culture performed for suspected bloodstream infection from 1st January 
2010 to 31st December 2013 will be included in this retrospective analysis.  
 
Routinely, a member of the hospital staff records the date of blood draw, the patient’s 
age, sex, and suspected diagnosis, the number of blood culture bottles inoculated, the 
result of the culture (whether positive or negative) and the susceptibility of the isolate to 
commonly used antimicrobial agents. Data from these records are subsequently entered 
into Excel (Microsoft office v12, Microsoft Corp, Redmond, WA, USA). These will be 
source data for this study. The number of patients admitted to the hospital annually will 
be obtained from hospital records. 
 
5.4. Definition of bacteremia 
A bloodstream infection episode in this study is defined as isolation of at least one 
clinically relevant pathogen from one blood culture, drawn from a patient with a clinical 
syndrome indicative of a bloodstream infection. Episodes will be identified from the 
electronic database as detailed above. As it is not practical to obtain and review the 
hospital records of all patients with a positive blood culture episode to ascertain whether 
a pathogen was clinically relevant for that particular patient, the following potential 
contaminant organisms will be excluded: coryneforms (Corynebacterium, etc.), 
coagulase-negative staphylococci, micrococci, Propionibacterium, Bacillus, alpha 
hemolytic streptococci, environmental Gram-negative bacilli, and non-pathogenic 
Neisseria. The overall contamination rate of these organisms will not estimated in this 
study. 
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5.5. Study size 
As this is retrospective descriptive study the sample size is dependent on the number of 
patients with available data according to the inclusion criteria during from 2010-2013 
 
5.6. Sampling 
All bacteria isolated during the outlined period of analysis will be studied for their 
antimicrobial susceptibly profiles and the presence/absence of antimicrobial resistance 
genes. Only selected organisms will be genome sequenced and will be selected 
prospectively on the basis of their susceptibility profiles and resistance gene content. 
Therefore, we cannot predict how many genomes will be sequenced. 
 
5.7. Re-culturing and identification of bacteria 
Typically, for blood culturing, HTD uses the BACTEC blood culture system, with 5–8 
mL aliquots (for adults) and 2–5 mL aliquots (for infants and children) of venous blood 
inoculated into BACTEC plus aerobic bottles (Becton Dickinson). Inoculated BACTEC 
bottles are then incubated at 37 ◦C in a BACTEC 9050 automated analyzer for up to five 
days and sub-cultured when the machine indicates a positive signal. All sub-cultures are 
then performed onto fresh sheep blood agar, on chocolate agar if Haemophilus 
influenzae or Neisseria meningitidis is suspected, (media - Oxoid Unipath, Basingstoke, 
UK). Plates are incubated at 37 ◦C in air (for blood-agar), 5% CO2 (for chocolate agar) 
for 48 hours. Organisms are then identified by standard microbiological methods 
including API20E identification kits (Bio-Mérieux, Craponne, France). All bacteria will 
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be re-cultured and checked as per the primary culture identification method. Any that 
are incorrect will be subjected to specific molecular testing (16s RNA) to ensure 
accuracy. 
 
5.8. Antimicrobial susceptibility testing 
When required for checking or to non-routine antimicrobials, antimicrobial 
susceptibility testing of the pathogens isolated will be performed by the disk diffusion 
method using guidelines established by the Clinical and Laboratory Standards Institute 
(CLSI) and, when required, by minimum inhibitory concentrations (MICs) by Etest or 
by VITEK automated machine. We will aim to generate a database of antimicrobial 
susceptibilities against Nalidixic acid, Ciprofloxacin, Ceftriaxone, Ceftazidime, 
Augmentin, Ampicillin, Trimethoprim-sulfamethoxazole, Azithromycin, 
Chloramphenicol, Imipenem and Amikacin for all Gram-negative organisms. 
 
The production of extended-spectrum -lactamases (ESBL) will be investigated using 
the double-disc synergy test by comparing zone sizes between ceftazidime discs against 
ceftazidime-clavulanic acid discs and cefotaxime discs against cefotaxime-clavulanic 
acid discs. Isolates with an increase in diameter of inhibitory zone of equal to or more 
than 5 mm by the synergy of clavulanate will be considered ESBL positive. 
 
5.9. Isolation of nucleic acids 
After re-culturing and identification, DNA will be extracted from all bacterial isolates 
using the Wizard Genomic DNA Extraction Kit (Promega, Fitchburg, USA). This is a 
standard method in the laboratories at OUCRU-VN. The quality and concentration of 
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the DNA will be assessed using a nano-drop spectrophotometer prior to PCR 
amplification and the Quant-IT Kit (Invitrogen, Carlsbad, CA) prior to DNA 
sequencing. 
 
5.10. PCR for resistance genes 
The primary focus study is to investigate the distribution of antimicrobial resistance 
genes in bacteria causing bloodstream infections at HTD. Therefore, all Gram-negative 
organisms will be subjected to PCR to detect genes catalyzing resistance to third 
generation cephalosporins, fluoroquinolones and carbapenems. Namely, all organisms 
will be subjected to conventional PCR for the following classes of resistance genes 
using previously described methods. The multiplex and monoplex PCRs are described 
in these publications (Dallenne et al., 2010; Parry et al., 2010; Pérez-pérez and Hanson, 
2002; Thi et al., n.d.; Woodford et al., 2006), This panel of PCRs will be used; PCR1 - 
AmpC (MOX-1, MOX-2, CMY-1, CMY8-11), PCR2 - AmpC (LAT-1 to LAT-4, 
CMY2-7, BIL-1), PCR3 - AmpC (DHA1 and DHA-2), PCR4 - AmpC (ACC), PCR5 - 
AmpC (MIR-1T, ACT-1), PCR6 - AmpC (FOX-1-5b), PCR7 - ESBL (CTX-M1), PCR8 
- ESBL (CTX-M2), PCR9 – ESBL (CTX-M9), PCR10 - ESBL (CTX_M8/M25), 
PCR11 - ESBL (TEM), PCR12 – ESBL (SHV), PCR13 – ESBL (OXA1, 4, 30), PCR13 
– qnrA, B, S, and PCR13 – gyrA, B, C. 
 
5.11. Genome sequencing  
Selected bacterial isolates will be sequenced at OUCRU-VN or at one of our 
collaborating genome sequences institutions (see later). Briefly, index-tagged paired end 
Illumina sequencing libraries will be prepared using one of 96 unique indexing tags as 
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previously described. These will be combined into pools of uniquely tagged libraries 
and sequenced on the Illumina Genome Analyzer GAII or HiSeq sequencer according to 
manufacturer’s protocols to generate tagged 54-100 bp paired-end reads. This is a 
previously described for Gram-Negative organisms and Staphylococcus (Harris et al., 
2013; Holden et al., 2013; Holt et al., 2013). 
 
5.12. Data entry and storage 
All available data will be entered onto an electronic database. Only the named 
investigators or their designee(s) will have access to this information. Other 
investigators from HTD and OUCRU-VN will be updated regularly and will be granted 
access to data when requested. Patients will not be identified by their names. 
 
6. Analysis plan 
6.1. Statistical comparisons 
Data will be presented in the form of tables and bar charts for descriptive variables i.e. 
number of specific organisms per year and number of resistant organisms per year. 
Time trends (over the 4-year period), including the proportion of cultured isolates by 
year, the antimicrobial susceptibility patterns and HIV positivity rate will be determined 
by logistic regression, and odds ratios will be presented in units of time (per year). All 
statistical analysis will be performed using Stata version 11 (StataCorp LP, College 
Station, TX, USA); and p-values of ≤0.05 will be considered significant.  
 
6.2. Antimicrobial resistance genes 
 259 
 
The presence/absence of antimicrobial resistance genes will be reported as proportions 
per organism and then stratified by organism, year, and hospital ward. 
  
6.3. Genome sequencing 
Genome sequences will be analyzed to study phylogenetic relationships, the 
presence/absence of genes and also antimicrobial resistance gene content and firstly 
analyzed by species and then a group of Gram-negative organisms. Briefly, for 
phylogenetic analysis, chromosomal Single Nucleotide Polymorphism (SNP) alleles 
will be concatenated for each strain to generate a multiple alignment of all SNPs. For 
maximum likelihood (ML) analysis, RAxML will be run 10 times using the generalized 
time-reversible model and one thousand bootstrap pseudo-replicate analyses were 
performed to assess support for the ML phylogeny. Root-to-tip branches will be 
extracted from the ML tree using the program TreeStat. The relationship between root-
to-tip distances and year of isolation were analyzed using linear regression. For BEAST 
analysis (v1.6), a GTR+Γ substitution model and defined tip dates, as the date of 
isolation will be used (Harris et al., 2013; Holden et al., 2013; Holt et al., 2013).  
To detect the presence or absence of genes read sets will be assembled using the de 
novo short read assembler Velvet and Velvet Optimizer. Strain specific read sets will 
then be aligned to the pan-genome. Taxonomic investigation of accessory and resistance 
genes will be performed using MG-RAST v3.2 (http://metagenomics.anl.gov). 
 
7. Sample shipments 
7.1. Sample shipment and overseas investigations 
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Investigations in part of this study may take part at HTD, OUCRU-VN or other 
collaborating institutions internationally i.e. samples will be required to be sent overseas 
for laboratory analysis outside current laboratory capabilities of HTD and OUCRU-VN 
to the collaborating institutions. All investigators will be informed on any material 
leaving HTD/OUCRU-VN and appropriate requests to regulatory authorities will be 
made. The current locations identified for collaboration include; the Wellcome Trust 
Sanger Institute, the University of Sydney Australia and the University of Melbourne 
Australia. The material sent overseas for this study will constitute in the primary 
incidence nucleic acid for DNA sequencing only as HTD/OURCU-VN currently does 
not have the capacity for large-scale bacterial genome sequencing. This material will be 
sent under MOU’s and collaboration agreement between OUCRU-VN and these 
institutions. HTD/OUCRU-VN will remain the owners of all sequence data and will 
oversee all analyses. Therefore collaborations to achieve the aims of this protocol are 
essential Depending on the genomic sequences, bacteria may also need to be shipped for 
secondary analysis or phenotyping, as HTD/OURCU-VN currently does not have the 
capacity for high-throughput phenotyping. For other studies outside this protocol, 
additional IRB approval will be sought. 
 
7.2. Future investigations at HTD/OUCRU-VN 
Additional investigations may be performed on isolated nucleic acids and bacteria 
collected as part of this study. These samples will only be used to study the aetiology, 
the epidemiology, or the phenotype of these organisms and will occur in the HTD 
microbiology laboratory or the OUCRU-VN laboratory of Dr Stephen Baker and will 
not be distributed to other investigators in Vietnam without permission from all 
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collaborating institutions. The principal investigators will make decisions on these 
studies. For other studies outside this protocol, additional IRB approval will be sought. 
 
8. Protection of human subjects 
8.1. Use of stored human specimens 
No human samples will be used in this study; this study will only investigate the 
bacteria cultured from those with bacterial bloodstream infection. 
 
8.2. Long term storage of data 
Data will be protected in the custody of HTD/OUCRU-VN under joint ownership of 
HTD and OUCRU-VN.  Data will be stored in password-protected computer servers, 
which will be located in locked rooms. Only investigators or their designee(s) will have 
access to the data, all data will be identified by an individual patient identification code 
and will be anonymous.  
 
8.3. Long term storage of specimens 
The HTD microbiology laboratory currently holds and stores the samples for this study 
and this collection under an HTD SOP HTD. Nucleic acid extractions will be stored 
until all analyses for this study have been performed and then destroyed when all 
molecular studies are complete.  
 
8.4. Study withdrawal 
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This is a retrospective study and patients will not be prospectively enrolled. 
 
8.5. Risks and benefits 
This is a no patient risk study because it does not involve any investigational new drugs 
or interventions.  The collection of all biological samples for use in this study have been 
performed as part of a clinical assessment and are consistent with the local standard of 
care and good clinical practice. 
   
8.6. Regulation and quality assurance 
The study will be conducted in compliance with this protocol, relevant sections of the 
International Conference on Harmonization Good Clinical Practice (ICH GCP) 
guidelines and any applicable regulatory requirement(s).  Quality assurance and quality 
control procedures will be implemented for all data collection, documentation, and 
specimen handling.   
   
8.7. Institutional review board/ethics committee 
This protocol and the relevant supporting information will be submitted to the EC/IRB 
of HTD for review and will not be initiated at that site until after approval. Any 
amendments will also need to be approved by HTD IRB/IEC prior to implementing 
changes in the study.   
 
8.8. Informed consent process 
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This is a retrospective analysis of bacteria and data collected as part of a routine 
microbiological provision for diagnosis, there is no requirement for informed consent. 
 
8.9. Participant confidentiality 
1. All data will be stored securely at the study site in locked file cabinets or password 
protected devices in areas with access limited to study staff.  
2. All specimens, reports, study data collection, process, and administrative forms will 
be identified by a coded number.  
3. Study databases will be secured with password-protected access systems and 
controlled distribution web-based security certificates.  
4. No identifying information will be included in publications or presentations resulting 
from this work.   
 
8.10. Data handling and record keeping 
1. The investigator is responsible for maintaining all study records. The investigator is 
responsible for the timeliness, completeness and accuracy of the information in the 
original dataset and the clinical data management system.  
2. HTD/OUCRU-VN staff will enter data into computers, which will upload data 
securely to an Internet-based database.    
3. Laboratory staff will record specimens (and their aliquots), their storage location, 
their shipments using a central commercial database system (Freezerworks). 
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4. All necessary tools, instruction, and training will be provided to all site staff involved 
in data entry to ensure the correct and consistent completion database prior to the study 
starting.  
 
8.11. Study records retention 
Data from this study will be entered into an electronic database in password-protected 
computer servers, which will be located in locked rooms. Only investigators or their 
designee(s) will have access to the data, all data will be identified by an individual 
patient identification code and will be anonymous. These data will be stored 
indefinitely. 
 
9. Publication plan 
Data from this study is of substantial interest to the scientific and clinical research 
communities. Therefore, we aim to publish a number of manuscripts from this work in 
international peer-reviewed journals. Additionally, these data will contribute to the data 
required for Dr Nguyen Phu Huong Lan’s PhD thesis at the Open University UK and a 
number of HTD/OUCRU-VN collaborative MSc projects. As this is a HTD/OUCRU-
VN collaboration then HTD and OUCRU authors will both be recognized in 
predominant authorships, these will be principal investigators. Manuscripts that may be 
published from this work will be comprised of the following data. 
1. General description of the bacterial causes of bloodstream infections and their 
antimicrobials susceptibility profiles at HTD. 
2. The presence absence of the outlined antimicrobial resistance genes. 
3. The emergence of methicillin resistant Staphylococcus aureus in Vietnam. 
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4. The accessory gene pool of Gram–negative organisms causing bloodstream infections 
at HTD 
 
10. Support 
OUCRU-VN will provide support for the study through the Sir Henry Dale fellowship 
funding of Dr Stephen Baker from the Royal Society and the Wellcome Trust of the 
United Kingdom. 
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Appendix B: Protocol for Study 09EN 
Project: 
Invasive nontyphoidal Salmonella in Hospital for Tropical Diseases  
 
Principal Investigators:  
Dr Nguyen Phu Huong Lan (Lead Investigator HTD) bshuonglan@gmail.com 
Dr Stephen Baker (Lead Investigator OUCRU-VN) sbaker@oucru.org 
 
Other Investigators:  
Dr Nguyen Van Vinh Chau (HTD) 
Nguyen Huu Hien (HTD) 
Le Thi Phuong Tu (OUCRU-VN) 
  
Collaborating Institutions and Departments: 
The Hospital for Tropical Diseases microbiology laboratory, HCMC, Vietnam 
Oxford University Clinical Research Unit, HCMC Vietnam  
 
Proposed Start Date:  
January 2012 
1. Introduction 
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This is a retrospective study to describe epidemiological, clinical features and bacterial 
characteristics of bacteremia cases due to nontyphoidal Salmonella in Hospital for 
Tropical Diseases from 2008 to 6/2013. 
2. Background 
Salmonella are gram- negative bacilli that belong to the family Enterobacteriacea. The 
genus Salmonella was named after Daniel Elmer Salmon, who firstly described this type 
of organism as a pathogen in 1884.  
It is reported that there were 22 milion cases of typhoid fever annually around the world 
with 200.000 mortality cases (Bhutta and Threlfall, 2009).  According to a global 
analysis in 2008, the highest incidence of typhoid (>100 cases per 100.000 population 
annually) is in South Central Asia, Southeast Asia and Southern Africa (Bhutta and 
Threlfall, 2009). The crude incidence of typhoid cases was as high as in Southern Africa 
(233 cases/ 100.000 population annually) and Southern central Asia (622 cases/ 100.000 
population annually).  
The medium high incidence (10-100 cases/ 100.000 population annually) is in the rest 
of Asia, Africa, Latin America, Caribbean islands and Oceania.  Whereas the lowest 
incidence (<10 cases per 100.000 population per year) was documented in Europe, 
North America, Australia and New Zealand in which most cases were associated with 
travelling to epidemic areas. 
 
Although Vietnam is located in Southeast Asia, the medium incidence of typhoid from 
1991 to 2011 is around 23.2/100.000 per year which is not as high as some epidemic 
areas in the region. A data from Hochiminh city-Vietnam shows that Salmonella Typhi 
is the dominant pathogen in blood stream infection until 2002 (Nga et al., 2012). Since 
then, the number of infection has been declined steadily about 30% per year. 
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In contrast, NTS diseases is not as common as typhoid. There is no global epidemic of 
invasive NTS infection until now. Therefore, studies of NTS are still limited. As far as 
we know, infection of nontyphoidal Salmonella (NTS) has two main types: 
gastroenteritis and invasive diseases(de Jong et al., 2012). People get sick after they 
consumed a large amount of nontyphoidal Salmonella bacteria. The clinical 
manifestation can be a self-limited gastroenteritis disease or develop to a septicaemia 
(the most frequent type of NTS invasive diseases) in 10% cases. Blood-stream infection 
of NTS species is found in those risk groups such as immunocompromised individuals, 
HIV patients, malnutrition children(Feasey et al., 2012; Melita A Gordon et al., 2002; 
Khan et al., 2010)... It is reported that 93.8 million cases of NTS infection every year in 
the world with 155.000 fatal cases (13).  
Enteric infections caused by NTS have similar clinical manifestations to those induced 
by other enteric bacteria, and thus can rarely be distinguished based on presenting 
clinical characteristics. NTS-induced gastroenteritis is characterised by abdominal pain, 
fever, watery diarrhoea, and occasionally mucoid or bloody diarrhoea. Vomiting and/or 
nausea occur frequently but are not severe or protracted. The incubation period is 
varied, depending on the host and bacterial serotype, but typically ranges from 6 to 72 
hours. The disease is usually self-limiting but can be more severe in the very young and 
elderly or immunocompromised, with a typical duration of illness of 4 to7 days.  
The international study in ASIA revealed that nine serogroups (B, C1, C2, D, E, G, I, K, 
and M) were responsible for NTS gastroenteritis disease(Majowicz et al., 2010). It is 
also found that serogroup B and D were the two commonest in most of the research 
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sites. Serotype S.enterica serotype Choleraesuis and S. Virchow were the predominant 
serotypes based on the study result. 
NTS gastroenteritis imposes a substantial burden in both developed and developing 
regions (Majowicz et al., 2010; Voetsch et al., 2004). Salmonella-associated 
gastroenteritis is estimated to be responsible for a globally annual number of 93.8 
million cases and 155 thousands deaths; 86 % of all cases are thought to be foodborne 
infections (Majowicz et al., 2010). In the US, FoodNet surveillance has estimated that 
nearly 1.4 million persons are infected with NTS annually, resulting in 168,000 clinic 
visits, 15,000 hospitalisations and 400 deaths (incidence: 12.3 cases per 100,000 
population) (Voetsch et al., 2004). Whereas in the UK, there were 41.000 infection of 
NTS each year (population 60 million) resulting in 1,500 hospitalization and 119 deaths 
(Zaidi et al., 2006). A case series in Spain showed a mortality rate of 12.2% in adults 
which most of them were suffered from septic metastatic diseases(Gordon, 2011).  
Outbreaks of NTS gastroenteritis are common and often of zoonotic origin (Voetsch et 
al., 2004). Severe NTS infections are more frequently observed in resource-limited 
countries, with mortality rates ranging from 18 to 24 %. 
In these severe illnesses, antimicrobials should be prescribed. There is no effective 
vaccine against NTS; hence, disease prevention and control programs mostly rely on 
improving personal hygiene and sanitation with particular attention paid to food safety. 
About 5 % of all cases of NTS gastroenteritis may progress into bacteraemia and require 
medical attention. Even more dramatic are NTS bacteraemia that develop without any 
apparent gastrointestinal disease.  
The epidemiology of invasive NTS infections is highly geographical and common in 
parts of sub-Saharan Africa. Over the past 10-15 years this disease has come to 
forefront of Salmonella research, lead mainly by groups in Kenya, Malawi and Tanzania 
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(Gordon, 2011). It appears that invasive NTS disease is causing a regional epidemic in 
sub-Saharan Africa and is associated strongly with HIV and also Malaria. The disease 
appears to affect children and can have a mortality rate as high as 40% in some 
locations(Gordon, 2011) .Additionally, a systemic review on blood culture positive 
patients in Africa showed that NTS organisms accounted for 17% of 5,578 positive 
samples and associated with HIV infection while S. Typhi were found at a lower rate 
(9.9%) and mostly in non HIV infected individuals.  S. Typhimurium and S. Enteritidis 
are the two common serovars causing NTS infections in these locations(Gordon, 2011) 
 
Due to the fact that very few study of invasive NTS infection have been performed in 
Asia, information of clinical symptoms of this disease is mostly described in the Sub-
Saharan African population. The common illness caused by NTS serovars in this 
population is similar to general symptoms of bacteraemia s. Namely, a high fever is 
frequently observed while diarrhoea and other gastrointestinal complaints are rare. 
Pneumonia is also usually associated with NTS but can be caused by co-infections 
organisms such as Streptococcus pneumoniae and Mycobacterium tuberculosis 
(Gordon, 2011). Splenomegaly is also frequently a clinical sign associated with invasive 
NTS infection, but this is not specific. Meningitis may also be associated with infection 
in the sub-Saharan African population but this is not as common as sepsis, but NTS 
strains have been reported as a second most common cause of bacterial meningitis in 
Malawi. NTS meningitis is associated with schistosomiasis, it is hypothesis that the 
parasite carries the bacteria to the central nervous system. Notably, and unlike enteric 
fever the fatality rate of NTS meningitis and NTS bacteraemia is very high in both 
children and adults.  
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Available data of invasive NTS in Asia remains limited both in number and with respect 
to the disease in different patient groups. A multi-centre study in Asian people 
conducted under15 years old showed that NTS accounted for less than 1% (only 6 
cases/ 20,537 total blood samples) of all the febrile pathogens (Khan et al., 2010). 
Children accounted for five of these six NTS infections, there were only one adult 
infected. Karachi (Pakistan) had the highest incidence of (7.2/100,000 population) of 
invasive NTS while Hue (Vietnamese study site) had no invasive NTS case. This study 
did collect data regarding the co-infection with HIV or malaria but the incidence of 
these diseases are considerably lower that in an equivalent age distributed population in 
sub-Saharan Africa. In the six invasive NTS cases, group D Salmonella were isolated in 
all of the three cases from Pakistan, one isolate from each Salmonella group A, C, E 
were from India and Indonesia.  
 
Invasive non-typhoidal Salmonella infections in Vietnam 
 
The only exiting data regarding invasive NTS infections in Vietnam arises from a 15 
years- retrospective study of blood culture data performed at the Hospital for Tropical 
Diseases in Ho Chi Minh City, Vietnam (Nga et al., 2012). In this study, amongst 
66,111 blood cultures performed, a clinically relevant pathogen was isolated in 7,645 
episodes (positivity rate; 116/1,000 cultures). S. Typhi was the predominant pathogen 
until 2002; however, a considerable annual decline in the proportion of S. Typhi was 
observed over the period of investigation (OR 0. 6993, 95% CI [0. 6885, 0.7103], p < 
0.0001). Conversely, there was a significant increase in the proportions NTS organisms, 
Cryptococcus neoformans and Penicillium marneffei, concurrent with increasing HIV 
prevalence. This paper documented a substantial longitudinal shift in bloodstream 
infection etiology in southern Vietnam. We proposed that such changes were related to 
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increasing economic prosperity and HIV prevalence, and this pattern marks a substantial 
change in the epidemiology of invasive salmonellosis in Southeast Asia. 
 
3. Aims  
To describe epidemiological characteristics, clinical features of all NTS bacteremia 
cases from 2008 to 6/2013 
To describe the different clinical features, treatment and outcome between HIV and  
non- HIV patients. 
To describe the antibiotic susceptibility patterns of nontyphoid Salmonella, how it 
correlates to treatment and outcome, and in comparison with Salmonella Typhoid at the 
same period of time. 
To describe the phenotype distribution of nontyphoid Salmonella. 
 
4. Research plan 
4.1. Study design 
The study is performed in Hospital for Tropical Diseases (HTD), the reference hospital 
for infectious diseases in Hochiminh city and the South of Vietnam. It is a 550 beds-
setting that receives adult and children, including HIV patients.  
This is a retrospective and descriptive study to all NTS bacteremic patients in HTD 
including patient charts and NTS strains from 2008 to 6/2013. 
 
4.2. Study sites 
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1. The Hospital for Tropical Diseases 
2. Oxford University Clinical Research Unit 
 
4.3 Method: 
Protocol of this study was submitted to the Ethical and Scientific Committee of HTD in 
2012 and got approval in 2012. By that I have the permission to access to all study 
patient charts that kept in the Hospital storage. I developed a special clinical case report 
for inputting all necessary information from the patient charts. I am also permitted to 
access to all NTS data kept in the logbooks of Microbiology laboratory, to use the all 
the NTS strains stored in freezers of Microbiology laboratory for identification, 
antibiotic susceptibility testing and molecular analysis. 
 
4.4 Data and Samples 
-  Patient data which obtained from the patient charts, and would be recorded in patient 
record form. 
-  Information of NTS strains and Salmonella Typhi strains that kept in HTD 
Microbiology laboratory. 
- NTS strains from the storage of HTD Microbiology laboratory: 
          - Reculturing and reidentify, re –examine the antibiotic susceptibility of NTS 
strains in the study period. 
          - Molecular analysis: MLST to phenotype all NTS strains, detect resistant genes if 
available. 
4.5 Inclusion and Exclusion criteria 
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-This is a retrospective study and the inclusion data is for all the patients that have blood 
culture positive with nontyphoid Salmonella strain from 2008 to 6/2013 
-There is no exclusion criteria. 
 
4.6 Sample size 
Because NTS infection is not a popular infection in Southeast Asia and HTD, the 
number of more than 100 for patient charts and survival NTS strains is expected to be 
enough for analysis. 
 
4.7  Reculturing and identification of Nontyphoidal Salmonella 
All nontyphoidal Salmonella as well as all the pathogens isolated from the blood culture 
were kept routinely in BHI glycerol at -20 C in Microbiology storage stock. We have 
recultured all the stored isolates into MacConkey agar. We used the second subcultured 
generation for identification and antimicrobial susceptibility testing. 
-Identification of Salmonella  is based on routine biochemical testing and antisera test.  
 
4.8  Antimicrobial susceptibility testing 
Antimicrobial susceptibility testing will perform for all Salmonella nontyphoid isolates. 
Testing media were Muller-Hinton agar and antibiotic paper disks were from Oxoid, 
USA. Performance procedure, quality of media and antibiotic disks were all checked 
with all the standard quality control of HTD Microbiology laboratory that were 
accredited with ISO 15189-2008. Antibiotic testing includes: ampicillin, ceftriaxone, 
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cefepim, ofloxacin, ciprofloxacin,  trimethoprime-sulfamethoxazol, cloramphenicol, 
amikacin and imipenem and other antimicrobials. 
 
4.9  MLST 
 MLST will be performed to phenotype all NTS strains. 
 
4.10 Data entry and storage 
All available data will be entered onto an electronic database. Only the named 
investigators or their designee(s) will have access to this information. Patients will not 
be identified by their names. 
 
4.11 Data analysis 
Data will be presented in the form of tables and bar charts for descriptive variables. All 
statistical analysis will be performed using Stata version 11 (StataCorp LP, College 
Station, TX, USA); and p-values of ≤0.05 will be considered significant.  
 
5. Protection of human subjects 
5.1. Use of stored human specimens 
No human samples will be used in this study; this study will only investigate the 
bacteria cultured from those with bacterial bloodstream infection. 
 
5.2. Long term storage of data 
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Data will be protected in the custody of HTD/OUCRU-VN under joint ownership of 
HTD and OUCRU-VN.  Data will be stored in password-protected computer servers, 
which will be located in locked rooms. Only investigators or their designee(s) will have 
access to the data, all data will be identified by an individual patient identification code 
and will be anonymous.  
 
5.3. Long term storage of specimens 
The HTD microbiology laboratory currently holds and stores the samples for this study 
and this collection under an HTD SOP HTD. Nucleic acid extractions will be stored 
until all analyses for this study have been performed and then destroyed when all 
molecular studies are complete.  
 
5.4. Study withdrawal 
This is a retrospective study and patients will not be prospectively enrolled. 
 
5.5. Risks and benefits 
This is a no patient risk study because it does not involve any investigational new drugs 
or interventions.  The collection of all biological samples for use in this study have been 
performed as part of a clinical assessment and are consistent with the local standard of 
care and good clinical practice. 
   
5.6. Regulation and quality assurance 
 330 
The study will be conducted in compliance with this protocol, relevant sections of the 
International Conference on Harmonization Good Clinical Practice (ICH GCP) 
guidelines and any applicable regulatory requirement(s).  Quality assurance and quality 
control procedures will be implemented for all data collection, documentation, and 
specimen handling.   
   
5.7. Institutional review board/ethics committee 
This protocol and the relevant supporting information will be submitted to the EC/IRB 
of HTD for review and will not be initiated at that site until after approval. Any 
amendments will also need to be approved by HTD IRB/IEC prior to implementing 
changes in the study.   
 
5.8. Informed consent process 
This is a retrospective analysis of bacteria and data collected as part of a routine 
microbiological provision for diagnosis, there is no requirement for informed consent. 
 
5.9. Participant confidentiality 
1. All data will be stored securely at the study site in locked file cabinets or password 
protected devices in areas with access limited to study staff.  
2. All specimens, reports, study data collection, process, and administrative forms will 
be identified by a coded number.  
3. Study databases will be secured with password-protected access systems and 
controlled distribution web-based security certificates.  
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4. No identifying information will be included in publications or presentations resulting 
from this work.   
 
5.10. Data handling and record keeping 
1. The investigator is responsible for maintaining all study records. The investigator is 
responsible for the timeliness, completeness and accuracy of the information in the 
original dataset and the clinical data management system.  
2. HTD/OUCRU-VN staff will enter data into computers, which will upload data 
securely to an Internet-based database.    
3. Laboratory staff will record specimens (and their aliquots), their storage location, 
their shipments using a central commercial database system (Freezerworks). 
4. All necessary tools, instruction, and training will be provided to all site staff involved 
in data entry to ensure the correct and consistent completion database prior to the study 
starting.  
 
5.11. Study records retention 
Data from this study will be entered into an electronic database in password-protected 
computer servers, which will be located in locked rooms. Only investigators or their 
designee(s) will have access to the data, all data will be identified by an individual 
patient identification code and will be anonymous. These data will be stored 
indefinitely. 
 
6. Publication plan 
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Data from this study is of substantial interest to the scientific and clinical research 
communities. Therefore, we aim to publish a number of manuscripts from this work in 
international peer-reviewed journals. Additionally, these data will contribute to the data 
required for Dr Nguyen Phu Huong Lan’s PhD thesis at the Open University UK and a 
number of HTD/OUCRU-VN collaborative MSc projects. As this is a HTD/OUCRU-
VN collaboration then HTD and OUCRU authors will both be recognized in 
predominant authorships, these will be principal investigators.  
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Case report form 
 
Clinical characteristic and epidemiology of Nontyphoidal Salmonella infection in Hospital 
for Tropical Diseases from 2008 to 2013 
 
 DEMO 
Study number:  
[__|__|__] 
 Patient Initials 
[ _ |__|__|__|__] 
 
I. Demographic data: 
 
1. Date of birth: [__|__]/[__|__]/[__|__] (dd/mm/yy)  
2. Hospital number: [_________/____] 
3. Gender:     Male  Female 
4. Ethnics:   Kinh   Other : _______________ 
5. Occupation:   Farmer    Seller   Driver  
 Worker   Officer      
  Unemployed  Other:___________________ 
6. Address:  [_________________________________________] 
7. District: [_________________________________________] 
8. Province/City:  [_________________________________________] 
9. Date of admission:  [__|__]/[__|__]/[__|__] (dd//mm/yy)  
10. Ward of admission:    ICU  Ward E  Ward A    Other….. 
11. Where did the patient live: [_________________________________________] 
12. HIV status:  Yes   No 
If  yes, day of diagnosis: [__|__]/[__|__]/[__|__] (dd/mm/yy) 
13. Hepatitis:  Yes  No 
 Hepatitis B  Hepatitis C   Alcoholic cirrhosis   Other : …….. 
14. Other undelying disease :   Yes   No 
15. If yes :  Diabetes  Cancer  Steroid medication/supression medication 
        Autoimmune disease 
        Other :……………… (please specify) 
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 MEDHIST 
Study number:  
[__|__|__|__|__|__] 
 Patient Initials 
[ _ |__|__|__|__] 
 
 
1. Day of illness : [__|__] 
2. Reason for admission :    
a. Fatigue ............. …   
b. Fever ................    
c. Cough ..............    
d. Anemia ............    
e. Cachexia  .........    
f. Shock ...............    
g. Jaundice ...........    
h. Headache .........    
i. Abdominal enlargement…  
j. Diarrhea ...........    
k. Abdominal pain ……...  
l. Chest pain .. ……...   
m. Dyspnoea ... ……...   
n. Dizziness ... ……...   
o. Confusion .. ….......   
p. Nausea ....... ……...   
q. Anorexia .... ……...   
r. Weightloss . ……...   
s. Cold/Shivery ……...  
t. Other:  ........ ……...   ___________ 
 388 
3. Treatment prior admission :    HIV clinic   
 Liver clinic  
 Private clinic  
 Other hospital    
 Don’t know 
 
4. Receiving ARV:   Yes       No       Don’t know  If yes, time: [__|__] day 
5. Cotrimoxazole medication:   Yes      No       Don’t know 
If yes, time: [__|__] month 
6.   Antibiotic treatment prior admission:    Yes       No      ……………. 
 
7. Risk factors :  
a. Injection drug user ............................  Yes     No 
8. a. CD4: [__|__|__]  b. % CD4: [__|__]  c. CD8: [__|__|__] 
9. Tuberculosis : ………….. Yes   No Time: [__|__]/[__|__]/[__|__] 
10. P.marneffei coinfection: ......  Yes    No Time: [__|__]/[__|__]/[__|__] 
11. C.neoformans coinfection....  Yes    No Time: [__|__]/[__|__]/[__|__] 
12. Dermatomycosis: .................  Yes    No Time: [__|__]/[__|__]/[__|__] 
13. Other:[_____________________________] Time: [__|__]/[__|__]/[__|__]
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 EXAM 
Study number: 
[__|__|__|__|__|__] 
 Patient Initials 
[ _ |__|__|__|__] 
 
1. Blood pressure:[__|__|__]/[__|__],   Pulse: [__|__|__],     Respiratory rate: [__|__],    
Weight: [__|__] kg 
2. Fever:  .....................  Yes   No      Highest temperature: [__|__]  
a. If yes, please specify:    Continuous fever  
      Intermittent fever  
      Mild fever  
      Sometime 
 
3. Habitus: ..................  Normal  Cachexia  Emaciated  Oedema 
4. Anemia:  .................  Yes    No 
a. If yes,  .................  Severe  Moderate  Mild   
5. Skin appearance: .....  Normal  Jaundice  Paleness 
6. Lymph nodes: .........  Armpit  Neck   Poop  Other______ 
7. Respiratory rate:  ....  Normal breath rate   Abnormal 
If abnormal:    Tachypnea  
   Dyspnea   
   Respiratory failure 
    Rale  
 Pleural infusion  
 Pneumothorax   
 Other_______________________________ 
8. Cardiovascular: .......  Normal  Abnormal 
If abnormal, please specify: [____________________________________________________] 
[______________________________________________________________________] 
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9. Digestive system: ...  Normal   Abnormal 
If abnormal, please specify: 
   Hepatomegaly    
 Splenomegaly   
 Ascites   
 Abdominal lymphadenopathy 
   Other__________________________ 
 
10. Central nervous system:  Normal  Abnormal 
  Meningismus  
 Focal neurologic signs ______________________________________________ 
  Other____________________________________________________ 
 
11. Ear throat nose : ......  Normal  Abnormal 
If abnormal, please specify: [___________________________________________________] 
[_______________________________________________________________________] 
 
12. Other signs:  
[_______________________________________________________________________] 
[_______________________________________________________________________] 
[______________________________________________________________________ ] 
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 LAB 
Study number: 
[__|__|__|__|__|__] 
 Patient Initials 
[ _ |__|__|__|__] 
 
1. Hct (Hb):  
a. At admission:  ......... [__|__].[__] % ([__|__].[__] g/dL)  
b. At discharge:........... [__|__].[__] % ([__|__].[__] g/dL) 
 
2. Leukocyte:  .......................... [__|__].[__] K/uL  
 (N[__|__].[__]%   M[__|__].[__]%  E[__|__].[__]%  L[__|__].[__]%) 
 
3. Platelets :  ............................ [__|__|__].[__] K/uL 
4. Creatinin: ............................. [__|__|__] umol/L (Male: 62-120, Female: 53-100 umole/L)  
5. AST:  ................................... [__|__|__].[__] (< 37 U/L).   
6. ALT:  ................................... [__|__|__].[__] (< 40 U/L)   
7. GGT:  ................................... [__|__].[__] (Male: 11-50 U/L, Female: 7-32 U/L) 
8. Electrolyte test:   
a. Na:  ................................ [__|__|__].[__] mmol/L (135-145 mmol/L)  
b. K: .................................. [__].[__] mmol/L (3.5-5 mmol/L)  
c. Ca: ................................. [__].[__] mmol/L (2.15-2.6 mmol/L) 
 
9. Xray chest: Normal 
  Tuberculosis 
 Pneumocystic  
 Pneumonia   
 Pleural infusion  
 Pneumothorax 
   Other_________________________________________  
 
10. Ultrasound:  Hepatomegaly Size:   
 Splenomegaly  
 Ascites  
 Abdominal lymphadenopathy 
    Other_________________________________________ 
 
11. a. CD4: [__|__|__]  b. %CD4: [__|__|__]  c. CD8: [__|__|__] 
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12. Stool direct examination:  Yes   No 
 Erythrocyte …….. 
 Leukocyte ……... 
 Enteric parasites………. 
13. a. Stool culture: ....................  Postive   Negative 
     If positive: .......................  Salmonella spp   Other______________________ 
b. Cultured day:   [__|__]/[__|__]/[__|__]c. Grown day: [__|__]/[__|__]/[__|__] 
d. Identification day: [__|__]/[__|__]/[__|__] 
14. a. Blood culture: 
 Positive  ..........................  
  Coinfection__________________________ 
 
b. Culture day:   [__|__]/[__|__]/[__|__]c. Grown day: [__|__]/[__|__]/[__|__] 
d. Identification day: [__|__]/[__|__]/[__|__] 
e. Serotype: Serology:………………… 
                     MLST type:…………………….. 
15. Antibiotic resistant pattern: 
 AMP AUG AZI CRO C CIP CN NA OFL SXT CAZ ESBL 
Resistant             
Intermediate             
Sensitive             
 
 
16. Other laboratory testing: 
[_______________________________________________________________________] 
[_______________________________________________________________________] 
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 TREAT 
Study number: 
 [__|__|__|__|__|__] 
 Patient Initials 
[ _ |__|__|__|__] 
 
1. Medication 
Medication Dosage From To Note 
Ciprofloxacin [__|__|__] mg/day ____/____/____ ____/____/____  
Ceftriaxone [__|__|__] g/day ____/____/____ ____/____/____  
Amikacin [__|__|__] mg/day ____/____/____ ____/____/____  
Cotrimoxazol [__|__|__|__] mg/day ____/____/____ ____/____/____  
ARV  ____/____/____ ____/____/____  
Other 
……………. 
 ____/____/____ ____/____/____  
 
2. Fluid infusion :   Yes   No 
If yes    Nutrition  Glucose  Saline 
 
3. Blood transfusion :   Yes   No 
4. Other treatment: 
[_______________________________________________________________________] 
5. Diagnosis when discharged: 
 Septicemia by Salmonella  
 Diarrhoeal infection ________________________ 
 Pneumonia ________________________ 
 Other ________________________ 
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 PROGRESSION 
Study number: 
 [__|__|__|__|__|__] 
 Patient Initials 
[ _ |__|__|__|__] 
6. Progression:  Discharge    Improvement   Worsening   
   Death   Nonassessable 
7. Improvement or discharge: 
a. Fever clerance day: .......................... [__|__]/[__|__]/[__|__]  
b. Day of recovery respone: ................. [__|__]/[__|__]/[__|__]  
8. Day of discharge: .................................... [__|__]/[__|__]/[__|__]  
9. Duration of stay:[      ]  
10. Other note : 
 
